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Well we know where we’re going
But we don’t know where we’ve been
And we know what we’re knowing
But we can’t say what we’ve seen
And we’re not little children
And we know what we want
And the future is certain
Give us time to work it out
We’re on a road to nowhere
Come on inside
Taking that ride to nowhere
We’ll take that ride
We're on a road to nowhere
(Talking Heads)
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5Abstract
T cell migration to sites of inflammation is an essential step of an effective immune
response. T cell recruitment is enhanced by the recognition of their cognate antigen
presented by the endothelium and their retention in the tissue is controlled by resident
antigen presenting cells. Vav1 is a guanidine exchange factor for RhoGTPases that is
activated through TCR signalling and is important for the cytoskeletal re-arrangements
occurring during T cell activation and migration. In this study we have investigated the
role of Vav1 in the recruitment and retention of antigen-specific T cells to sites of
inflammation.
HY-specific Ab-restricted WT and Vav1-/- T cells were generated and fully
characterised for specificity and expression of migration-related markers. Vav1-/- T cells
showed defects in adhesion, migration in response to ICAM-1, CXCL12 and CXCL10
and increased migratory speed in in vitro assays. Despite displaying defective motility in
vitro, both constitutive migration and recruitment of Vav1-/- T cells to antigenic sites
occurred normally. However, retention of Vav-1-/- T cells into antigenic tissue was
profoundly impaired. This may be due to the inability by Vav-1-/- T cells to respond to
‘stop’ signals delivered by co-engagement of TCR and CD28. In contrast to recent
reports on wild type T cells, Vav1-/- T cell migration and retention to sites of
inflammation was not affected by engagement of the co-stimulatory molecule CD28,
suggesting that Vav-1 recruitment during CD28-mediated signalling is instrumental for
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Introduction
1. T cell migration
1.1. The multi-step paradigm of lymphocyte migration
From the moment they complete their development and leave the thymus, T cells
constantly traffic in the bloodstream. Naïve T cells circulate in the blood and enter
lymphoid organs such as lymph nodes or spleen, until they encounter antigen and get
activated. Activated effector T cells must then exit the blood and enter peripheral tissues
during the inflammatory response, while memory T cells continue re-circulating between
peripheral tissues and secondary lymphoid organs (reviewed in Choi et al., 2004;
reviewed in Cines et al., 1998; reviewed in Janeway et al., 2001).
The process of exiting the bloodstream through the vascular endothelium is
regulated by several steps, which have been summarised as the “multi-step paradigm” of
lymphocyte migration (Figure 1). More specifically, lymphocytes tether and roll on the
surface of the vascular bed, a process primarily mediated by selectins and some integrins.
Chemokines present on the surface on the endothelium subsequently increase integrin
affinity leading to arrest and tight adhesion to integrins. Finally, T cells cross the
endothelium, in a process known as diapedesis. (reviewed in Cines et al., 1998; (reviewed
in Ebert et al., 2005; reviewed in Garrood et al., 2006).
Regulation of T cell migration by the guanidine exchange factor Vav1
Rachel David
16
Figure 1: The multi-step paradigm of lymphocyte migration
Circulating T cells tether and roll on the surface of the vascular bed in a process
mediated by selectins presented on the endothelium, and some integrins on the T cell (1).
Chemokines presented on the apical surface of the endothelium in conjunction with shear
force mediate integrin conformational changes leading to arrest (2) and firm adhesion
(3). The cell undergoes morphological changes and transmigrates through the
endothelium (4).
1.1.1  Rolling: selectins and their ligands
While lymphocytes are circulating in the bloodstream, they may tether and roll on
the surface of the endothelium, in a process mediated by selectins. This mechanism slows
the migrating lymphocytes down and allows them to initiate contact with the endothelium
(reviewed in Garrood et al., 2006).
Selectins are type I transmembrane glycoproteins that bind to sialytated
carbohydrate moieties (reviewed in Garrood et al., 2006; reviewed in Patel et al., 2002).
They are primarily expressed on microvillus structures on the endothelial cell (EC)
(Bruehl et al., 1996) (Stein et al., 1999), which promotes contact between the EC and the
lymphocyte, thus mediating rolling (Stein et al., 1999).
Three selectins have been described, L-selectin, P-selectin and E-selectin (Table 1).
L-selectin is expressed in most leukocytes and can bind to glycosylation-dependent cell
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adhesion molecule (GlyCAM), mucosal addressin cell adhesion molecule (MadCAM), E-
selectin, CD34 and Sgp200 in the high endothelial venules (HEV) of lymph nodes
(reviewed in Garrood et al., 2006; reviewed in Patel et al., 2002). L-selectin has been
shown to have an important role in lymphocyte migration, particularly in homing to
lymphoid organs (reviewed in Garrood et al., 2006). T cells from L-selectin-deficient
mice show defects in rolling (Arbones et al., 1994), while T cells from mice expressing
low levels of L-selectin also display a similar phenotype, including increased rolling
velocity in vivo (Galkina et al., 2007). In addition, L-selectin is important in the
recruitment of T cells to inflammatory sites (reviewed in Cines et al., 1998), as L-selectin
deficient mice show reduced T cell infiltration to sites of inflammation (Arbones et al.,
1994)
P-selectin is a 140KDa protein expressed in platelets and ECs of inflamed tissues,
where it is stored in granules which allow its effective expression during inflammation
(reviewed in Cines et al., 1998; reviewed in Patel et al., 2002). Its major ligand is P-
selectin glycoprotein ligand-1 (PSGL-1), which is expressed on both myeloid and
lymphoid cells (reviewed in Garrood et al., 2006).
E-selectin is expressed on inflamed endothelium, but unlike P-selectin, it is
transcriptionally activated during the inflammatory response by inflammatory mediators
such as tumour necrosis factor (TNF)-alpha and interleukin (IL)-1 (Bevilacqua et al.,
1987; reviewed in Garrood et al., 2006; reviewed in Patel et al., 2002). Its major ligand is
cutaneous lymphocyte antigen (CLA) in humans and PSGL-1 in mouse, while it can also
bind L-selectin (reviewed in Garrood et al., 2006).
Table 1: Selectins and their ligands
Selectin Ligands
L-selectin (CD62L) GlyCAM, MadCAM, E-selectin, CD34 and
Sgp200
P-selectin PSGL-1
E-selectin CLA, L-selectin
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Other than selectins, activated T cells have also been shown utilise CD44 for entry
into sites of inflammation. The latter can bind to hyaluronate and this interaction has been
found to induce rolling and adhesion (DeGrendele et al., 1997). In addition, vascular
adhesion protein (VAP)-1 has been shown to be important in rolling as well as
transmigration to inflammatory sites and lymphoid tissues (Stolen et al., 2005). Integrins,
which will be discussed in detail later on, are also thought to be involved in rolling on the
vascular endothelium (Janeway et al., 2001).
1.1.2. Arrest: chemokines
Once lymphocytes start rolling on the endothelium, they may succumb to shear
forces of the blood flow and become detached, or they may arrest. This event is
controlled by chemokines (reviewed in Ebert et al., 2005).
Chemokines are small proteins with four conserved cysteins joined by a disulphide
bond. They can be distinguished as CC or CXC chemokines, depending on whether the
cysteins are adjacent or separated by one amino acid (reviewed in Baggiolini, 1998;
reviewed in Ebert et al., 2005). They can also be distinguished functionally to
homeostatic or inflammatory chemokines. The former are constitutively produced
independently of inflammation and are thought to regulate homing to different tissues as
will be explained later on, while the latter are only produced under inflammatory
conditions and are thought to recruit effector T cells during inflammation (reviewed in
Ebert et al., 2005).
Chemokines can be soluble or be presented on the apical surface of the EC,
anchored on glucosaminoglycans (reviewed in Garrood et al., 2006). Once they have
stimulated the T cells by binding to the transmembrane G protein coupled chemokine
receptors, they can induce actin polymerisation and lamellipodia formation which are
important for migration (reviewed in Ebert et al., 2005). In addition, they may increase
integrin avidity by mediating conformational changes, which are necessary for the next
step of transendothelial migration, firm adhesion (reviewed in Baggiolini, 1998).
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1.1.3. Firm adhesion: integrins
Integrins are heterodimeric transmembrane proteins which belong to the integrin
superfamily and can bind to ligands on the surface of cells or to the extracellular matrix.
They consist of a large α chain that pairs non-covalently with a smaller β chain. There
are several sub-families of integrins which are defined based on the β chain. β1 integrins
include very late antigen 1 (VLA-1, α1β1)  and VLA-4 (α4β1), while β2 integrins include
leukocyte associated function antigen (LFA-1, αLβ2) and macrophage receptor 1 (Mac-1
αΜβ2) (reviewed in Janeway et al., 2001).  In lymphocytes, they may exist in high and
low affinity binding states, the latter being induced by chemokine-mediated
conformational changes, thus allowing efficient binding to their ligands (reviewed in
Garrood et al., 2006).
 Integrins may bind to adhesion molecules on the surface of ECs, such as
intracellular adhesion molecules (ICAMs) ICAM-1, ICAM-2 and ICAM-3, all of which
are important in lymphocyte activation and migration and can bind to LFA-1 on the
surface of T cells (reviewed in Janeway et al., 2001) (reviewed in Ebert et al., 2005). The
differential distribution of adhesion molecules that bind distinct integrins on T cells is
thought to regulate their migration to different sites, as will be discussed later on; thus,
adhesion molecules are also sometimes termed vascular addressins as they can direct T
cells to different sites of the body (reviewed in Ebert et al., 2005).
Integrins are activated via “inside-out” signalling. More specifically, upon binding
of the chemokine receptor on the lymphocyte to immobilised ligand, a signalling cascade
is initiated which results in increased integrin avidity and activation (reviewed in Muller,
2002). The latter involves conformational changes or integrin clustering and in turn leads
to binding of the adhesion molecule on the surface on the EC, resulting in firm adhesion
(reviewed in Muller, 2002). Integrins can also initiate “outside-in” signalling pathways,
i.e. internal signalling in response to external stimuli (reviewed in Garrood et al., 2006).
Of the various possible heterodimers, two integrins have been shown to be most
important in T cell migration, namely LFA-1 and VLA-4. The ligands for LFA-1 are
ICAM-1 (CD54), 2 (CD102) and 3 (CD50) (de Fougerolles et al., 1991)(reviewed in
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Janeway et al., 2001), which are cell surface adhesion molecules of the immunoglobulin
superfamily (Hopkins et al., 2004). ICAM-1 is expressed on vascular epithelial cells and
ECs (Dustin et al., 1986), and its expression is upregulated by inflammatory cytokines
such as IL-1 and TNF-a (Henninger et al., 1997) (Hopkins et al., 2004). ICAM-2 is
primarily expressed on the resting endothelium (Lehmann et al., 2003) and is thought to
facilitate lymphocyte transmigration and have a role in angiogenesis, as demonstrated in
studies using ICAM-2 deficient mice (Huang et al., 2005).
ICAM-1 and ICAM-2 are thought to have a redundant role in lymphocyte re-
circulation to lymphoid tissues, as antibody blocking of either ICAM-1 or ICAM-2 did
not affect lymphocyte recirculation, while blocking of both molecules dramatically
diminished entry to the lymph nodes. However, ICAM-1, is thought to be more important
in migration to sites of inflammation, as antibody blocking of ICAM-1 alone resulted in
dramatic decrease in migration to inflamed skin in vivo, which was not observed with
antibody blocking of ICAM-2 (Lehmann et al., 2003).
Furthermore, the ligand for VLA-4 is vascular cell adhesion molecule 1 (VCAM-1,
CD106). It is expressed at lower levels than ICAM-1 but follows similar activation
kinetics in inflammation (Henninger et al., 1997) and has been involved in several
inflammatory diseases such as inflammatory bowel disease, atherosclerosis and asthma
(reviewed in Cook-Mills, 2002).  Other than VLA-4, it can also bind to other adhesion
molecules such as α4β7, whose importance in T cell homing will be discussed in detail in
chapter 1.3.2 (reviewed in Garrood et al., 2006).
The role of both LFA-1 and VLA-4 in transendothelial migration has been
extensively demonstrated. Antibody blocking of LFA-1 led to 80% inhibition of
transmigration (Schreiber et al., 2007)  while antibody blocking of VLA-4 also
significantly reduced transmigration (Pryce et al., 1997). In addition, ICAM-1 and VLA-
4 presented on the apical surface of the endothelium have been shown to cluster with
actin-rich structures and form a major docking structure in vitro, thus facilitating
lymphocyte transmigration (Barreiro et al., 2002).
Integrin activation and firm adhesion to the endothelium brings the re-circulating
lymphocyte to a stop and allows for diapedesis to occur.
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1.1.4. Cell polarisation
An essential part of lymphocyte transendothelial migration is polarisation of the
migrating cell. The latter is the result of a change in the distribution of filamentous actin
which alters the normally spherical shape of the cell into a polarised one and is mediated
by chemokines. Polarisation may occur during a variety of cell-to-cell interactions, such
as antigen presentation as well as interaction with the endothelium (reviewed in Sanchez-
Madrid and del Pozo, 1999).
As the cell polarises, two distinct parts are established, the leading edge and the
uropod/trailing edge (del Pozo et al., 1995). The former is characterised by the presence
of chemokine receptors and integrins in the active conformation, while the latter is
primarily enriched with adhesion receptors, suggesting that the leading edge is involved
in chemotaxis and the uropod with adhesion and de-adhesion of the cell, as well as
recruitment of other lymphocytes (reviewed in Sanchez-Madrid and del Pozo, 1999).
Lipid rafts, which are cholesterol–rich structures that facilitate signalling (reviewed in
Katzav, 2004) are thought to be fundamental in establishing cell polarity, as cholesterol
depletion abolished the formation of both the leading edge and the uropod (Gomez-
Mouton et al., 2001).
In migrating lymphocytes, actin is re-distributed throughout the cell, and is mostly
concentrated at the leading edge. An abundance of receptors can also be found at this part
of the cell, such as integrins, urokinase plasminogen activator receptor and chemokine
receptors (reviewed in Sanchez-Madrid and del Pozo, 1999), as well as the ganglioside
lipid-raft associated protein GM3 (Gomez-Mouton et al., 2001). It is thus thought that the
leading edge, as the name suggest, directs migration of the cell, primarily mediated by the
chemokine receptors (Fais and Malorni, 2003).
The uropod is characterised by the presence of intracellular adhesion molecules
such as CD2, CD44, CD43, as well as PSGL-1 and L-selectin (del Pozo et al., 1995;
reviewed in Sanchez-Madrid and del Pozo, 1999). The ganglioside lipid raft associated
protein GM1 has also been found to localise the uropod (Gomez-Mouton et al., 2001).
Uropod formation is induced through triggering by adhesion molecules, such as ICAM-1,
3 and VCAM-1, as well as chemokines, such as CCL5 and monocyte chemottactic
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protein (MCP)-1. In fact, distinct chemokines can stimulate uropod formation in different
T cell subsets, for example macrophage inflammatory protein (MIP-)1α in CD4+ T cells
and MIP-1β in CD8+ T cells (del Pozo et al., 1995).
In terms of function, the uropod is thought to mediate contact with the ECs and the
extracellular matrix via the adhesion molecules that accumulate in this part of the cell
(reviewed in Sanchez-Madrid and del Pozo, 1999). In addition, the uropod has also been
found to be important for the contact between polarised T cells, in an interaction
mediated by ICAM-1,3 and LFA-1 (del Pozo et al., 1997).
Cell polarisation requires cytoskeletal re-organisation, which is mediated by
intracellular pathways such as phosphoinositide (PI) 3 kinase and Rho guanosine
triphosphate (GTP)ases (reviewed in del Pozo et al., 1995; Sanchez-Madrid and del Pozo,
1999). The importance of these pathways will be discussed in detail later on.
1.1.5. Diapedesis
Diapedesis is possibly the least understood step of lymphocyte migration. Although
traditionally lymphocytes have been thought to transmigrate between the EC junctions,
termed paracellular route, recent evidence has shown that they can also migrate through
the EC itself, known as transcellular route (reviewed in Engelhardt and Wolburg, 2004).
In the paracellular route, lymphocytes are thought to pass between the ECs,
transiently replacing the molecules in the tight junctions. Molecules that are thought to be
important in this process include CD31, CD99, VE-cadherin, ICAM-1, and junction
adhesion molecules (JAMs) (reviewed in Engelhardt and Wolburg, 2004; reviewed in
Garrood et al., 2006; reviewed in Muller, 2002). Of these molecules, CD31 has been
studied in great detail. It is a member of the immunoglobulin superfamily, and is
expressed in both ECs and haemopoetic cells. It is thought to form homophilic
interactions between the T cell and the EC, thus facilitating migration. Its importance in
diapedesis has been demonstrated in vitro as antibody blocking prevented the migration
of monocytes and neutrophils (Muller et al., 1993). This effect has also been observed in
vivo, as injection of a blocking antibody prevented leukocyte accumulation on to the sites
of inflammation (Bogen et al., 1994; Muller, 2003). However, leukocytes can still
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transmigrate to some extent in CD31-deficient mice, suggesting that other mechanisms
compensate for the loss of CD31 (Duncan et al., 1999).
CD99 is expressed on the surface of most leukocytes and is found concentrated at
the borders between confluent ECs. It is thought to be a co-stimulatory molecule, and
recently has been shown to have a role in migration. As with CD31, it forms homophilic
interactions between the migrating leukocyte and the EC (Muller, 2003). Antibody
blocking experiments resulted in dramatic decrease in transendothelial migration of
monocytes in vitro (Schenkel et al., 2002). Interestingly, blocking of both CD99 and
CD31 had an additive effect in inhibition of migration, suggesting that the two molecules
control different aspects of diapedesis (Schenkel et al., 2002).
VE-cadherin is located at the junctions between ECs. It is a member of the cadherin
superfamily and is thought to be important for permeability as blocking antibodies result
in increased permeability of ECs (Muller, 2003).
The JAMs (JAM A, B, C) belong to the immunoglobulin superfamily and are
expressed on leukocytes and ECs. As with CD99 and CD31, JAMs are capable of
homophilic interactions, although recent evidence suggests that they also interact with
integrins on the surface of the migrating leukocyte (Muller, 2003). JAM A has been
found to engage LFA-1 and thus control T cell transendothelial migration through the
tight junctions. JAM B can interact with JAM C and VLA-4 while JAM C can interact
with Mac –1 (reviewed in Engelhardt and Wolburg, 2004). Binding of the JAM proteins
to lymphocyte integrins suggests a promising role in lymphocyte migration.
The importance of ICAM-1 in lymphocyte migration has already been highlighted.
Briefly, ICAM-1, the ligand for LFA-1, is thought to form a docking structure with
VCAM-1 on the surface of the EC, thus facilitating migration (Barreiro et al., 2002). In
addition, a recent study using human umbilical cord ECs and Chinese hamster ovary cells
expressing ICAM-1 showed that engagement of ICAM-1 by LFA-1 resulted in the
formation of actin-rich projections. The latter surrounded the leukocytes and based on the
time-scale they occurred, were thought to have a role in diapedesis (Carman et al., 2003).
Millan et al. (2006) also observed that translocation of ICAM-1 to F-actin and caveaolin-
1- rich areas of the endothelium resulted in transendothelial migration of human T cells,
further confirming the importance of this molecule in diapedesis.
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Other than the paracellular route of migration, research has also extensively focused
on the transcellular route, i.e. migration through the ECs. The transcellular route was
initially discovered in migration through the blood brain barrier and into the central
nervous system (CNS) in mouse models of experimental autoimmune encephalomyelitis
(EAE) and experimental autoimmune uveitis (EAU) (Engelhardt and Wolburg, 2004;
Greenwood et al., 1994; McMenamin et al., 1992; Raine et al., 1990). However, this
phenomenon is not isolated to the CNS; neutrophils were found to cross the endothelial
monolayer of the skin through the transcellular route as well in guinea pigs injected with
their natural ligand, the chemoattractant N-formyl-methionylleucyl-phenylalanine (fLMP)
(Feng et al., 1998).
It is thus thought that, although the paracellular route is probably the main route of
transendothelial migration, under certain circumstances and possibly limited to certain
tissues, the transcellular route is also possible (reviewed in Engelhardt and Wolburg,
2004).
1.2. Shear force in lymphocyte migration
Under physiological conditions, lymphocyte migration does not happen under static
conditions; shear force is constantly applied by the blood to the migrating lymphocyte.
Although traditionally a largely ignored subject, it has become clear that shear force
directly influences the different aspects of lymphocyte transendothelial migration.
As mentioned earlier, chemokines mediate integrin conformational changes,
allowing the lymphocyte to tightly adhere to the endothelium and subsequently
transmigrate (Baggiolini, 1998). In vitro studies have shown that chemokines presented
on the apical surface of the cytokine-treated human endothelium trigger rapid
transendothelial migration of human lymphocytes in the presence of shear flow (Cinamon
et al., 2001; Schreiber et al., 2007). This effect was not observed under static conditions,
suggesting that flow directly affects this interaction (Schreiber et al., 2007).
Using in vitro video miscoscopy, a recent study using human peripheral blood
lymphocytes has shown that lymph node chemokines, such as CCL21, induce integrin
adhesiveness in conditions of shear force alone. Interestingly, in the absence of shear
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force, CCL21 failed to trigger the activation of LFA-1 in T cells (Woolf et al., 2007).
Therefore, it has been suggested that shear forces facilitate integrin signalling induced by
chemokines, which allow for integrin conformational changes that result in adhesion to
their ligands and lymphocyte transmigration (reviewed in Alon and Dustin, 2007).
Finally, some studies suggest that diapedesis can occur in the presence of
continuous shear force alone; human lymphocytes were able to transmigrate in vitro
following antibody blocking of LFA-1 and VLA-4 (Cinamon et al., 2001).
1.3. The concept of T cell homing
T cells do not migrate randomly; the expression of tissue-selective receptors
(termed homing receptors), including integrins and chemokine receptors direct them to
specific peripheral tissues. In addition, ECs express distinct adhesion molecules in
different tissues (termed vascular addressins), which can also allow T cells to home to
specific peripheral tissues.
Studies have demonstrated different homing potentials for different T cell subsets.
Naïve T cells preferentially migrate from the blood to lymphoid organs via HEV where
they may encounter antigen and become activated (see Figure 1) (Mackay et al., 1990;
reviewed in Mora and von Andrian, 2006). In contrast, memory T cells have been shown
to preferentially migrate from the blood to peripheral non-lymphoid tissues and then to
lymphoid organs via the afferent lymphatic system (Mackay et al., 1990).
Memory T cells can be further subdivided based on their homing potential to
central memory and effector memory T cells. The former express molecules such as
CCR7 and preferential migrate to lymphoid organs such as peripheral lymph nodes,
mesenteric lymph nodes and Peyer’s patches, as well as spleen, where they can activate
antigen presenting cells (APCs) such as B cells and dendritic cells (DCs) (Sallusto et al.,
1999; Weninger et al., 2001).  In addition, unlike naïve T cells, central memory T cells
have been found to utilise a second peripheral lymph node homing pathway in the
absence of the CCR7 ligands CCL19 and CCL21, which is dependant on CXCL12
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(Scimone et al., 2004). Central memory T cells have also been found to migrate more
efficiently to the bone marrow compared to the other subsets (Mazo et al., 2005).
Effector memory T cells on the other hand do not express CCR7, and thus cannot
respond to CCL21 and CCL19, which are primarily expressed on stromal cells of
lymphoid tissues. They have in fact been shown to preferentially migrate to sites of
inflammation, where they can mediate further inflammation and cytotoxicity (Sallusto et
al., 1999; Weninger et al., 2001).
In terms of cytolytic function, IFNγ production was initially thought to be restricted
in CD8+ effector memory T cells in response to DCs pulsed with bacterial superantigen
(Sallusto et al., 1999). However, this has recently been contested, as both CCR7+ and
CCR7– T cells were found to be able to display cytotoxic activity in response to viral
infection (Unsoeld et al., 2002).
As mentioned earlier, ECs can also regulate migration. This is due to the expression
of distinctive adhesion molecules by ECs from different tissues, such as MadCAM in
HEV of Peyer’s patches (reviewed in Cines et al., 1998; Hillyer et al., 2003). In addition,
ECs have been shown to produce different chemokines in different tissues, thus directing
lymphocyte trafficking (reviewed in Baggiolini, 1998; Hillyer et al., 2003). They also
contribute to lymphocyte compartmentalisation within lymphoid tissues by secreting
chemokines that direct T cells to different anatomical sites, for example CXCR5 which
directs T cells to the germinal centre of lymph nodes (reviewed in Baggiolini, 1998).
The homing potential of T cells based on the expression of adhesion molecules and
chemokines receptors will be discussed in detail and are summarised in Table 2.
1.3.1 Homing to the lymph nodes
Naïve T cells trafficking in the blood can enter the lymph nodes via the HEV. This
process follows the afore mentioned “multi-step paradigm” of lymphocyte  migration and
is tightly controlled by chemokines. The two chemokines that have been shown to be
essential for entry to the lymph nodes are CCL19 and CCL21, both of which can bind to
the chemokine receptor CCR7 (reviewed in Ebert et al., 2005)
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CCR7 is primarily expressed by naïve T cells as well as central memory T cells,
which retain the ability to migrate to the lymph nodes (reviewed in Ebert et al., 2005).
The importance of CCR7 for homing to the lymph nodes was demonstrated in
experiments using CCR7-deficient mice, which showed severe morphological alterations
to their secondary lymphoid organs, primarily due to the lack of T cells (Forster et al.,
1999). In addition, in a study using plt mice, which lack expression of the chemokines
CCL19 and CCL21, homing to the mesenteric lymph nodes by adoptively transferred T
cells was abolished (Okada et al., 2002).
Furthermore, the study by Okada et al. (2002) also demonstrated a role for CXCR4
in the migration of T cells to the lymph nodes. Using the plt mice, they showed that in the
absence of CCR7 ligation by CCL19 or CCL21, some cells still migrate to the lymph
nodes, and this is abolished in CXCR4-deficient mice (Okada et al., 2002). A more recent
study suggested that CXCL12, the ligand for CXCR4 might contribute to the migration of
central memory T cells, as antibody blockade of the former reduced central memory T
cell homing to peripheral lymph nodes (Scimone et al., 2004).
L-selectin has also been shown to be involved in T cell homing to the lymph nodes.
L-selectin is expressed by naïve T cells, and is though to be downregulated during the
transition to memory phenotype (reviewed in Picker et al., 1993). Its importance in
homing to the lymph nodes was demonstrated in L-selectin-deficient mice, which showed
reduction in migration to all lymphoid organs as well as spleen (Arbones et al., 1994). In
addition, a study by Galkina et al. (2007) showed that reduced expression of L-selectin
correlated with reduced homing to the lymph nodes (Galkina et al., 2007).
Due to the lack of expression of other chemokine receptors, naïve T cells are naïve
in migration potential, as homing is restricted to lymphoid tissue. It is thus thought that T
cell priming allows activated T cells to gain homing receptors to different peripheral
tissues, depending on the lymph node they get activated in, as will be explained later on
(reviewed in Ebert et al., 2005).
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1.3.2 Homing to the gut
Memory T cells can acquire homing receptors that direct them to the intestinal
immune system when activated at the mesenteric lymph nodes or Peyer’s patches
(Stenstad et al., 2006). A distinctive feature of gut-tropic T cells is the acquisition of the
chemokine receptor CCR9.  The ligand for the latter is CCL25/ thymus-expressed
chemokine (TECK), which is expressed in the small intestine, thus suggesting its
importance in migration to gut (reviewed in Ebert et al., 2005; Kunkel et al., 2000; Zabel
et al., 1999).  Studies using CCR9-deficient T cells show that these T cells are
significantly disadvantaged at localising to the intestine (Stenstad et al., 2006).  In
addition, a study by Svensson et al. (2002) directly showed that CCR9+ T cells localise to
the small intestine, and antibody blocking of TECK prevents their homing(Svensson et
al., 2002). However, Stenstad et al. (2002) have suggested that there are CCR9-
independent mechanisms for entering the lamina propria of the gut, as they still find some
T cells in this part of the body in CCR9-deficient mice, which also display a distinct array
of chemokine receptors to the lamina propria homing CCR9+ T cells.
In addition to CCR9, α4β7 integrin has been found to be important in homing to
mucosal tissues (Abitorabi et al., 1996; Campbell and Butcher, 2002; Hamann et al.,
1994; Schweighoffer et al., 1993). α4β7 integrin preferentially binds to MadCAM1, which
is a tissue-specific vascular addressin for mucosal ECs (Nakache et al., 1989; Streeter et
al., 1988), and VCAM-1, but the latter with less affinity (Berlin et al., 1993; Pachynski et
al., 1998; Rott et al., 1996).
Studies with α4 or β7 deficient mice have demonstrated their importance in T cell
gut homing; α4−deficient mice have no Peyer’s patches (Arroyo et al., 2000), while β7 -
deficient mice show hypoplasia in their gut-assosiated lymphoid tissue, particularly the
Peyer’s patches, due to reduced lymphocyte adhesion on the HEV, but with surprisingly
normal architecture (Wagner et al., 1996). In addition, antibodies to α4β7 integrin have
been shown to improve chronic colitis in tamarins (Hesterberg et al., 1996), suggesting
that they block T cell migration to the intestine. The complete α4β7 integrin heterodimer
is thought to be required for homing to the gut, as α4β1 preferentially binds to VCAM-1
(Berlin et al., 1993; Rott et al., 1996). α4β7 integrin-positive T cells have been shown to
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be generated in the intestinal lymphoid tissues (Campbell and Butcher, 2002) and express
CCR9 (Svensson et al., 2002).
Finally, ICAM-1 and P-selectin have both been found to be important in the
development of the intestinal immune system. ICAM-1 and P-selectin-deficient mice
have fewer T cells in the intraepithelial lymphocyte compartment, lamina propria and the
Payer’s patches (Huleatt and Lefrancois, 1996; Steinhoff et al., 1998), implying a role for
the two molecules in T cell migration to the gut.
1.3.3 Homing to cutaneous tissues
T cells can acquire skin homing receptors when activated in cutaneous lymphoid
tissue (Picker et al., 1993). One of the most extensively studied molecules is CLA, which
is the ligand for E-selectin (reviewed in Berg et al., 1991; Garrood et al., 2006) and is
generated by post-translational carbohydrate modification of PSGL-1 in humans
(Fuhlbrigge et al., 1997). Its importance in skin homing was first described by Picker
(1990), who observed that human lymphocytes in inflammatory skin lesion specimens
preferentially expressed an epitope (later named CLA) that reacted to the HECA-451
antibody (Picker et al., 1990). Furthermore, in studies examining patients with psoriatic
arthitis, Pitzalis et al. (1996) observed that despite the presence of inflammatory lesions
in both skin and joint, CLA+ T cells preferentially migrated to the skin, thus confirming
its importance in homing to cutaneous tissues (Pitzalis et al., 1996).
Most CLA+ skin-homing T cells have been shown to express the chemokine
receptor CCR4. The ligand to the latter is thymus and activation-related chemokine
(TARC)/CCL17, which preferentially induces adhesion to the dermal endothelium
(Campbell et al., 1999). CD4+ T cells in skin lesions of patients with psoriasis have been
found to express high levels of CCR4, and patients with cutaneous subtypes of system
lupus erythromatosus express higher levels of TARC/CCL17 in the skin that healthy
controls (Wenzel et al., 2005). However, a study examining the effects of different routes
of immunisation in T cell homing in mice observed that CCR4 was not solely expressed
by T cells generated through intracutaneous immunisation, and was in fact transiently
expressed in activated T cells independently of the immunisation route. This study
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suggests that CCR4 is probably not an exclusive marker for skin homing (Dudda et al.,
2004).
Finally, CCR10 has also been shown to be expressed by most skin infiltrating T
cells (reviewed in Garrood et al., 2006; Homey et al., 2002). The ligand for CCR10 is
CCL27, whose intracutaneous injections in mice has been shown to attract T cells to the
skin, while, more importantly, it is constitutively produced by epidermal keratinocytes
(Homey et al., 2002).
1.3.4 Homing to sites of inflammation
Although evidence of the existence of homing receptors to other bodily sites is
poorly understood, other molecules have been suggested which may play a role in the
migration of T cells to distinct peripheral tissues. One example is VAP-1 which was first
described by Salmi et al. (1992) as an EC marker, and whose expression in HEV is
upregulated in inflammatory conditions (Salmi and Jalkanen, 1992) (Salmi et al., 1993).
Interestingly, a blocking antibody to VAP-1 was shown to affect T cell adhesion to the
hepatic endothelium, suggesting that it may play a role in T cell recruitment to the liver
(McNab et al., 1996). A circulating form of VAP-1 was also found to be higher in
inflammatory liver diseases and alcohol liver disease in particular, compared to colitis or
rheumatoid arthritis (Kurkijarvi et al., 1998). In addition to VAP-1, recruitment to the
liver is thought to require LFA-1, CCR5, which is involved in recruitment to portal tracts
and CXCR3, which is important in recruitment to the hepatic parenchyma (Grant et al.,
2002).
Several chemokine receptors have been implicated in the migration of T cells to the
inflamed CNS. More specifically, in mouse models of EAE, T cells crossing the
blood/brain barrier have been shown to express CCR7 and CXCR3 (Alt et al., 2002;
Columba-Cabezas et al., 2003). As mentioned earlier, the ligands for CCR7 are CCL21
and CCL19, while CXCR3 can act as an alternative receptor. The two chemokines have
been shown to be produced at high levels at the blood brain barrier in EAE, suggesting
some involvement in T cell migration to the inflamed CNS (Alt et al., 2002). Moreover,
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T cells from patients with inflammatory CNS conditions such as multiple sclerosis also
express CCR7 and CXCR3, along with CCR5 (Giunti et al., 2003).
In addition to inflammatory CNS conditions, CXCR3 has been shown to be
involved in the recruitment of T cells to sites of inflammation. T cells expressing CXCR3
have high homing potential to inflammatory sites (Qin et al., 1998), while it has also been
involved in allergic rhinitis (Francis et al., 2007). Furthermore, CXCR3-deficient mice
showed reduced cardiac allograft rejection, which a CXCR3 blocking antibody prolonged
cardiac allograft survival in wild type mice, suggesting that this chemokine receptor is
important in transplantation (Hancock et al., 2000).
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Table 2: Summary of homing receptors guiding T cells to different tissues
Tissue Receptor Ligand Comments Reference
CCR7 CCL19/CCL21 Expressed by naïve and
central memory T cells
CXCR4 CXCL12 Utilised by central
memory T cells
Forster, 1999;
Okada, 2002,
Scimone, 2004
Lymph nodes
L-selectin GlyCAM,
MadCAM,E-selectin,
CD34 and Sgp200
Expressed by naïve T
cells
Picker, 1993;
Arbone, 1994;
Galkina, 2007
CCR9 CCL25 CCR9 independent
mechanisms for entry to
lamina propria
(reviewed in
Ebert., 2005;
Kunkel 2000;
Zabel 1999)
α4β7 MadCAM1 Complete heterodimer
required for homing to
the gut
Schweighoffer,
1993; Hamann.,
1994; Abitorabi,
1996;  Wagner,
1996; Arroyo,
2000
ICAM-1 LFA-1 Deficient mice have
fewer cells in the gut
Huleatt and
Lefrancois, 1996
Gut
P-selectin PSGL-1 Deficient mice have
fewer cells in the gut
Steinhoff., 1998
CLA E-selectin Glycosylation variant of
PGSL-1
Picker, 1990;
Berg., 1991;
Pitzalis, 1996;
CCR4 CCL17 Probably not an
exclusive skin homing
marker
Campbell, 1999;
Skin
CCR10 CCL27 Intracutaneous injection
of ligand attracts T cells
Homey, 2002
VAP-1 unknown Probably involved in
migration to the
inflamed liver
Salmi, 1993;
McNab, 1996;
Kurkijarvi, 1998
Sites of
inflammation
CXCR3 CXCL10 Involved in migration
during inflammatory
liver disease,
inflammatory CNS
disease, allergic rhinitis,
transplantation
Qin, 1998;
Hancock, 2000;
Alt, 2002;,
Guinti, 2003;
Francis, 2007
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1.4. A role for dendritic cells in T cell homing
So how do T cells acquire homing receptors that direct them to peripheral tissues?
It has already been hinted that the location of the lymphoid tissue where antigen
stimulation occurred has an essential role in imprinting T cells with an “area code” that
directs them to different parts of the body. T cells stimulated in the cutaneous-associated
lymphoid tissue express higher levels of CLA (Picker et al., 1993), while those
encountering antigen in intestinal lymphoid tissue acquire α4β7 (Campbell and Butcher,
2002). It is thus reasonable to suggest that the lymphoid microenvironment, including
resident APCs such as DCs, will have a role in the acquisition of homing receptors.
Interestingly, a study by Dudda et al. (2004) demonstrated that the immunisation
route defines the homing potential of T cells. They observed that intracutaneous
immunisation of DCs elicited a strong ear-swelling response, with the T cells from the
auricular lymph node expressing high levels of CCR4 and E-selectin. In contrast,
intraperitoneal immunisation resulted in the generation of α4β7-expressing gut-homing T
cells. It is interesting to note that intravenous immunisation did not elicit any particular
response, probably because it did not target a specific lymphoid tissue.
Indeed DCs have been found to contribute to gut-specific imprinting of T cells, i.e.
the acquisition of homing receptors allowing the T cells to migrate to the gut. Co-culture
of murine T cells and DCs from the gut-associated lymphoid tissue, including mesenteric
lymph nodes and Peyer’s patches, have been shown elicit higher T cell expression of α4β7
and CCR9 in vitro (Johansson-Lindbom et al., 2003; Mora et al., 2003; Mora et al.,
2005). In addition, murine T cells stimulated by gut-associated lymphoid tissue DCs
migrated better towards TECK and downregulated the expression of L-selectin
(Johansson-Lindbom et al., 2003; Mora et al., 2003). Interestingly, once these T cells
were adoptively transferred they migrated to the lamina propria and the intraepithelial
lymphoid compartment of the gut, but not the colon, suggesting that different homing
receptors exist for distinct parts of the gut (Mora et al., 2003)
DCs have also been shown to contribute to skin-specific imprinting of T cells.
Studies have shown that murine T cells stimulated by DCs from peripheral lymph nodes
expressed higher levels of P and E-selectin and had higher levels of mRNA of the
Regulation of T cell migration by the guanidine exchange factor Vav1
Rachel David
34
enzyme required for post-translational modification of PSGL-1. In addition, they
expressed higher levels of CCR4 and migrated more efficiently to the inflamed skin when
adoptively transferred (Mora et al., 2005).
The exact mechanism of imprinting is unclear, although Iwata et al (2004) observed
an interesting effect when analysing vitamin A-deficient mice. Retinoic acid, a vitamin A
metabolite, was found to induce α4β7 and CCR9 expression in vitro, while at the same
time downregulating CCR4 expression. In addition, vitamin A-deficient mice showed a
reduction of α4β7 + T cells as well as depletion of T cells from the lamina propria of the
gut. DCs from the gut associated lymphoid tissue seem to express high levels of retinoic
acid, and consequently may be able to induce a gut homing phenotype in T cells (Iwata et
al., 2004; Mora et al., 2005).
In addition to this, Sigmundsdottir et al. (2007) recently observed that vitamin D3
has a similar effect on the imprinting of skin homing T cells. More specifically, the
metabolite of vitamin D3, 1,25(OH)2D3 was found to signal T cells to express the skin-
homing CCR10 and suppress the gut-homing a4β7 and CCR9. More excitingly, they
observed that DCs isolated from skin-draining lymph nodes were able to convert vitamin
D3 to 1,25(OH)2D3 in vitro, suggesting that DCs from skin-associated lymphoid tissue
can induce a skin-homing phenotype in T cells (Sigmundsdottir et al., 2007)
Finally, it is important to note that the T cell homing phenotype was found to be
reversible by Mora et al. (2005). When Peyer’s patches-activated murine T cells were re-
stimulated with peripheral lymph node DCs, they gained selectin ligand expression, while
peripheral lymph node-activated T cells re-stimulated with Peyer’s patches DCs can
acquire α4β7 expression. In addition, adoptive transfer of vesicular stomatis virus-
specific, non-gut tropic, non-β7-expressing T cells into mice infected with the virus
induced up-regulation of β7 integrin expression as well as migration to mucosal tissues,
suggesting that T cells can be “re-educated” to migrate to different parts of the body
depending on the challenge (Masopust et al., 2004; reviewed in Mora and von Andrian,
2006).
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1.5. Exit from peripheral tissues
Although extensive studies have been done to identify how T cells enter peripheral
tissues, their exit has been largely ignored. Traditionally, exit from peripheral tissues and
entry to the afferent lymphatics was not thought to utilise specific molecular mechanisms,
however recent evidence suggests that the chemokine receptor CCR7 is involved. More
specifically, CCR7 has been implicated in the T cell exit from the skin, as T cells from
CCR7-deficient mice, which were adoptively transferred to wild type mice by footpad
injection were unable to reach the draining lymph nodes. In addition, cannulation of the
skin-draining afferant lymphatics of sheep indicated that present T cells expressed
functional CCR7 (Debes et al., 2005) .
CCR7 has also been implicated in T cell exit from the lung. CCR7-deficient T cells
were found to accumulate in the lung after challenge with aerosolised antigen. In
addition, adoptively transferred transgenic T cells expressing CCR7 in higher levels than
the wild type were found in lower numbers in the lung after re-challenge with aerosolised
antigen and were primarily accumulating in the draining mediastinal lymph nodes
(Bromley et al., 2005).
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2. Regulation of T cell migration by the TCR and co-stimulatory
molecules
2.1. TCR-dependent control of T cell migration
Homing receptors, such as α4β7, confer some level of specificity to T cell migration
to tissues such as the gut. However, patrolling the latter, which can be up to 6 meters long
in adult humans, would be a very inefficient way of finding their cognate antigen. It has
therefore been hypothesised that additional mechanisms operate, which allow the T cell
to localise its cognate antigen in the tissue. Indeed, evidence suggests that the
endothelium may present antigen to T cells, therefore regulating antigen-specific T cell
migration.
2.1.1 Functional consequences of antigen presentation
ECs have been shown to express Major Histocompatibility Complex (MHC)
molecules, but expression differs between species; human ECs express both MHC class I
and II while murine one only express class I, but can be induced to express class II upon
interferon (IFN) gamma activation (reviewed in Choi et al., 2004; Haraldsen et al., 1998;
Savage et al., 1995). Expression has been shown to differ between tissues as well, with
non-lymphoid vascular ECs having the highest expression (reviewed in Choi et al.,
2004). In addition to expressing MHC molecules, ECs have in fact been found to be able
to present antigen to T cells (Bagai et al., 2005; Greening et al., 2003; Haraldsen et al.,
1998; Murray et al., 1994; Savage et al., 1995), and this is thought to be in a proteasome
dependent, transporter for antigen presentation (TAP) –dependent manner (Bagai et al.,
2005).
Other than T cell receptor (TCR) stimulation in the context of MHC, T cells require
an additional signal in order to become activated and not become anergic. This is
normally delivered by the co-stimulatory molecules CD80 and CD86, which can activate
CD28 on the surface of the T cell (reviewed in Choi et al., 2004; reviewed in Janeway et
al., 2001). In addition to CD80/CD86 and CD28 mediated co-stimulation, other
molecules such as inducible co-stimulatory molecule (ICOS) and OX40, which bind to
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the ICOS and OX40 ligands respectively, have also been shown to provide co-stimulatory
signals for T cells (reviewed in Lane, 2000; reviewed in Rudd and Schneider, 2003).
Expression of co-stimulatory molecules by ECs has been shown to differ between
species, with human ECs lacking expression of both CD80 and CD86 and murine ones
having low expression of CD80 (Marelli-Berg et al., 2001a; reviewed in Marelli-Berg
and Jarmin, 2004). Other co-stimulatory molecules, such as ICOS-L (Khayyamian et al.,
2002) and programmed cell death (PD)-1 (Eppihimer et al., 2002) have been shown to be
constitutively expressed in human ECs, and in conjuction with adhesion molecules are
thought to partially compensate for the lack of CD80/CD86 and prevent anergy induction
upon antigen presentation by the endothelium (reviewed in Marelli-Berg and Jarmin,
2004).
The functional consequences of antigen presentation to T cells differ significantly
depending on the context it occurs (Figure 2, Table  3). Evidence suggests that
engagement of the TCR, as occurs with DCs, results in loss of migratory ability, allowing
the T cell to polarise to the APC and proliferate (Dustin et al., 1997). Antigen
presentation by ECs does not result in proliferation in the absence of cytokines (Lodge
and Haisch, 1993; Pardi and Bender, 1991) and in fact has been shown to increase
migration (Marelli-Berg et al., 2000), while presentation by epithelial cells results in
anergy induction and loss of migratory ability (Marelli-Berg et al., 2001a).
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Figure 2: Effects of antigen presentation on T cell migration and activation
The effects of antigen presentation on T cell migration differ depending on the context it
occurs. Low-avidity antigen presentation by ECs results in enhanced migration to target
tissue (1). High-avidity antigen presentation by professional APCs such as DCs (2) or by
antibody stimulation (3) delivers a stop signal to the migrating T cell (4), which allows it
to proliferate (5).
Table 3: Functional consequences of antigen presentation
APC Effect on T cell  Reference
DC Stop signal
Polarisation and proliferation
(Dustin et al., 1997)
EC Increased migration (Lodge and Haisch, 1993;
Pardi and Bender, 1991)
(Marelli-Berg et al., 2000)
Epithelial cell Loss of migratory ability
Anergy
(Marelli-Berg et al., 2001a).
 Indeed, Dustin et al. (1997) showed that engagement of the TCR in murine T cells
in vitro by peptide and IL-2 increased adhesion to ICAM-1 and delivered a stop signal to
T cells, allowing them to re-polarise their microtubule organising centre from the uropod
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to the contact areas (Dustin et al., 1997). Similar results were obtained in a study using
murine CD4+ T cells, where antibody engagement of the TCR and CD28 abrogated
migration in vitro (Berg et al., 2002). Loading of external cognate antigen on the
endothelium has also been shown to result in loss of migratory ability of CD8+ T cells in
vitro, suggesting that the avidity of the signal is important in determining the effect on T
cell motility (Marelli-Berg et al., 2001b).
2.2. ECs can recruit T cells to sites of inflammation
The ability of ECs to influence T cell recruitment has been observed in vitro in a
study using CD4+ memory T cells. Recognition of antigen presented by the ECs resulted
in two-fold increase of migration through human ECs (Marelli-Berg et al., 1999). In
addition to this, CD8+ T cell clones were found to migrate more through murine IFNγ-
treated ECs, i.e. those induced to upregulate MHC class I expression, than resting ones in
vitro (Marelli-Berg et al., 2000).
In line with these observations came a study by Greening et al. (2003) using human
T cells and ECs. IFNγ treated glutamic acid decarboxylase (GAD) -pulsed ECs were
found to increase the migration of GAD-specific T cells in vitro. Antibody-blocking of
MHC or LFA-1 resulted in inhibition of migration suggesting that the enhanced
migration of T cells is dependant on peptide presented by the endothelium as well as
adhesion.
The ability of ECs to influence T cell motility has also been observed in vivo. A
study by Savinov et al. (2001) showed that injection of CD8+ T cells in IFNγ-deficient
mice resulted in arrest in the pancreatic islet entrance rather that entry into the pancreas
itself. This effect was reversed by systemic application of IFNγ, which as mentioned
earlier, increases MHC class I and induces MHC class II expression, thus allowing for
antigen presentation.,
Moreover, Savinov et al. (2003) subsequently observed that homing of
diabetogenic T cells is dependent on presentation of insulin peptides produced by β cells
and presented by pancreatic ECs. This process was found to be dependent on MHC I
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expression, as in a mouse model of diabetes lacking MHC class I, CD8+ T cells did not
localise to the islets (Savinov et al., 2003).
Antigen-dependent recruitment of T cells has also been directly visualised in vivo.
In this case, injection of male minor histocompatibility antigen HY-specific CD4+ T cells
resulted in recruitment and retention to the inflamed peritoneum in male but not female
mice. Interestingly, visualisation of the vascular bed using intra-vital microscopy
revealed that cognate recognition of the endothelium resulted in enhanced diapedesis of T
cells in the tissue, without affecting rolling and adhesion. This suggests that recognition
of antigen facilitated the selective recruitment of antigen-specific T cells (Marelli-Berg et
al.,  2004).
Based on the previous observations, two purposes for the role of TCR-mediated
control of T cell motility have been suggested; first, it facilitates the recruitment of
antigen-specific T cells into sites of inflammation by antigen displayed on the
endothelium; and second, during antigen presentation by professional APCs, it allows for
T cells to stop and polarise on the APC (reviewed in Marelli-Berg and Jarmin, 2004).
Given the importance of the cytoskeleton in T cell migration, it is likely that molecules
linking the TCR with the cytoskeleton will have a fundamental role in TCR-mediated T
cell migration.
2.3. Overview of CD28 co-stimulation
Along with TCR triggering by the peptide:MHC complex, co-stimulation is also
necessary for sustaining an effective immune response. One of the best-characterised co-
stimulatory molecules is CD28, which is expressed in both naïve and effector T cells.
Upon triggering of the TCR, CD28 binds to CD80 or CD86 on the surface of professional
APCs initiating various signalling cascades, which lead to increased cytokine production,
IL-2 mRNA stability and expression of the anti-apoptotic protein Bcl-XL (Parry et al.,
2003). Thus, CD28 signalling is essential for the sustained proliferation and survival of T
cells; in the absence of this signal, T cells become anergic or apoptose. CD28 is also
thought to lower the threshold of T cell activation by reducing the number of TCRs
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required for activation (reviewed in Alegre et al., 2001; Brunner-Weinzierl et al., 2004;
Salomon and Bluestone, 2001)
The regulation of migratory events is associated with the activation of signalling
pathways that mediate cell adhesion and cytoskeleton rearrangements, which CD28 has
recently been found to engage.
2.3.1 Regulation of adhesion and cytoskeletal re-organisations by CD28
CD28-mediated signals have been involved in the regulation of T cell adhesion.
CD28 cross-linking increased adhesion of human CD4+ T cells to fibronectin, ICAM-1
and VCAM-1, in a process involving protein kinase C (PKC) (Shimizu et al., 1992).
Similarly, CD28 was shown to enhance LFA-1:ICAM-1-mediated interactions between
human T cells and CD80-expressing melanoma cells via PKC-activation (Turcovski-
Corrales et al., 1995). Further evidence for the contribution of CD28-mediated signals to
integrin function came from the observation that β1 integrin-mediated adhesion of a
myelomonocytic cell line was enhanced by CD28 activation (Zell et al., 1998). This
event involves an interaction of its Src homology 2 domain (SH2) with the p85 catalytic
subunit of PI3kinase, a process regulated by the adaptor molecule Casitas-B-lineage
lymphoma protein (Cbl)-b (Zell et al., 1998).
CD28 has also been implicated in the regulation of cytoskeletal re-organization.
CD28 triggering increases F-actin levels in mouse T cells, in a process involving the Ras
homologue GTPases Rac1 and Cdc42 (Kaga et al., 1998a, b). Cdc42 activation upon
CD28 engagement is thought to be mediated by Src kinases independently of zeta chain
associated protein (ZAP)-70 activation (Salazar-Fontana et al., 2003). CD28 can also
activate the guanidine exchange factor (GEF) for Rho GTPases Vav1 independently of
the TCR (Michel et al., 2000).
In addition to activating Rho GTPases, CD28 engagement has also been found to
induce actin polymerisation in a Wiskott-Aldrich syndrome protein (WASp)-dependent
manner (Badour et al., 2007). The latter molecule plays a major role in coupling TCR
signals with cytoskeletal re-arrangements, in a process mediated by Vav1 and Rho
GTPases as will be explained in chapter 3. WASp interacts with the actin related protein
Regulation of T cell migration by the guanidine exchange factor Vav1
Rachel David
42
(Arp)2/3 complex, and together they induce actin filament nucleation (reviewed in Sechi
and Wehland, 2004). CD28 is thought to interact with WASp via PI3kinase and sorting
nexin 9 activation (Badour et al., 2007).
2.3.2 Regulation of migration by CD28
Experimental models of autoimmunity have highlighted a role for CD28 co-
stimulation in the localisation of memory T cells to antigenic sites. Resistance to EAE in
CD80/CD86- and CD28-deficient mice correlated with reduced development of
parenchymal T cell infiltrates of the CNS following immunization with MOG35-55 peptide,
despite the occurrence of efficient T cell priming (Chang et al., 1999). Selective
deficiency of CD80 or CD86 molecule expression led to disease development comparable
to wild type mice, suggesting a redundant role for CD28 ligands in the development of T
cell-mediated inflammation (Chang et al., 1999).
Similarly, in an EAE model induced by PLP56-70 immunisation of female non-obese
diabetic mice, antibody blockade of CD80/CD86 abrogated tissue infiltration,
inflammation and demyelination. Notably, the complete lack of histological damage was
only observed when CD80 and CD86 monoclonal antibodies were used in conjunction
(Girvin et al., 2000).
A direct involvement of CD28 in the control of T cell migration has been suggested
by recent studies. CD28-deficient murine T cells stimulated with APCs or peptide secrete
significantly less CC chemokine MIP1α (Herold et al., 1997). In addition, CD28-
dependent up-regulation of OX40 is instrumental to CXCR5 expression and helper T cell
migration to germinal centres in mice (Walker et al., 1999).
We have recently reported that CD28 co-stimulatory signals are essential for
primed T cells to reach their antigenic sites. CD28Y170F mice carry a mutation in the
cytoplasmic tail of CD28 that abrogates PI3K recruitment without leading to defects in
clonal expansion (Okkenhaug et al., 2001). OT-II (ovalbumin-specific, MHC class II
restricted TCR-transgenic) and OT-II/CD28Y170F double transgenic mice were generated
and their T cells were shown to proliferate equally following immunization with
ovalbumin. However, only OT-II T cells were able to localise to ovalbumin-expressing
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peritoneal tissue and cavity, suggesting that CD28-induced, PI3K-mediated signals are
necessary for the recruitment of T cells to antigenic sites (Mirenda et al., 2006).
In addition, we observed that dominant CD28 signals were also able to overcome
the requirement for TCR engagement to sustain T cell localization to non-lymphoid
tissue. Optimal antibody activation of CD28 in HY-specific H2-Db-restricted CD8+ T
cells led to unregulated infiltration of kidney, liver, spleen, heart, and ‘homing-
privileged’ gut tissue in syngeneic female mice. Enhanced trafficking was specifically
induced in memory but not in naïve T cells and abrogation of PI3K activation in CD28-
activated CD28Y170F HY-specific CD8+ T cells prevented this effect (Mirenda et al.,
2006).
Aberrant migration of primed T cells into non lymphoid tissue due to dominant
CD28 signalling may explain the multiple organ failure described in healthy human
subjects recently treated with a CD28 superagonist (TGN1412, Tegenero). This
compound was found in the pre-clinical trials to stimulate and expand T cells
independently of the TCR-triggering, in particular Th2 and CD4+ CD25+ regulatory T
cells (Rodriguez-Palmero et al., 1999). Despite the lack of pro-inflammatory effects in
the pre-clinical trials, when administered in six healthy male individuals, the compound
led to multi-organ failure, severe lymphopenia and a cytokine storm, with increased
levels of the pro-inflammatory cytokines TNFα, IL-2, IL-10 and IFN−γ (Suntharalingam
et al., 2006).  Given that the human T cell repertoire comprises around 50% memory T
lymphocytes, the CD28 superagonist may have induced uncontrolled extravasation of
memory T cells into non-lymphoid tissue, and subsequent T cell-mediated tissue damage.
The specific effect on memory T cells may have been overlooked in experimental models
where the T cell repertoire is mainly composed by naïve T lymphocytes (reviewed in
David and Marelli-Berg, 2007).
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3. The Vav family of proteins
The Vav proteins are a family of GEFs, which in mammals consist of three known
members, Vav1, 2 and 3. The first member to be described was Vav1, which was initially
termed vav, where it was identified as a proto-oncogene present primarily in cells of
haematopoetic origin (Coppola et al., 1991; Katzav et al., 1989). Vav1 was subsequently
mapped to chromosone 19 (Martinerie et al., 1990).  The isolation of the other two
members of the Vav family, Vav2 and Vav3, followed, both of which were found to be
present in cells of haematopoetic and non-haematopoetic origin (Movilla and Bustelo,
1999; Schuebel et al., 1998). Analysis of the structure of Vav proteins suggested that they
are important in both signalling as well as cell architecture as will be explained in the
next chapter.
The Vav family of proteins can be found in different species such as Drosophila
melanogaster (termed DroVav) where their effector functions are conserved; DroVav
acts as a GEF for Drosophila GTPases (Hornstein et al., 2003). In addition, DroVav is
also thought to regulate the actin cytoskeleton, as a mutated version, DMVav was found
to induce lamellipodia and membrane ruffling when injected in NIH3T3 fibroblasts, a
phenotype similar to the one induce by the mammalian Vav (Couceiro et al., 2005).
3.1. Structure
As Vav1 is the focus of this study, its structure will be explained in detail (Figure
3). Vav1 is a 95KDa GEF for RhoGTPases which is composed of domain characteristic
of signal transducers. More specifically, Vav1 has a dbl homology domain (DH), which
is thought to be essential for all its biological activities (Zugaza et al., 2002). The DH
domain is thought to have the GEF activity for RhoGTPases (reviewed in Tybulewicz et
al., 2003) as it contains Tyr174 which is involved in GEF activity of Vav1. The DH
domain is autoinhibited through an N-terminal autoinhibitory arm, and phosphorylation
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of Tyr174 results in release of the DH domain, thus exposing the GEF site and allowing
Vav1 to act as a GEF for RhoGTPases (Aghazadeh et al., 2000)
Furthermore, Vav1 has a calponin homology (CH) domain which is thought to
negatively regulate the GEF activity of the DH domain and is involved in Ca2+ signalling
(Cao et al., 2002; reviewed in Tybulewicz et al., 2003). In addition, the CH domain has
also been found to be important in nuclear factor of activated T cells (NFAT)- activator
protein-1 (AP-1) – mediated gene transcription and development of effector function in
lymphocytes as indicated in mutagenesis studies (Billadeau et al., 2000; Zugaza et al.,
2002)
Vav1 also has an SH2 and two SH3 domains, which are known to mediate protein-
to-protein interactions and are generally present in signalling molecules. In Vav1 in
particular, the SH domains are thought to mediate the interaction with Src homology 2
domain-containing leukocyte protein of 76 kDa (Slp-76) during TCR signalling
(reviewed in Hornstein et al., 2004; reviewed in Tybulewicz et al., 2003) and to act as
scaffolding ensuring proper phosphorylation and engagements of downstream effectors
(Zugaza et al., 2002). Mutation of the SH2 and SH3 domains have been shown to impair
the transforming activity of Vav1, suggesting a role in its the oncogenic properties
(Groysman et al., 1998; Katzav, 1993).
Moreover, Vav1 has a pleckstrin homology (PH) domain which, as the DH domain,
is thought to be essential for all biological activities (Zugaza et al., 2002). The PH
domain has recently been shown to regulate Vav1 GEF activity in vivo, as well as
selectively regulate proliferation of CD4+ T cells in mice (Prisco et al., 2005).
Finally, Vav1 has cystein rich domain (CD), which contains two zinc ions that are
throught to be required for the formation of the Vav1/Rac1 complex (Brooun et al., 2007;
Heo et al., 2005).
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Figure 3: The structure of Vav1
Structural studies have shown that Vav1 has a CH, DH, PH, CD and SH domains which
are important in its function as a GEF for RhoGTPases as well as TCR signalling.
3.2. Vav1 in the development of T cells
Vav1 was initially described as being important for the development of cells of
haematopoetic origin (Coppola et al., 1991) with Vav1 expression in the newborn mouse
concentrated in haematopoetic tissues, and in the adult in the thymus, spleen and lymph
nodes (Bustelo et al., 1993). Subsequent studies using antisense RNA or homologous
recombination to abolish Vav1 function showed conflicting results in the relevance of
Vav1 in murine embryonic stem cell haematopoetic development (Wulf et al., 1993;
Zmuidzinas et al., 1995), with Zhang et al. (1995) discrediting previous studies as they
observed little effect in haemotopoietic development in the absence of Vav1 when using
gene targeting on embryonic stem cells (Zhang et al., 1995). In addition, Luger et al.
(1996),  suggested that Vav1 is important for erythroid cell development but dispensable
for myeloid cell growth and differentiation. In this case, they diminished Vav1 function
with anti-sense oligonucleotides in an adult human system, and observed no defects in
myeloid cell proliferation and maturation.
In T cells, the importance of Vav1 has been demonstrated by the extensive studies
using Vav1-/- mice, the latter generated through deletion of Vav1 in embryonic stem cells
(Fischer et al., 1995) or disruptive mutation of Vav1 from the germline by homologous
recombination (Tarakhovsky et al., 1995; Turner et al., 1997). One of the first studies on
Introduction
47
Vav1-/- mice showed that Vav1-deficient embryonic stem cells generate a limited
number of T and B cells, indicating that Vav1 is important in T and B cell development
(Fischer et al., 1995).
Subsequent studies showed that Vav1-/- mice have altered thymic development,
with reduced thymic cellularity resulting in decreased thymus size due to the decline of
double positive thymocytes (Fischer et al., 1998; Tarakhovsky et al., 1995; Turner et al.,
1997).  A recent study using thymocytes expressing Vav1 with a mutation in the DH
tyrosine 174 (Y174F) mimicked the phenotype of Vav1-/- mice, i.e. diminished thymic
cellularity and decreased double positive population. This indicates that tyrosine 174 is a
key residue in Vav1 regulating T cell development (Miletic et al., 2003).
 Furthermore, Vav1-/- mice have altered T cell development with a partial block at
the CD4+ CD8+ double positive to single positive CD4+ or CD8+ mature T cell, possibly
due to impaired pre-TCR signalling and defective positive selection (Fischer et al., 1998;
Turner et al., 1997). Tarakhovsky et al. (1995) also observed a reduction of single
positive CD4+ or CD8+ mature T cells in the spleen and lymph nodes of Vav1-/- mice. In
addition, this study showed a disproportionate ratio of CD4:CD8 mature T cells in the
spleen but not the lymph node of Vav1-/- mice. Interestingly, Vav1-/- mice show normal
development of mature γδ T cells, with comparable numbers of cells in the spleen and
comparable levels of TCR expression (Swat et al., 2003).
Moreover, a study by Gomez et al. (2000) indicated an interesting link between
Vav1 and Rac1 in development using Vav1-/- mice. More specifically, transgenic mice
expressing a constitutively active form of Rac1 (L61Y40Rac-1) in Vav1-/- background
displayed full reconstitution of thymic cellularity and prevented the skewed profile of
depleted douple positive thymocytes. This study suggests that some of the defects in T
cell development in Vav1-/- mice may be due to defective Rac1 activation.
A recent study has investigated the role of the other Vav proteins in T cell
development. Fujukawa et al. (2003) examined Vav1/2/3-/- mice as well as different
combinations of Vav proteins to investigate the function of each protein and identify
potential redundancies. Their results show that Vav1 is the most important regulator of T
cell development, as mice lacking Vav2 and 3 showed no T cell abnormalities. Vav3 did
partly compensate for the loss of Vav1, and the triple Vav1/Vav2/Vav3 knockout had a
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more severe developmental block than the Vav1/Vav3 knockout, with an almost
complete absence of double positive thymocytes, suggesting that Vav2 also has a role in
T cell development.
3.3. Vav1 in T cell function
The role of Vav1 in mature T cell function has also been extensively researched.
Several studies have shown impaired TCR-induced proliferation in T cells from Vav1-/-
mice, but normal proliferation with signals that bypass the antigen receptor, such as
phorbol myristate acetate (PMA) or ionomycin (Costello et al., 1999; Fischer et al., 1998;
Penninger et al., 1999; Zhang et al., 1995). Vav1-/- γδ T cells, which were shown to have
normal development, also display reduced proliferation (Swat et al., 2003).
In addition, Vav1-/- T cells show reduced IL-2 production, which is the direct result
of impaired CD3/CD28 signalling (Tarakhovsky et al., 1995). The importance of Vav1 in
IL-2 production has also been demonstrated in a study examining the effects of
methylation inhibitors in a mouse model of EAE. This study suggested a correlation
between arginine methylation of Vav1 in autoreactive CD4+ T cells and amelioration of
disease due to reduced IL-2 production (Lawson et al., 2007). These findings have also
been confirmed in studies using Vav1-/- Jurkat T cells generated through gene targeting,
where reduced activity of the IL-2 promoter and reduced IL-2 production have been
reported (Cao et al., 2002). Vav1-/- T cells also show reduced IL-4 production when
examined by flow cytometry, and a skewed Th1 T cell profile (Tanaka et al., 2005).
Studies on T cells from Vav1-/- mice have also shown defective Ca2+ flux i.e.
undetectable or at very low levels, resulting from defective signalling (Costello et al.,
1999; Fischer et al., 1998). This has also been confirmed in studies examining Vav1-/-
Jurkat T cells (Cao et al., 2002). Similar results have been obtained from cells from
patients with common variable immunodeficiency (CVID). The latter, and more
specifically T-CVID , is a primary dysfunction of the immune system, making patients
more susceptible to bacterial infections, autoimmunity and cancer (Sneller, 2001). T-
CVID is characterised by defective TCR-dependent early tyrosine phosphorylation
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cascade in T cells. Close examination of T cells from these patients revealed that they
have reduced Vav1 mRNA levels, which resulted, amongst other defects, in impaired
Ca2+ flux (Paccani et al., 2005).
Vav1-/- mice are also thought to display impaired T cell help in the context of
immunoglobulin class switching. Vav1-/- mice show defective immunoglobulin class
switching and germinal centre formation, a phenotype which was reversed when using
chimeras with normal T cells, suggesting that the defect is due to impaired T cell help
(Gulbranson-Judge et al., 1999).
The role of Vav1 in effector T cell function has been examined in a study by
Penninger et al. (1999), who investigated the role of Vav1 in cytotoxic T cell function.
By challenging Vav1-/- mice with viral infections, they observed that Vav1-/- T cells had
impaired primary cytotoxic responses in vivo, as Vav1-/- mice showed reduced footpad
swelling after viral infection. The ability to respond was found to depend on viral
challenge, with Vav1 being necessary for vesicular stomatitis virus clearance. However,
once re-stimulated in vitro, Vav1-/- T cells were able to clear infection, suggesting that
Vav1 is important for primary cytotoxic responses.
Korn et al. (2003) further examined Vav1-/- T cell effector function in a study of
EAE. They observed that priming of Vav1-/- T cells with the EAE peptide MOG35-55 was
defective despite effective antigen presentation, and Vav1-/- mice were not susceptible to
EAE development. In addition, they examined cytokine secretion in Vav1-/- T cells
through stimulation with MOG35-55 peptide, which did not result in IL-2, IL-4 or IFNγ
induction in vitro.
Finally, in a transplantation study using Vav1-/- and Vav2-/- mice, Vav1-/- T cells
showed reduced graft versus host disease reaction, as adoptively transferred
carboxyfluorescein diacetate succinimyl ester (CFSE) labelled Vav1-/- T cells did not
proliferate in the spleen of severe combined immunodeficiency mice. More importantly,
both Vav1-/- and Vav2-/- mice showed increased heart allograft survival compared to the
WT, with only mild cellular rejection observed upon histological examination of the
transplant after 100 days (Weckbecker et al., 2007). This study indicates that Vav1 plays
an important role in effector T cell function in the context of transplantation.
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3.4. Vav1 in the cell cycle and apoptosis
In addition to its role in T cell development and function. Vav1 is also involved in
the cell cycle and the prevention of apoptosis. Indeed Vav1 has been shown to be a
caspase target, and to be cleaved into two products, Vav1p76 and Vav1p19 (Hofmann et
al., 2000).
 Vav1-/- T cells show defects in cycling, which is thought to be the result of
reduced phosphorylation of forkhead box O (Foxo)1. The latter is a member of the
forkhead family of transcription factors and plays a critical role in the regulation of the
cell cycle and apoptosis (Coffer and Burgering, 2004). As Foxo1 is a target of PI3kinase,
it is thought that Vav1 controls the TCR/CD28 dependent phosphorylation of Foxo1 in T
cells via Akt (Charvet et al., 2006).
In thymocytes, Vav1 activity has been found to be involved in peptide-specific
apoptosis, which is in accord with its role in TCR-dependent positive and negative
selection. In a study by Kong et al., (1998) Vav was found to regulate apoptosis in
thymocytes through changes in the actin cytoskeleton and activation of PKC.
Moreover, a study by Tuosto et al. (2002) indicated that Vav1 activity prevents
apoptosis, as in the absence of Vav1, the levels of pro-apoptotic Bax increased, leading to
mitochondrial damage. The researchers have suggested that activation of the Src kinase
leukocyte specific protein tyrosine kinase (Lck) activates T cells apoptotic pathways, an
event counteracted by Vav1 through its co-operation with CD28 in boosting TCR
signalling.
However, another study using a constitutively active form of Vav1 in
haematopoetic progenitor cells showed increased apoptosis, including both early
apoptotic (annexin positive) and late apoptotic (annexin and 7-AAD positive) cells. In
addition, cells expressing the constitutively active form of Vav1 showed reduced
expression of anti-apoptotic BCL-XL and BCL-2. (Gu et al., 2006).
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3.5. Vav proteins and the actin cytoskeleton
Vav1 is a GEF for RhoGTPases whose role in cytoskeletal remodelling will be
described later on. As a regulator of RhoGTPase function, it is reasonable to postulate
that Vav1 activity is necessary for re-arrangements of the cytoskeleton. The evidence of
Vav1’s involvement in this process will be described in detail in this chapter.
3.5.1. Vav1 interacts with WASp
Vav1 has been shown to associate with WASp which is thought to couple TCR
signals with the cytoskeleton. WASp encodes for a proline-rich protein, a mutated form
of which causes Wiskott-Aldrich syndrome, an X-linked recessive immunodeficiency
disorder characterised by eczema, thrombocytopenia and recurrent infections (Derry et
al., 1994). T cells from WASp patients display cytoskeletal abnormalities (Gallego et al.,
1997), while other WASp-deficient cells show reduced microvilli, impaired migration in
response to chemoattractants and increased cell polarisation (Anton et al., 2002; Gallego
et al., 1997; Remold-O'Donnell et al., 1997). The actin polymerisation function of WASP
is regulated by a tyrosine phorphorylation of tyrosine 291 (Cory et al., 2002). A proline-
rich WASp-interacting protein was isolated (WIP) which co-immunoprecipitated with
WASP in lymphocytes and has actin binding motifs (Ramesh et al., 1997).  WIP1-/- T
cells fail to proliferate, secrete IL-2, polymerise F-actin, polarise and form conjugates
with superantigen-presenting B cells (Badolato et al., 1998) (Anton et al., 2002). WIP co-
operates with Vav1 for NFAT/ AP1 gene transcription via its 112-237 amino acid
terminal domain; complex formation between WASp and WIP is necessary for this
function (Savoy et al., 2000).
WASp has been shown to interact with the actin-related protein (Arp)2,3 complex
to perform actin filament enucleation (reviewed in Sechi and Wehland, 2004; Welch et
al., 1997).  WASp could be recruited to the TCR through association of its C-terminal
domain SH3 domain and Slp-76 (reviewed in Sechi and Wehland, 2004) , which would
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place it in proximity to Vav1. WIP may also play a role in recruiting WASp to the TCR
and bring it in proximity to Vav1 (reviewed in Sechi and Wehland, 2004).
3.5.2. Vav1 is involved in the formation of the immunological synapse
Vav1 has been shown to have an important role in the formation of the
immunological synapse, also known as supramolecular activation cluster. The latter is the
tight interphase between the T cell and the APC which is thought to facilitate the
degradation of the TCR, and hence cessation of signalling (reviewed in Hornstein et al.,
2004; Monks et al., 1998). Upon TCR triggering, molecules involved in T cell signalling
become associated with specialised regions of the cell membrane known as lipid rafts,
which are enriched with cholesterol, phospholipids and glycosphyncolipids (reviewed in
Janeway et al., 2001). Examples of such molecules include Src family kinases such as
Lck and Fyn, which phosphorylate downstream signalling molecules such as Vav1
(reviewed in Janeway et al., 2001). Upon phosphorylatuon, Vav1 translocates to the lipid
rafts and is responsible for transducing signals necessary for the transcription of NF-AT
and nuclear factor kappa B (NfkB) (Manicassamy et al., 2006). This facilitates
downstream signalling cascades which lead to activation of transcription factors and gene
expression (reviewed in Hornstein et al., 2004; Monks et al., 1998). The formation of the
immunological synapse involves changes in the T cell cytoskeleton, allowing for the T
cell to polarise towards the APC. These changes are thought to be mediated primarily by
integrin receptors such as LFA-1 (reviewed in Hornstein et al., 2004; Monks et al., 1998).
A number of studies have implicated Vav1 in the formation of the immunological
synapse, and in particular for the TCR– induced activation of LFA—1. More specifically,
Vav1-/- thymocytes were defective in transducing LFA-1 “inside-out” signals for the
formation of conjugates and cell polarisation (Ardouin et al., 2003). This effect was also
observed using peripheral Vav1-/- T cells from TCR-transgenic mice, which showed
reduced ability to form peptide-specific conjugates and reduced LFA-1 clustering
(Krawczyk et al., 2002; reviewed in Cantrell, 2003).
In addition, Vav1 is necessary for the formation of lipid raft clusters, as lipid rafts
in Vav1-/- T cells fail to translocate to the immunological synapse upon antigen
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stimulation (Villalba et al., 2001). However, a different study using Vav1-/- Jurkat T cells
observed no defects in lipid raft clustering or PKCθ translocation to lipid rafts (Cao et al.,
2002).
Finally, Vav1-/- T cells have defective TCR/MHC class II accumulation in the
centre of the immunological synapse (Wulfing et al., 2000), diminished actin cap
formation and TCR clustering following TCR engagement, as well as abolished
interaction of actin with CD3ζ (Fischer et al., 1998; Hornstein et al., 2004).
3.5.3. Vav proteins induce cytoskeletal re-arrangements in different cell
types
Extensive research has shown that all Vav proteins can induce cytoskeletal re-
arrangements, which are important for cell polarisation, adhesion and spreading. This has
been directly shown by Fischer et al. (1998), who observed that loss of Vav1 in
thymocytes results in severe defects of actin polymerisation.
Firstly, Vav1 is important in adhesion of thymocytes and T cells.  In thymocytes,
loss of Vav1 results in lack of adhesion to fibronectin, laminin, collagen type IV,
vitronectin and ICAM-1, following TCR activation (Krawczyk et al., 2002). The same
phenotype was observed with Vav1-/- T cells, suggesting the importance of Vav1 in T
cell adhesion (Krawczyk et al., 2002).
The ability of Vav1 activity to mediate T cell adhesion has been confirmed in a
study using Jurkat T cells. In this case, adhesion of Jurkat T cells to fibronectin was
shown to result in rapid phosphorylation of Vav1 (Yron et al., 1999).
In addition, Vav1 is important in T cell spreading, the latter being a process
intermediary to adhesion and motility which is important in determining whether a cell
proliferates, becomes quiescent or dies post-adhesion and is characterised by adhesion
and actin polymerisation (McGrath, 2007). T cells with a truncated form of Vav1 lacking
the SH domain display defects in spreading on VCAM-1-coated plates when stimulated
with CXCL12. Cells expressing lower levels of Vav1 were also shown to have increased
levels of detachment from VCAM-1-coated plates in conditions of shear stress (Garcia-
Bernal et al., 2006).
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Vav1 has also been shown to inactivate ezrin-moesin-radoxin (ERM) proteins in T
cells. The latter are regulated through threonine phosphorylation and are co-expressed
and co-localised at locations where actin filaments are associated with the plasma
membrane (eg membrane ruffles). They are thus thought to be regulators of cell rigidity
(Roumier et al., 2001; Tsukita and Yonemura, 1999). Vav1-/- T cells show reduced ERM
de-phosphorylation, suggesting that Vav1 may be responsible for ERM protein de-
phosphorylation and indirectly for the regulation of cell rigidity (Faure et al., 2004).
Vav1 is also involved in cytoskeletal-dependent morphological changes in T cells.
A study by Zaffran et al. (2001) showed that CD46 co-stimulation results in Vav1
phosphorylation and Rac1 activation, which in turn was shown to induce the formation of
actin-rich lamellipodia and filopodia.
Vav proteins are also important in the cytoskeletal re-arrangements of other cell
types. In neutrophils, all three Vav proteins have been shown to be expressed, with Vav1
and Vav3 being the most important. Vav1-/- and Vav3-/- neutrophils were shown to be
defective in adhesion and spreading to their natural ligand C3bl, with the double
knockout Vav1,3-/- having a more severe phenotype (Gakidis et al., 2004). In addition,
neutrophils from Vav1-/- mice displayed reduced generation of F-actin in response to the
chemoattractant fMLP (Kim et al., 2003).
Moreover, in platelets, Vav1 and Vav3 are redundant while Vav2 plays no role
(Pearce et al., 2004). In terms of the cytoskeleton, Vav1,3-/- platelets adhere to
fibronectin with the same efficiency as the wild type but show fewer filopodia and
lamellipodia; Vav1-/- and Vav3-/- platelets show an intermediate phenotype (Pearce et
al., 2007).
Furthermore, the role of the three Vav proteins in macrophages has not been studied
extensively, but a study by Wells et al., (2005) showed reduced adhesive area in both
Vav1-/- and Vav2-/- macrophages. However, Vav1-/- but not Vav2-/- macrophages
showed reduced adhesion to fibronectin, suggesting a more important role for the former.
Vav proteins have also been shown to be involved in dendritic cell morphological
changes. More specifically, the human immunodeficiency virus (HIV) protein Nef was
found to trigger phosphorylation of Vav1 in infected DCs, which was followed by
morphological changes such as formation of uropods, membrane ruffling, re-
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arrangements of actin filaments and polarisation of vinculin. This study suggests that HIV
infection of DCs results in activation of a Vav1-mediated signalling pathway which
induces morphological changes (Quaranta et al., 2003). Indeed Vav1 has been found to
be the binding partner for Nef during HIV infection, and to induce structural changes in
the infected cell (Fackler et al., 1999) which may facilitate conjugate formation between
DCs and T cells and enhance viral transmission (Quaranta et al., 2003).
Vav proteins have also been shown to play a role in osteoclast remodelling and
spreading. More specifically, CSF treatment, which is known to affect osteogenesis, has
been shown to translocate Vav3 to the plasma mebrane, leading to increased spreading of
osteoclasts (Sakai et al., 2006).
The role of Vav proteins in remodelling of the cytoskeleton has also been examined
through ectopic expression of the proteins on different cell types. One study used a
human mammary epithelial cell line (MCF-10A) transformed with a constitutively active
form of Vav1, resulting in morphological changes including membrane ruffling and
lamellipodia formation. This study also identified the DH, PH or CD domains as being
important for the morphological changes, as transformation of the human mammary
epithelial cell line with a mutated form of Vav1 lacking the afore mentioned domains did
not induce this phenotype (Wilsbacher et al., 2006).
Finally, extensive studies on the role of Vav protein in the regulation of the actin
cytoskeleton have used fibroblasts. More specifically, Vav1 expression in REF-52 (rat
embryo) fibroblasts induced filopodia formation (Han et al., 1997), while an oncogenic
version of Vav1 expressed in NIH3T3 (mouse fibroblast) cell line resulted in both
lamellipodia and filopodia formation (Lopez-Lago et al., 2000). Overexpression of Vav2
in a NIH3T3 cell line resulted in lamellipodia formation in a Src kinase dependent
manner (Marignani and Carpenter, 2001). A study by Shuebel et al. (1998) observed
different morphological changes induced by Vav1 and Vav2 when expressed in NIH3T3
cell line, suggesting that in this cell line, the two Vav proteins act using distinct signalling
pathways .
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3.6 Vav proteins and migration
As important regulators of the cytoskeleton, Vav proteins are likely candidates for
the regulation of migration. Studies in T cells and other cell types have indeed indicated
that Vav proteins are important regulators of migration and chemotaxis (summarised in
Table 4).
Firstly, a study by Vicente-Manzanares et al. (2005) has shown that Vav1 has a role
in T cell chemotaxis. More specifically, when using Vav1-/- murine T cells, they
observed no effect on chemotaxis, lymphocyte migration and F-actin polymerisation in
response to CXCL12. However, using human peripheral blood lymphocytes nucleofected
with a dominant negative form of Vav1 resulted in impaired chemotaxis, actin
polymerisation and cell polarisation. Redundancy between Vav proteins explains why no
defect in migration to CXCL12 was observed in the murine Vav1-/- T cells. However, the
dominant negative form of Vav1 would bind to the Vav interaction site on the CXCR4
signalosome, thus blocking access and preventing the other Vav proteins from
compensating for the loss of Vav1.
Another study has also implicated Vav1 in CXCL12-mediated chemotaxis. In this
case a dominant negative form of Vav1 abbrogated CXCL-12-mediated chemotaxis in
Jurkat T cells (Ticchioni et al., 2002). This has been further examined by Garcia-Bernal
et al., (2005) who showed that Vav1 and Rac1 are necessary for CXCL12-induced
adhesion and transendothelial migration.
Moreover, using an EAE model, Korn et al. (2003) showed that T cells from Vav1-
/- mice show reduced T cell infiltration of the brain compared to the WT, which was
partly reversed with administration of cytotoxic T lymphocyte associated protein (CTLA-
4) Ig, suggesting a role for co-stimulatory signalling in the regulation of T cell migration
by Vav1.
As with the regulation of the cytoskeleton, Vav proteins have been shown to affect
motility in other cell types as well. In macrophages, Vav1-/- cells were selectively found
to have reduced migratory speed, probably due to altered microtubule dynamics as
demonstrated by the reduced levels of α-tubulin (Wells et al., 2005). In agreement with
this was the study showing that loss of the Vav1 N terminal domain (i.e. oncoVav1)
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resulted in increased spontaneous migration of macrophages four to five-fold, suggesting
that Vav1 regulates migratory speed in macrophages. The same study also showed that
loss of the Vav1 GEF activity abrogated chemotaxis  (Vedham et al., 2005).
Furthermore, neutrophils from Vav1-/- mice were shown to have reduced migration
to medium alone compared to WT cells, as well as reduced chemotaxis to high
concentrations of chemoattractant FMLP both in vitro and in vivo (Kim et al., 2003). A
different study using Vav1,3-/- neutrophils showed no defect in migration and
chemotaxis in response to C3bl compared to wild type in vitro, but indicated higher
migratory speed compared to the control (Gakidis et al., 2004).
Vav has also been shown to be involved in melanoma cell invasion, mediated by
CXCL12. Melanoma cells express both Vav1 and 2, and blocking of the two Vav
proteins resulted in impaired activation of Rac and inhibition of CXCL12-mediated
invasion (Bartolome et al., 2006).
Finally, a study using human mammary epithelial cells transformed with a
constitutively active form of Vav1 observed enhanced migration compared to the wild
type control in response to epidermal growth factor which is necessary for the migration
of these cells. This study also indicated a role for the the SH2 and CSH3 Vav1 domain in
the migration of human mammary epithelial cells, as a mutant lacking this domain did not
display this phenotype (Wilsbacher et al., 2006).
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Table 4: Summary of experimental evidence implicating Vav proteins in migration
Cell type Vav
protein
Experimental
system
Effect on migration Comments Reference
Murine Vav1-/-
cells in vitro
No defect in response to
CXCL12
Human T  cells
transfected with
dominant
negative form
in vitro
Impaired chemotaxis, actin
polymerisation and polarisation
Dominant
negative
form blocked
access to
CXCR4,
preventing
compensation
by other Vav
proteins
Vicente-Manzanares,
2005
Jurkat T cells
trasfected with
a dominant
negative form
of Vav1
Abrogated CXCL12 chemotaxis Ticchioni, 2005
Murine Vav1-/-
T cells in vitro
Required for CXCL12-
inducedtransendothelial
migration
In
conjunction
with Rac1
Garcia-Bernal, 2006
T cells Vav1
Adoptive
transfer in EAE
model
Reduced brain infiltration Partly
reversed by
CTLA-Ig
Korn, 2003
Murine Vav1-/-
cells in vitro
Reduced migratory speed Wells, 2005
Murine Vav1-/-
cells with no N-
terminal
domain in vitro
Increased spontaneous migratuon
Macrophages Vav1
Murine Vav1-/-
cells with no
GEF activity in
vitro
Defect in chemotaxis
Vedham, 2005
Vav1 Murine cells
Vav1-/- in
vitro, in vivo
Reduced chemotaxis Kim, 2003Neutrophils
Vav1,
Vav3
Murine
Vav1,3-/- cells
in vitro
Increased migratory speed No defect in
chemotaxis
Gakidis, 2004
Melanoma
cells
Vav1,
Vav2
Murine cells
with blocked
Vav1,2 In vitro
Inhibition of CXCL12-mediated
melanoma invasion
Bartolome, 2006
Mammary
epithelial
cells
Vav1 Constitutively
active form in
vitro
Increased migration Wilsbacher, 2006
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4. Vav1 and TCR/CD28 signalling
4.1. Overview of TCR signalling
Triggering of the TCR-CD3 complex by the MHC-peptide complex displayed by
APCs leads to rapid activation of Src family kinases such as Lck, which is constitutively
associated with the cytoplasmic domain of the co-receptors CD4 and CD8, and Fyn,
which associated with the cytoplasmic domain of the ζ and CD3ε upon receptor
clustering. Thus, both Lck and Fyn can phosphorylate immunoreceptor tyrosine based
activation motifs (ITAMS) upon TCR trigerring (reviewed in Janeway et al., 2001).
Lck subsequently phosphorylates ZAP70 which in turn can phosphorylate linker for
activation of T cells (LAT), Vav1 and Slp76. LAT is a cytosplasmic protein that can
associate with the inside of the plasma membrane through palmitoylation of its cystein
residues, which become associated with lipid rafts. The latter are cholesterol rich areas of
the plasma membrane that are essential in the recruitment of signalling molecules and the
propagation of signals from the membrane to the inside of the cell (reviewed in Janeway
et al.,  2001; reviewed in Katzav, 2004).
Once phosphorylated, LAT is thought to recruit Grb2-related adaptor downstream
of Shc (Gads), which associates with Slp-76. In addition, upon phosphorylation of Slp76
by ZAP70, the former can bind to Vav1 through the latter’s SH2 domain, thus recruiting
Vav1 to the signalling complex (Aghazadeh et al., 2000; reviewed in Tybulewicz et al.,
2003; Wu et al., 1996). This complex serves to propagate the signal from the plasma
membrane to the inside of the cell through the activation of signalling pathways that
ultimately result in gene transcription (reviewed in Janeway et al.,  2001).
4.2. Upstream of Vav1
One of the first steps of TCR signalling post-triggering is the activation of the Src
family kinases Lck and Fyn. Studies have focused on examining the effect the two
kinases have on the activation of Vav1, and have shown that both can induce Vav1
phosphorylation. While Lopez-Lago et al. (2000) showed that Lck can indeed
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phosphorylate Vav1 at tyrosine residue 174, a study using JCaMI Jurkat T cells
concluded that Vav1 is phosphorylated primarily by Fyn, with the later showing 40%
higher phosphorylation than the unstimulated control  (Huang et al., 2000).
Moreover, studies have shown that Vav1 can be activated by Syk and Zap70, two
kinases that contain two SH2 domains and two regulatory regions (Bustelo, 2000). Syk is
expressed primarily in immature T lymphocytes and is thought to interact with Vav1
through its SH2 domain, as a mutation in a conserved arginine residue of the latter
abolished this interaction (Arudchandran et al., 2000; reviewed in Bustelo, 2000; Deckert
et al., 1996). Once again, the Vav1 tyrosine 174 seems to be important, as the Y174F
Vav1 mutant was not phosphorylated by Syk (Deckert et al., 1996).
Studies on ZAP70 have indicated that it has an important role in Vav1 activation.
More specifically, ZAP70 has been shown associate with and tyrosine phosphorylate
Vav1 upon TCR triggering (Gouy et al., 1995; Huby et al., 1995; Michel et al., 1998).
The ZAP70 tyrosine 315 plays a critical role in the binding to the SH2 domain of Vav1,
as a mutation in this residue impaired the function of ZAP70 and eliminated its
interaction with Vav1 (Wu  et al., 1997). In addition, ZAP70 has been shown to
phosphorylate Slp76 in sites that allow for Vav1 binding, thus facilitating the downstream
signalling pathway (Raab et al., 1997). ZAP70 also facilitates the translocation of Vav1
and Son of Sevenless to the lipid rafts upon TCR triggering, as demonstrated in studies
using ZAP70-deficient Jurkat T cells (Salojin et al., 2000).
 It is thought that under physiological conditions, the apparent requirement for Lck
and Fyn for the phosphorylation of Vav1 is in fact to phosphorylate ZAP70 which can in
turn phosphorylate Vav1. Syk kinase follows a similar mechanism of activation but does
not require phosphorylation by Lck or Fyn for the final activation step. However, there is
some evidence that Lck and Fyn can activate Vav1 directly, but it is thought that this
would only occur under abnormal conditions (reviewed in Bustelo, 2000) A summary of
the events occurring upstream of Vav1 post-TCR triggering is summarised in Figure 4.
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Figure 4: TCR signalling upstream of Vav1
Upon TCR triggering by a peptide/MHC complex, activated Lck phosphorylates ZAP70,
which phosphorylates LAT, Slp76 and Vav1. LAT recruits Gads, and along with
phosphorylates Slp76 and Vav1, this forms the signalling complex.
Vav1 has also recently been shown to be activated by the co-stimulatory molecule
CD46 (Zaffran et al., 2001). CD46 is expressed in human T cells and highly promotes T
cell proliferation (Astier et al., 2000). It has also been shown to induce morphological
changes mediated by Vav1 and Rac1 (Zaffran et al., 2001).
4.3. Adaptor molecules interacting with Vav1
Vav1 interacts with adaptor molecules which facilitate its downstream effects.
Adaptors lack enzymatic activity, and primarily function as scaffolds by binding to other
proteins. They can act both as positive and negative regulators of T cell function, with
examples such as LAT, Slp76, Grb-2 and WASp (Wilkinson et al., 2004).
As mentioned earlier, LAT, a transmembrane adaptor, is phosphorylated upon TCR
triggering, and can thus recruit Gads to the lipid rafts (reviewed in Janeway et al., 2001;
Wilkinson et al., 2004). Studies have shown that LAT can be phosphorylated by ITK,
which allows for its association with Vav1 via the LAT phosphorylated tyrosine 171 and
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the Vav1 SH2 domain (Perez-Villar et al., 2002). This was further confirmed by studies
using a Vav1 SH2 domain mutant, where association of Vav1 with LAT as well as its
translocation to the plasma membrane were inhibited. (Arudchandran et al., 2000).
Slp76 is another adaptor protein which plays an integral role in the activation of
downstream signalling pathways (Wilkinson et al., 2004).  It associates with Vav1 via the
latter’s SH2 domain (Wu et al., 1996), and has been shown to be important in bringing
together Vav1 and WASp, thus regulating the re-arrangement of the actin cytoskeleton
(Zeng et al., 2003). In addition, Slp76 is involved in NFAT transcription and IL-2
production, with overexpression having a similar effect to that of Vav1 (Wu et al., 1996).
4.4. Negative regulators of Vav1
Research on the negative regulators of Vav1 has been far less extensive, but has
identified one key regulator, Cbl-b. The latter is a ubiquitously expressed protein with a
multidomain structure, which belongs to a well known family of E3 ubiquitin ligases that
inhibit signalling cascades by downmodulating the activity of kinases, or ubiquitinating
membrane tyrosine kinase receptors (Bustelo, 2000).
The observation that Cbl-b negatively regulates Vav1 came from a study that
showed that Cbl-b overexpression in rodent fibroblasts resulted in inhibition of signalling
pathways mediated by Vav1. The two molecules are thought to associate via the entire
SH3-SH2-SH3 domain of Vav1 and proline-rich stretch in the central region of Cbl-b
(Bustelo et al., 1997). In addition, T cells from cbl-b -/- mice stimulated with anti-
CD3/CD28 were found to have higher GEF activity that the WT, suggesting that Cbl-b
regulates the GEF activity of Vav1 (Chiang et al., 2000). Moreover, cbl-b-/- mice
develop autoimmunity and T cell infiltration into multiple organs. As TCR-triggering
alone in T cells from cbl-b -/- mice resulted in comparable levels of proliferation as TCR
and CD28 –triggered wild type cells, it is thought that loss of Cbl-b results in lowering of
the threshold for T cell activation and subsequent uncontrolled activation of Vav1 in the
absence of CD28 co-stimulation (Bachmaier et al., 2000).
c-Cbl has also been shown to associate with Vav1 upon TCR activation in both
thymocytes and peripheral T cells. This association is dependent upon tyrosine
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phosphorylation of c-Cbl and the SH2 domain of Vav1, and is thought to negatively
regulate the function of Vav1 (Marengere et al., 1997).
4.5. Downstream signalling cascades
4.5.1. Vav1 as a GEF for RhoGTPases
4.5.1.1 Rho GTPases, regulators of the cytoskeleton
The mammalian Rho superfamily consists of nine proteins which share 50-55%
homology and are widely expressed. These proteins are RhoA, RhoB, RhoC, Rac1, Rac2,
Cdc42, G25K, RhoG and TC10 (reviewed in Hall, 1994). Rho GTPases cycle between
two conformational states, a GTP-bound state (active) and a GDP-bound state (inactive).
This conformational change is regulated by GEFs, which promote the cycling from the
GDP-bound inactive state to the GTP-bound active state by hydrolysing phosphate
(reviewed in Hall, 1994; reviewed in Hornstein et al., 2004; Millan and Ridley, 2005).
Studies on the function of RhoGTPases have uncovered that they are important in
the regulation of the cytoskeleton, having an integral role in adhesion, polarisation and
cell migration (Table 5)(reviewed in Etienne-Manneville and Hall, 2002). More
specifically, in a series of classic experiments, Paterson et al. (1990) first observed that
microinjection of a constitutively active form of Rho in 3T3 fibroblasts resulted in
dramatic changes in cell morphology, with a typical contracted cell body. They went on
to observe that microinjection of an inactive form resulted in complete rounding up of
cell, suggesting that Rho is necessary for the regulation of the actin cytoskeleton.
Similar experiments were carried out by Ridley et al. (1992) examining the role of
Rac1. Microinjection of a mutated form of Rac1 with diminished activity resulted once
again in rounding up and detachment of the injected fibroblasts, while microinjection of
functional Rac1 resulted in accumulation of membrane ruffles, increase in stress fibres
and formation of focal adhesions containing talin and vinculin. This once again suggested
that Rac1 has a vital role in the regulation of the cytoskeleton.
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Another member of the RhoGTPases family, Cdc42, was first described as being
important in the budding site of dividing yeast, thus suggesting a role in the regulation of
the cytoskeleton (Hall, 1994). A series of classic microinjection experiments confirmed
its role in mammalian cells as well; microinjection of Cdc42 in 3T3 fibroblasts resulted in
the formation of microspikes, which were found to be components of filopodia (Kozma et
al., 1995).
Several studies have since tried to describe the individual roles that Rho, Rac1 and
Cdc42 have in mammalian cells. More specifically, Nobes and Hall (1995) performed a
series of microinjection experiments using all three members, and examined the effect
each RhoGTPase had on the actin cytoskeleton. Their data suggested that Rho induces
increased adhesion and stress fibre formation, Rac1 stimulates lamellipodia formation,
while Cdc42 activation results in actin polymerisation and focal complex formation,
which leads to filopodia formation.  This was confirmed by another study, which
observed that expression of Cdc42 in 3T3 fibroblasts resulted in filopodia formation,
while constitutively active Rac1 induced lamellipodia formation (Schuebel et al., 1998).
The role of the three RhoGTPases in migration has also been investigated (Table
5). More specifically, a study using macrophages showed that Rho and Rac1 are required
for cell movement, while Cdc42 is more important in polarisation and gradient perception
(Allen et al., 1998). In addition, Rac1 has been directly visualised in migrating cells, and
was found to be concentrated in the leading edge in a gradient (Kraynov et al., 2000).
Table 5: Summary of experimental evidence on the role of Rac1, CDC42 and Rho in
the regulation of the cytoskeleton and migration
Name Effect on cytoskeleton Effect on migration Reference
Rho Adhesion and stress fibre
formation
Important for cell movement Ridley, 1992;
Nobes, 1995;
Allen, 1998
CDC42 Microspikes/ filopodia Important for gradient
perception
Kozma, 1995;
Allen, 1998
Rac1 Lamellipodia Important for cell movement Patterson,
1990; Nobes,
1995; Allen,
1998
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Furthermore, all three RhoGTPases have been shown to act by activating PI3kinase
(Bokoch et al., 1996; Kumagai et al., 1993; Zhang et al., 1993), with Rac1 and Cdc42
binding to the p85 subunit of the enzyme and thus activating its kinase activity (Zheng et
al., 1994).
In addition to their role in migrating cells, RhoGTPases have also been found to be
important in the EC during the process of transendothelial migration. RhoGTPases have
been found to be activated during ICAM-1 cross-linking (Adamson et al., 1999),
suggesting that these proteins are important in the stable  adhesion step of the
transendothelial migration (Wojciak-Stothard et al., 1999). It can therefore be speculated
that manipulation of RhoGTPases in the EC will interfere with lymphocyte
transnendothelial migration.
Indeed, a series of experiments pharmacologically manipulating RhoGTPases in
brain ECs have shown that inhibition of RhoGTPases prevents lymphocyte migration.
Adamson et al. (1999) showed that treatment with C3 transferase, which ribosyltes
RhoGTPases, rendering them inactive, resulted in inhibition of lymphocyte
transendothelial migration. In addition, treatment of brain ECs with prenylation inhibitors
which prevent essential post-translation prenylation of Rho proteins, resulted in inhibition
of lymphocyte tranendothelial migration and prevention of T cell infiltration to the brain
in a model of EAE (Walters et al., 2002). Finally, treatment with Lovastatin, which also
interferes with the prenylation step, resulted in inhibition of lymphocyte transendothelial
migration and attenuation of EAE in mice (Greenwood et al., 2003).
4.5.1.2 Vav1 as a GEF for Rho GTPases
The ability of Vav1 to act as a GEF for RhoGTPases was first described by Adams
et al. (1992) who observed the homology of Vav1 with the Dbl family of Rho. This was
also directly observed in a study where NIH3T3 cells were transformed with Vav1,
resulting in induction of foci similar to the ones induced by other RhoGTPases
(Khosravi-Far et al., 1994).
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Vav1 was initially identified as being a GEF for Ras in activated human T cell lines
and fibroblasts (Adams et al., 1992; Gulbins et al., 1994a; Gulbins et al., 1994b).
However, evidence obtained by Bustelo et al. (1994) suggested otherwise. More
specifically, they found that overexpression of Vav1 in rodent fibroblasts did not result in
increase of GTP bound Ras. In addition, Vav1 did not display Ras GEF activity in
GTP/GDP exchange assays and finally that the morphology of Vav1 transformed cells
did not resemble that of Ras transformed ones (Bustelo et al., 1994; Khosravi-Far et al.,
1994).
Subsequent studies showed that Vav1 could act as a GEF for RhoA, Rac1 and
Cdc42 and induce mitogen activated protein (MAP) kinase signalling cascades, as
microinjection of Vav1 in fibroblasts resulted in actin polymerisation similar to the one
induced by the former RhoGTPases (Olson et al., 1996). In addition, overexpression of
Vav1 was shown to increase the activity of Rac1 and Cdc42  in Jurkat T cells (Kaminuma
et al., 2001).
Further studies have suggested that Vav1 primarily acts as a GEF for Rac1 and
Cdc42 via its DH domain (Crespo et al., 1996; Garcia-Bernal et al., 2006; Garcia-Bernal
et al., 2005; Han et al., 1997). This activity has been shown to require Lck or Fyn
phosphorylation of tyrosine 174 which, as mentioned earlier, is thought to release the
GEF activity from the autoinhibitory arm (Arudchandran et al., 2000; Crespo et al., 1997;
Han et al., 1997).  In addition, the Y174F mutation of the DH domain enhances the Vav1
GEF activity for Rac1, suggesting that tyrosine residue acts as a negative regulatory site
for Vav1 (Kuhne et al., 2000).
Recent nucleomagnetic resonance studies have also indicated that Vav1 interacts
with Rac1 via its CD domain, with residues K116 and S83 being either part of the
interphase or undergoing conformational change in response to the CD binding (Heo et
al., 2005). Vav1 has also been shown to act as a GEF through the interaction of its SH2
domain with the Mer receptor tyrosine kinase which is known to regulate immune
ingestion of apoptotic cells in monocytes (Mahajan and Earp, 2003).
In addition to Vav1 being a GEF for Rac1, Vav2 has been shown to act as a GEF
for RhoA and other distant members of the Rho family such as RhoG. This was observed
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in a study comparing constitutively active forms of Vav1 and Vav2, which displayed
phenotype similar to Rac1 and RhoG respectively (Schuebel et al., 1998).
The association of Vav1 with Rac1 has been shown to activate subsequent
signalling pathways, such as MAPkinase and c-JUN N-terminal kinase (JNK) (Crespo et
al., 1996; Olson et al., 1996). These lead to activation of transcription factors resulting in
gene expression and cytoskeletal re-arrangements.
4.5.2. PI3 kinase pathway
Vav1 activation through tyrosine phosphorylation and its association with the afore
mentioned adaptor molecules results in the activation of downstream signalling cascades.
One of the pathways thought to be triggered is the PI3k pathway. PI3 kinases are a family
of enzymes which are divided into three classes based on their structure, regulation and in
vitro substrate (Leevers et al., 1999).
Vav1 is thought to activate the RhoGTPases Rac1 through its DH domain, which in
turn is thought to activate PI3kinase, leading to AKT and Tec family kinase (Tec, ITK)
phosphorylation (reviewed in Tybulewicz et al., 2003). Interestingly, there has been
evidence that Vav1 can also act downstream of PI3kinase, as PI3 kinase inhibition can
lead to reduced Vav1 phosphorylation. Thus, it has been suggested that PI3kinase and
Vav1 may act in a positive feedback loop (Reynolds et al., 2002; reviewed in Tybulewicz
et al., 2003).
The activation of the PI3kinase pathway leads to the activation of Tec and Itk
kinases through phospholipids phosphoinositol-3-phosphotase (PIP3). Tec and Itk kinases
have been shown to activate further signalling through (phospholipase C) PLCγ as well
facilitate Vav1 interaction with other proteins which mediate its localisation to the plasma
membrane (Dombroski et al., 2005). In addition, signalling through PLCγ is thought to
lead to the membrane recruitment of Ras (Reynolds et al., 2002).
PLCγ uses phosphoinositol 4.5 bisphosphate (PIP2) as a substrate for the
production of inositol triphosphate (IP3) and diaglycerol (DAG). Interestingly, Vav1-/- T
cells have higher levels of PIP2 than the WT, which indicates failure to activate PLCγ
(Reynolds et al., 2002).
Regulation of T cell migration by the guanidine exchange factor Vav1
Rachel David
68
The two products generated from PIP2 are IP3 and DAG.  They are both involved
in the activation of transcription factors, the former activating NFAT and the latter NF-
Kb. More specifically, IP3 leads to an increase in intracellular calcium, which mediates
an increase in calcineurin, thus activating NFAT (Costello et al., 1999; Fujikawa et al.,
2003). NFAT is the transcription factor for IL-2, which explains the reduction of IL-2
production in Vav1-/- mice (Costello et al., 1999; Fischer et al., 1998; Penninger et al.,
1999). Overexpression of Vav1 has also directly been shown to lead to NFAT
transcription and IL-2 expression in Jurkat T cells (Wu et al., 1995). Interestingly, the
negative regulator of IL-2, glycogen synthase kinase (GSK)3alpha (reviewed in Cantley,
2002), is activated independently of Vav1 in a pathway regulated by PI3kinase, as Vav1-
/- Jurkat and freshly isolated T cells can induce GSK3alpha phosphorylation upon
CD3/CD28 stimulation (Wood et al., 2006). NFAT is also the transcription factor for c-
Maf, which in turn is the transcription factor for IL-4, thus explaining the reduced
production of the later in Vav1-/- mice (Tanaka et al., 2005). Note that Vav1 can activate
NFAT through different signalling pathways as well (reviewed in Katzav, 2004). The
downstream signalling events upon Vav1 phosphorylation as summarised in Figure 5.
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Figure 5: Downstream signalling events
Vav1 phosphorylation leads to PI3K activation, which initiates a signalling cascade that
has as an end result the activation of the transcription factors NFAT and NFkB.
4.5.3. JNK kinase pathway
The second product generated from PIP2 is DAG, which has been shown to activate
PKC, an enzyme that activates the transcription factors NFκB  as well as activate JNK
(reviewed in Janeway et al., 2001).
JNK kinase is a serine threonine kinase involved in the phosphorylation of
transcription factors such as c-Jun (reviewed in Bustelo, 2000). Early studies showed that
Vav1 could activate JNK to levels similar to other GEFs via its DH and CH domains
(Crespo et al., 1996; Han et al., 1997). Mutation in the tyrosine regulatory sites of Vav1
have in fact been shown to induce JNK activation (Lopez-Lago et al., 2000).
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 Further studies showed that Vav1 can activate JNK by two pathways (Figure 6);
the first is a Ca2+-dependent pathway, and is controlled by Vav1 and PKCθ (Moller et al.,
2001). The second is a Rac1-dependent pathway, where Vav1 activates JNK via its GEF
activity (Kaminuma et al., 2001). JNK can in turn activate AP-1 by phosphorylating c-
Jun (Derijard et al., 1994), which acts as a transcription factor activating NFAT and
consequently IL-2 (Northrop et al., 1993).  Thus, as mentioned earlier, Vav1 can activate
NFAT through several pathways.
Figure 6: Activation of the JNK pathway by Vav1
Vav1 can activate JNK by two pathways. One is Ca2+ -dependent and is mediated by PKC
and the other is Ca2+ - independent and is mediated by Rac1.
4.5.4. MAPKinase pathway
Vav1 has also been shown to activate the MAPK pathway.  More specifically,
Vav1-induced transformation is thought to involve the MAPK pathway (Khosravi-Far et
al., 1994), while Vav1-/- T cells have been shown to have reduced extracellular signal
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regulated kinase (ERK) activation (Colucci et al., 2001). The mechanism of activation is
not really understood but it is thought that Vav1 may regulate ERK via PLCγ1, which
causes release of DAG, activating the GEF for Ras, leading to a Ras-mediated activation
of the MAPK pathway (reviewed in Tybulewicz, 2005). In addition, studies by Villalba et
al. (2000) have suggested that Ras and Vav1 may act in parallel pathway with respect to
the activation of ERK, where Ras plays a dominant role, overriding the effects of Vav1.
The same study suggested a role for Vav1 in CD69 upregulation, the later being regulated
by ERK.
4.6. Vav1 in CD28 signalling
Studies have shown that Vav1 has a pivotal role in CD28 signalling. More
specifically, Vav1 is thought to be phosphorylated upon CD28 ligation, in a process
dependent on residues 173-181 within the CD28 cytosplasmic tail (Klasen et al., 1998).
Vav1 phosphorylation has been shown to require Fyn via binding of its SH2 domain and
is thought to be stronger with concomitant TCR ligation (Michel et al., 1998; Michel et
al., 2000). It has to be noted that a recent study by Dennehy et al (2007) suggests that
CD28 signals are in fact dependent on TCR signals, as the latter is required for CD28-
mediated phosphorylation of the adaptor Slp76 and thus recruitment of Vav1.
Interestingly, a recent study has shown that CD28 mediated methylation of Vav1 on
arginine, causing it to localise to the nucleus. The localisation of Vav1 to the nucleus in
this case was observed around 30 minutes after stimulation, which contrasts the
seconds/minutes it takes post TCR/CD28 co-ligation and subsequent Vav1
phosphorylation. This suggests that arginine methylation, whose role is not yet fully
understood, marks a different function of Vav1 (Blanchet et al., 2005).
Furthermore, a study by Raab et al. (2001) has shown that CD28-dependent
activation of Vav1 also involves Slp76. Using transfected Jurkat T cells, they observed
that CD28 ligation resulted in both Vav1 and Slp76 translocation to the plasma
membrane, where they were found to form complexes. This CD28-dependent complex
formation subsequently led to the activation of downstream effectors such as NFAT for
the transcription of IL-2.
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By recruiting and activating Vav1, CD28 can activate signalling pathways
independently of the TCR, such as Akt, Tec and ITK kinases (reviewed in Michel and
Acuto, 2002; Tuosto et al., 2000), which in turn can lead to gene expression. Other than
the already mentioned transcription of IL-2 (Raab et al., 2001), CD28 ligation has been
found to induce activation of NFΚB in a Vav1-dependent manner (reviewed in Michel
and Acuto, 2002). More specifically, NFKB is a transcription factor that belongs to the
Rel family of proteins, and is important in innate immunity, as it acts to transcribe genes
that encode cytokines, chemokines, enzymes and anti-microbial peptides. Upon TCR
activation, the ΙΚΚβ, which is part of the I kappa B kinase (IKK) signalosome (IKKα,
IKKβ, and NEMO) and functions in sequestering NFKB in the cytoplasm, becomes
phosphorylated and ubiquitinated, hence degraded, thus allowing for the transcription
factor to translocate to the nucleus and act on its target genes (reviewed in Ben-Neriah,
2002).
CD28-dependent activation of NFKB does not follow the afore mentioned canonic
pathway. More specifically, upon CD28 stimulation, Vav1 has been found to associate
with IΚΚα in both Jurkat and primary CD4+ T cells, at the level of the CD28 clusters
(Piccolella et al., 2003). Degradation of IκΒα by the IKK signalosome leads to release of
NFKB in the nucleus and consequently allows for transcription of the genes it regulates
(Michel et al., 2000). This is thought to involve the MAPK signalling pathway (Marinari
et al., 2002).
Vav1 activated by CD28 ligation has been found to associate with the RhoGTPase
Rac1 while in a complex with Slp76, and result in remodeling of the actin cytoskeleton
(Raab et al., 2001). In addition, CD28-activated Vav1 has been found to associate with
WASp, which as mentioned earlier, is an important regulator of the actin cytoskeleton
(reviewed in Sechi and Wehland, 2004).
Finally, as with TCR-dependent activated Vav1, CD28/Vav1 signalling is thought
to be regulated by Cbl-b, the later acting as a ubiquitin ligase for Vav1 (Miura-Shimura et
al., 2003).
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5. Hypothesis and Aims
Vav1 acts as an essential link between TCR signalling and the re-arrangements of
the cytoskeleton which are essential for T cell migration. In addition to this, Vav1 has
been shown to regulate the migration of several cell types, including T cells. Based on
this, we had hypothesised that Vav1 activation, occurring post-TCR triggering by the
endothelium, will regulate the cytoskeletal re-arrangements resulting in recruitment and
retention of T cells in the sites of inflammation. Thus, it was predicted that loss of Vav1
will result in inefficient TCR-dependent recruitment and retention of T cells in antigenic
sites.
The initial aims of this study were the following:
• To establish a physiological role of Vav1 in the regulation of memory T cell
trafficking in vitro and in vivo
• To establish a physiological role of Vav1 in TCR-induced T cell recruitment
in vitro and in vivo.
In addition to this, Vav1 has been implicated in conjugate formation as well as
CD28-mediated co-stimulation. Prompted by our findings which suggested a role for
Vav1 in the regulation of the migratory stop signal in T cells, two new aims emerged:
• To establish a role for Vav1 in memory T cell conjugate formation and the
tranduction of the migratory stop signal in vitro and in vivo
• To assess the contribution of Vav1 in CD28-mediated regulation of T cell
trafficking in vitro and in vivo
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Materials and Methods
1. Mice
129sv and C57BL/6 male and female mice aged 7 to 9 weeks were purchased from
Harlan Olac (Bicester, UK) and used as tissue donors and for in vivo experiments. Wild
type (WT) and Vav1-/- 129sv mice used for the generation of T cells were previously
described (Turner et al., 1997). Experiments with animals were performed under the
Home Office authority (PPL 70/5872).
2. Cells
2.1. Endothelial cells
2.1.1 Generation of Endothelial cells
ECs were generated from WT 129sv male and female mouse lungs (Harlan Olac) as
previously described (Marelli-Berg et al., 2000). Mouse lungs were isolated, minced into
2-3mm2 square blocks and incubated with 0.5mg/ml collagenase (Sigma, Dorset, UK) for
30 minutes at 37 °C, followed by passing through a 70µm pore membrane (Marathon,
London, UK) to remove undigested tissue. The digested tissue was washed in phosphate
buffer saline (PBS) and further digested in trypsin/ Ethylenediaminetetraacetic acid
(EDTA) (Gibco, Paisley, UK) at 37 °C for 5 minutes to create a single cell suspension.
The trypsin was inactivated with foetal calf serum (FCS) (Globepharm, Guilford, UK)
and the cells washed in PBS 2.5% FCS for 5 minutes. The cells were then seeded in 2%
gelatinated (Sigma) 25 cm2 culture flasks (Helena biosciences, Sunderland, UK) with EC
medium as described in section 2.1.2.
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2.1.2 Culture of ECs
Primary mouse ECs generated from 129sv male and female mouse lungs were
cultured in 2% gelatinated 25 cm2 flasks at 37oC in the presence of 5% CO2. The EC
medium consisted of Dulbecco's Modified Eagle media (DMEM, Gibco) supplemented
with 2 mM glutamine (Gibco), 50 IU/mL penicillin (Gibco), 50 µg/mL streptomycin
(Gibco), 50 mM 2-Mercaptoethanol (2-ME) (Gibco), 1mM sodium pyruvate (Gibco),
20mM N-2-hydroxyethylpiperazine-N'-2-ethane sulfonic acid (HEPES) (Gibco), 1%
non-essential amino acids (Gibco), 20% FCS and 150µg/ml EC growth supplement
(Sigma). Medium was replaced every 48 hours. When confluent, the cells were detached
with trypsin/EDTA and passaged. For functional assays, the ECs were used between
passage 2 and 6 and treated with 600 U/mL murine IFNγ (PeproTech, Peterborough,
United Kingdom) for 48 to 72 hours prior to use in experiments. This led to up-regulation
of MHC class I, induction of MHC class II and antigen presentation, leading to
proliferation of antigen-specific T cells (Figure 7)
Figure 7: IFNγ treatment induced MHC class II induction and T cell proliferation
Treatment of murine ECs with 600units IFNγ  for 48 to 72 hours results in MHC class II
expression induction (left panel, courtesy of Eleanor Raynsford) and T cell proliferation
(right panel).
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2.2. T cells
2.2.1 Isolation of HY-specific T cells
Memory WT and Vav1-/- T cells specific for the male-specific minor
histocompatibility antigen HY in the context of H2-Db were obtained by two fortnightly
intraperitoneal immunisations of female mice with male splenocytes in PBS. Each
immunisation consisted of one whole male WT spleen in 100ml PBS suspension.
At day 28, the mice were culled and their spleens and lymph nodes extracted. The
cells from the spleen and lymph nodes were detached by processing through a 70µm pore
membrane and cultured in vitro.
2.2.2. T cell culture
HY-specific WT and Vav1-/- T cells isolated from immunised mice were further
expanded in vitro by fortnightly re-stimulation in 24 well plates (Helena biosciences)
with irradiated (60Gy) male splenocytes (50x106 splenocytes per 5x106 lymphocytes) and
20U/ml rIL-2 (Roche, Hertfoshire UK) in T cell medium (RPMI 1640 medium
supplemented with 10% FCS, 2 mM glutamine, 50 IU/mL penicillin, 50 µg/mL
streptomycin, 10mM HEPES and 50 mM 2-ME were cultured at 37oC in the presence of
5% CO2.
HY-specific WT T cells from C57BL/6 mice were already in culture in our
laboratory. They were cultured as previously described and used in the skin grafting
experiments.
For use in experiments, viable T cells were selected between 6 and 10 days by
density gradient centrifugation with Ficoll-Paque (Amersham Biosciences,
Buckinghamshire, UK).
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2.3. Bone marrow-derived dendritic cells
2.3.1 Isolation of bone-marrow dendritic cells
Bone marrow (BM) -derived DCs were obtained from WT C57BL/6 mice. Femurs
from 7–to-10-week-old female mice were removed and BM cells were flushed with
culture medium using a 26 gauge needle (Fischer Scientific, Loughborough, UK). Red
blood cells were lysed from the cell suspension with lysis buffer (Gentra systems,
Minneapolis, USA). BM cells (5 ? 106) were seeded per well in a 6 well plate (Helena
bioscience) in DC medium as described in section 2.3.2.
2.3.2 Dendritic cell culture
Bone marrow-derived dendritic cells were cultured in RPMI 1640 medium
supplemented with 10% FCS, 2mM glutamine, 50 IU/mL penicillin, 50 µg/mL
streptomycin, 50 mM 2-ME and 8-16% murine granulocyte-macrophage colony
stimulating factor (GM-CSF) obtained from the supernatant of the GMCSF hybridoma
(gift from Professor Andrew George, Imperial College, London, UK).  Cells were
culutured at 37oC in the presence of 5% CO2.  On days 3 and 5, fresh culture medium was
added to the plates.
For functional assays, immature DCs were matured overnight with 100ng/ml
lipopolysaccharide (LPS) (gift from Dr. Jian-Guo Chai, Imperial College, London, UK)
and were used between 7-to-10 days post-isolation.
3. Reagents
The HY peptides Uty, Smcy and Ab were a gift from Dr. Diane Scott  (Imperial
College, London, UK) and used at concentrations between 0-100nM. Tritiated thymidine
(Amersham) was used at 1µCi/well. Mouse IFNγ was purchased from Peprotech and used
at 600units/ml or 600units/injection. rICAM-1 was purchased from R&D systems and
was used between 2 and 5µg/ml diluted in Tris pH 8.5. Bovine serum albumin (BSA) was
purchased from Sigma. PKH26 was purchased from Sigma. CSFE was purchased from
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Molecular probes (Paisley, UK) and used between 100nM and 1µM diluted in PBS.
Phalloidin conjugated with Alexa 546 (Molecular probes) and anti-tubulin conjugated
with Fluorescein isothiocyanate (FITC) (Sigma) were a gift from Professor Anne Ridley
(Ludwig Institute of Cancer Research, UCL, London) and were used at 5: 200 and 1:300
dilution respectively. 0.2% 100x Triton was purchased from Sigma. Vectorshield medium
containing 4,6-diamidino-2-phenylindole (DAPI) was purchased from Vector
laboratories (Peterborough, United Kingdom). CXCL12 was purchased from Peprotech
and was used at 50ng/ml. CXCL10 was purchased from Peprotech and was used at
300ng/ml. PMA and ionomycin were purchased from Sigma and used at 5µg/ml and
2.5µg/ml respectively.  Golgiplug containing Brefeldin A which prevents protein
transport was purchased from BD Pharmingen (Oxford, UK), and used at 1µl per
condition. Cellfix containing paraformaldehyde was purchased from BD Pharmingen and
used at 1:10 dilution.
Materials and Methods
79
4. Antibodies
Antibody Clone Company
CD4-allophycocyanin
(APC)
CT-CD4 Caltag, Buckingham, UK
CD8-phycoerythrin
(PE)Cy5
53-6.7 BD Pharmingen
CD4-FITC H129.19 BD Pharmingen
CD3 CT-CD3 Caltag
LFA-1-FITC 2D7 BD Pharmingen
CD25-FITC PC61 Cambridge biosciences, Cambridge, UK
CD69-FITC H1.2F3 Cambridge biosciences
CD62L-FITC MEL-14 Cambridge biosciences
CXCR4-FITC 2B11 BD Pharmingen
CCR5-PE HM-CCR5 Cambridge biosciences
CCR7 N/A Calbiochem, Nottingham, UK
CXCR3-PE 220803 R&D systems, Abingdon, UK
CD28 37.51 BD Pharmingen
α4β7-PE DATK32 BD Pharmingen
PSGL-1 4RA10 BD Pharmingen
VCAM-1 N/A From hybridoma
CD105 MJ7/18 BD Pharmingen
CD11c-PE HL3 BD Pharmingen
Ab-FITC 25-9-17 BD Pharmingen
CD80-FITC 16-10A1 BD Pharmingen
CD86-FITC GL1 BD Pharmingen
IFN-γ-FITC XMG1.2 Caltag
IL-4 APC 11B11 Ebioscience (London, UK)
Db-blocking N/A Gift from Maggie Millrain, Imperial College,
UK
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5. Proliferation assays
5.1. Cells
WT and Vav1-/- T cells were used at 104/well between days 6 and 10 post-
stimulation. Splenocytes acting as APCs were used at 5x105 per well. They were isolated
from female C57BL/6 mice, passed through a 70µm membrane to create a single cell
suspension and irradiated at 60Gy to prevent proliferation. ECs acting as APCs were used
at 104 per well. 48-72 hours prior to the experiment, they were treated with 600u/ml IFNγ
and subsequently irradiated at 180Gy to prevent proliferation
5.2. Proliferation assay
HY epitope specificity was assessed with thymidine incorporation assays. WT and
Vav1-/- T cells were incubated with irradiated splenocytes or ECs, HY peptides UTY,
SMCY and Dby (concentrations 0nM-100nM) in a 96 well plate (flat-bottom for ECs, U-
bottom for splenocytes) in 200µl at 37oC in the presence of 5% CO2. In experiments
examining MHC class I antigen presentation, 50µl Db blocking antibody was added to the
culture. The plate was pulsed 48 hours later with 1µCi/well 3H thymidine and incubated
overnight at 37oC in the presence of 5% CO2.  The plate was harvested using the Tomtec
harvester 96 and filter (Wallac/PerkinElmer, Buckinghamshire, UK), counted using the
Wallac Microbeta counter for Windows. In experiments using ECs as APCs, the plate
was frozen for 5 hours to detach the cells and thawed at 37oC prior to harvesting. The
results were analysed using Microsoft Excel and Prism software.
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 6. Flow cytometry
6.1. Cytometer and analysis software
The flow cytometer used was a two laser BD fluorescence activated cell sorter
(FACS)calibur (Oxford, UK) connected to a Mac computer (OS 9) using Cellquest as
acquisition software.
Acquired samples were analysed using Flowjo (Treestar, USA) by gating on live
cells on the forward and side scatter plot.
6.2. Surface staining
For surface staining, cells were labelled with the appropriate volume of antibody or
isotype control according to the manufacturer’s instructions in 100µl PBS at 4oC in the
dark for 20 minutes. They were subsequently washed with PBS and fixed with 300µl
1xCellfix for analysis.
6.3. Intracellular staining
For intracellular staining of IFNγ and IL-4, 1x106 T cells were incubated with 5x106
female splenocytes pulsed with HY peptide and Golgiplug containing BrefeldinA for 4
hours at 37oC in the presence of 5% CO2. . T cells were incubated with 5µg/ml PMA and
2.5µg/ml ionomycin in the presence of Golgiplug as a positive control or Golgiplug alone
as a negative control. In experiments assessing cytokine secretion upon antibody
stimulation, T cells were activated with plastic-bound antibody as described in section 6.4
in the presence of Golgiplug. The cells were subsequently washed and staining for
intracellular antigen using the Fix&Perm kit (Caltag) according to the manufacturer’s
instructions. Briefly, T cells were incubated with surface antigen for 15 minutes at room
temperature in the dark, followed by incubation with permeabilising reagent A for 15
minutes at room temperature in the dark. The T cells were subsequently washed and
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stained for intracellular antigen in the presence of permeabiling reagent B for 20 minutes
at room temperature in the dark. Cells were fixed in 300µl 1xCellfix and analysed by
flow cytometry.
6.4. Activation experiments
For the activation experiments, WT and Vav1-/- T cells were activated for 24 hours
with plate-bound 1µg/ml anti-CD3 (BD Pharmingen) and 5µg/ml anti-CD28 or 2µg/ml
hamster IgG as a control (Sigma) and subsequently stained for analysis as described in
section 6.2. Antibody coating was done in the presence of 200µl Tris pH 8.5 for 2 hours
at 370C. The wells were washed with PBS prior to plating the T cells.
7. Adhesion assays
96 well plates were coated with rICAM-1 (5µg/l in Tris pH 8.5) for 2 hours at 370C.
Control wells were incubated with PBS alone. The plate was subsequently blocked with
2.5% BSA in PBS at 37°C for 1 hour, and washed with 0.5% BSA in PBS. T cells were
labelled with PKH26 as described in section 12.2 and were plated at 103 per well and
incubated for 10-60 minutes. Non-adherent T cells were removed by gentle washing and
the number of adherent cells was analysed with wide-field fluorescence microscopy as
described in section 12.4. Control wells were not washed. The number of cells present in
each well was estimated using the algorithm in the appendix. The percentage adhesion
was calculated with the following formula:
Experimental adhesion-min adhesion      x100
Control adhesion-min adhesion
8. Labelling the cytoskeleton
Glass coverslips (VWR, Lutterworth, United Kingdom) were coated with ICAM
(5µg/ml in Tris pH 8.5) for 2 hours at 37oC.  ICAM-1-coated coverslips were blocked
with 2.5% BSA in PBS for 1 hour at room temperature. Viable WT and Vav1-/- T cells,
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used between days 6 and 10 post-stimulation, were plated on ICAM-1-coated coverslips
at 0.5-1x106 cells per coverslip for 15 minutes at 37oC in the presence of 5% CO2. Non-
adherent cells were removed by gentle washing with PBS and fixed with 1xCellfix for 10
minutes at room temperature. 1xCellfix was washed with PBS and the cells were
permeabilised with 0.2% 100x Triton in PBS for 4 minutes at room temperature. The
coverslips were subsequently incubated with 0.5% BSA in PBS for 30 minutes, followed
by addition of Phalloidin and anti-tubulin for 1 hour at a dilution of 5:200 and 1:300
respectively. The antibodies were washed off with PBS and the coverslips were allowed
to dry overnight. The coverslips were mounted with vectorshield medium containing
DAPI which labels the nucleus and visualised with wide-field fluorescence microscopy as
described in section 12.4.
9. DC:lymphocyte conjugate formation assays
Female DCs were matured overnight with 100ng/ml LPS at day 7 post-isolation.
They were subsequently labelled with 100nM CFSE as described in section 12.2 and used
at 105 DCs per condition. Viable WT and Vav1-/- T cells were used at day 10 post-
isolation at 2.5x105 cells per condition and labelled with PKH26 as described in section
12.2.
For conjugate formation, female or female plus 50nM Dby peptide DCs were
incubated with 2.5x105 WT and Vav1-/- T cells between 1 and 2 hours at 37°C in the
presence of 5% CO2. The cells were spun at 650rpm for 5 minutes to increase the
possibility of cell contact. Conjugate formation was analysed with flow cytometry and
Flow Jo software. Conjugates were defined as the double positive population formed
from the contact between the CFSE-labelled DCs and the PKH26-labelled T cells. Single
stains were used as controls for compensation.
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10. In vitro transwell-based migration assays
10.1. Cells
ECs were treated for 48 to 72 hours with 600u/ml IFNγ. The day before the
experiment, they were detached and plated on gelatinated Costar Transwell tissue-culture
well inserts (diameter,12 mm), which contained polycarbonate membranes with a 3µm
pore size (Sigma), at 104 per transwell, and allowed to adhere. On the day of the
experiment, the transwells were gently washed to remove non-adherent cells.
Viable HY specific WT and Vav1-/- T cells were used between days 7 and 10 post-
stimulation and were plated on the top chamber in 200µl RPMI 2% FCS medium at 3-
5x105 cells per insert.
10.2. Induction of CD28 signalling
To induce CD28 signalling, viable 3-5x105 HY specific WT and Vav1-/- T cells per
transwell were treated with a mixture of hamster anti-mouse CD28 (5µg/5x106 cells), and
rabbit anti-hamster immunoglobulin (Ig) (2.5µg/5x106 cells) or Hamster Ig (5 µg/5x106
cells) and rabbit anti-hamster Ig (2.5 µg/5x106 cells) for 45 minutes at 37oC in the
presence of 5% CO2. The T cells were washed in PBS prior to use in the experiments.
10.3. Induction of stop signal
To induce the stop signal, 24-well plates were coated with a mixture of 5µg/ml
CD28 and 1µg/ml CD3 or hamster IgG (2µg/ml) as an isotype control in 200µl Tris pH
8.5 for 2 hours at 37oC. The wells were subsequently washed and 3-5x105 HY specific
WT and Vav1-/- T cells per transwell were plated on the coated wells for 45 minutes at
37oC in the presence of 5% CO2.The T cells were harvested and washed in PBS prior to
use in the experiments.
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10.4. Transwell-based migration assays
Purified HY specific WT and Vav1-/- T cells (3-5x105/transwell) in RPMI 1640
supplemented with 2% FCS were added into each insert and left to migrate through the
monolayer. In experiments examining the response to integrin, the transwells had
previously been coated with ICAM-1 (2µg/ml in Tris pH 8.5 for 2 hours at 37oC). In
experiments examining the response to chemokines, CXCL12 or CXCL10 were added
directly to the bottom well at a concentration of 50ng/ml and 300ng/ml respectively. In
experiments examining migration in response to antigen presentation by the endothelial
monolayer, the ECs were pulsed with IFNγ for 48 to 72 hours to induce MHC class II
expression and antigen presentation, were seeded on 2% gelatinated transwells and
allowed to form a monolayer as described in section 9.1.
 The number of migrated T cells was determined by counting the lymphocytes
present in the well media at different time points. Results were analysed with Microsoft
Excel and Prism software and are expressed as the percentage of transmigrated cells.
10.5 Cell counting
Migrated lymphocytes were counted at 2, 4, 6 and 24 hours by sampling 10µl of
well media into a haemocytometer (Sigma).  Cells present in the four corners of the
haemocytometer (depicted below) were counted and divided by four to take an average of
migrated cells. The derived number was multiplied by 104 to estimate the number of cells
per ml and divided by two to calculate the number of cells present in 500µl of well
medium.
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11. In vitro time-lapse migration assays
11.1. Cells
ECs were plated on 35mm dishes and were allowed to grow to confluence at 37oC
in the presence of 5% CO2 in EC medium. 48 to 72 hours prior to the experiment they
were pulsed with 600u/ml IFNγ .
Viable HY-specific T cells were selected through high density centrifugation and
were serum-starved for 2 hours in RPMI 2% FCS at 37oC in the presence of CO2. They
were subsequently plated at 1x106 per 35mm dish in 1ml of RPMI 2% FCS and allowed
to migrate.
11.2. Time-lapse microscopy
In time-lapse migration assays testing the response to ICAM-1, 35mm dishes were
coated with 5µg/ml ICAM-1 in PBS and incubated at 4°C overnight. The plate was
subsequently blocked with 2.5% BSA PBS at 37°C for 1 hour, and washed with 0.5%
BSA PBS. HY-specific WT and Vav1-/- T cells were serum-starved in RPMI 2% FCS for
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2 hours and subsequently seeded on ICAM-1 dishes at a concentration of 1x106 in 1ml
per dish. T cells were incubated for 5 minutes at 370 C and washed once to remove non-
adherent cells.
In time-lapse migration assays testing the migration through EC monolayer, male
and female IFNγ treated ECs were seeded on 2% gelatinated 35mm dishes and incubated
at 37°C for 3 days. Prior to the assay, the EC monolayers were gently washed with warm
medium to remove non-adherent cells. HY-specific WT and Vav1-/- T cells were serum-
starved in RPMI 2% FCS for 2 hours and subsequently seeded on EC-coated dishes at a
concentration of 1x106 in 1ml per dish. T cell migration was visualised directly after
seeding.
T cell migration was observed with time-lapse microscopy using Tempus software
(Kinetic Imaging Ltd, Nottingham, UK). The movie was made with the collection of
images taken by a KPM1E/K-S10 CCD camera (Hitachi Denshi, Japan) every 15-30
seconds for 25-50 minutes. The path of approximately 10 cells per movie was tracked for
the whole of the time-lapse sequence using Motion Analysis (Kinetic Imaging Ltd, UK).
Mathematical analysis was then carried out using Mathematica 6.0 (Wolfram Research
Institute) workbooks (Wells and Ridley, 2005).
12. In vivo migration assays
12.1 Cells
HY-specific WT and Vav1-/- T cells were used between 5 and 10x106 per iv
injection or between 2 and 3x106 per ip injection. For the chemokine experiment, T cells
were rested for two hours in 2% FCS prior to the injection.
Female DCs were matured with LPS as previously described and were used at 2 to
3x106 cells per ip injection.
12.2 PKH26 and CFSE labelling
For labelling with PKH26, T cells were washed and re-suspended at a concentration
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of 107/mL in PBS. The PKH26 Cell Linker was added at a final concentration of 5µΜ,
and cells were incubated at room temperature for 5 minutes. The reaction was inactivated
by adding an equal volume of FCS to the cell suspension and the cells were washed in
PBS 10% FCS for 10 minutes.
For labelling with CFSE, T cells were washed and re-suspended in 100nM-1µM
CFSE in PBS at room temperature for 10-15 minutes. The reaction was inactivated by
adding an equal volume of FCS to the cell suspension and the cells were washed in PBS
10% FCS for 10 minutes.
12.3 In vivo migration assays
To assess T cell trafficking, HY specific labelled WT and Vav1-/- T cells were
injected intravenously (iv) at 107 cells/injection in male and female 129sv or C57BL/6
mice. The mice were culled 2, 6 or 24 hours post-injection.
To assess chemokine -dependent recruitment, C57BL/6 female mice were injected
intraperitoneally (ip) with CXCL10 (1.2µg/ml) followed by an iv injection of 107 HY-
specific labelled WT or Vav1-/- T cells per injection. Prior to the assay, T cells were
rested for 2 hours in 2% FCS in the absence of IL-2 to promote chemokine-driven
migration. The mice were culled 16 to 20 hours post-injection
To assess antigen-dependent and CD28-dependent recruitment from the
bloodstream, C57BL/6 male and female mice received an injection of 6x105 units IFNγ
ip. On day 3, CD28-signalling was induced in labelled 10x106 WT and Vav1-/- cells as
described in section 5.4 and the cells were injected iv. The mice were culled 24 hours
later.
To assess antigen-dependent tissue infliltration, male and female C57BL/6 mice
received an injection of 6x105 units IFNγ ip. On day 3, labelled HY specific 2x106 WT
and Vav1-/- were injected ip into male and female mice. The mice were culled 24 hours
later.
To assess skin graft infiltration, female C57BL/6 were grafted on with skin from
the tail of male or female C57BL/6 mice according to the method of Billingham and
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Medawar (1951). On day 4, the mice received an iv injection of labelled HY-specific WT
and Vav1-/- T cells. The mice were culled 24 hours later.
To assess conjugate formation in vivo, female C57BL/6 mice were injected with
female DCs (2x106) pulsed with Dby peptide ip, followed by an iv injection of HY-
specific labelled WT and Vav1-/- T cells. Mice were culled 24 hours post-injection.
12.4 Wide-field fluorescence microscopy and flow cytometry
Tissue samples were embedded in optimal cutting temperature (OCT) compound
(Raymond Lamb, United Kingdom), snap-frozen, and stored until analysis. Frozen tissue
samples were sectioned at 5-10µm. The number of infiltrating cells obtained in six
randomly selected x10-magnified fields/sample from at least three animals were then
averaged and assessed statistically.
Cryostat sections were laid onto microscope slides (VWR), left to dry overnight,
and then mounted in Vectorshield mounting medium for fluorescence with DAPI which
labels the cell nucleus blue.
Peritoneal membranes were laid on polysine microscope slides (VWR), left to dry
overnight, and mounted in Vectorshield mounting medium for fluorescence with DAPI.
Slides were visualized with a Coolview 12-cooled CCD camera (Photonic Science,
Newbury, United Kingdom) mounted over a Zeiss Axiovert S100 microscope equipped
with Metamorph software (Zeiss, Welwyn Garden City, United Kingdom). 10x, 20x, 40x
and 100x (oil immersion)/0.6 NA objectives and standard epi-illuminating fluorescence
filter cubes were used and 12-bit image data sets were generated. Quantification of T-cell
infiltrates observed by wide-field fluorescence microscopy was performed using
aspecifically designed software to run in the LabView (V7.1; National Instruments,
Austin, TX) environment. This automatic cell-counting algorithm is based on a
combination of background subtraction, multiple thresholding, and morphologic
processing approaches which allows identification of single fluorescent cells within the
tissue (also see Appendix). Statistical analysis was performed using Microsoft Excel and
Prism software.
Enrichment of labelled T cells in the peritoneal lavage was assessed by flow
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cytometry using BD FACSDiva and analysed with Flowjo. To control for
autofluorescence, the peritoneal lavage of mice injected with PBS without T cells was
analyzed. Enrichment of labelled T cells in the spleen and lymph nodes was analysed by
processing the tissue sample through a 70µm membrane and assessed by flow cytometry.
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Results
Chapter 1: Generation and Characterisation of HY-specific WT
and Vav1-/- T cells
1.1. Introduction
Histocompatibility (H) antigens are products of polymorphic genes recognised by
the immune system upon exchange of tissues between genetically dissimilar individuals.
In the event of MHC-mismatch, the transplanted tissue is termed an allograft and is
rapidly rejected by the immune system due to allorecognition of major H antigens
(Janeway et al., 2001). However, T cell responses can also be observed when transplants
are matched for major H antigens between donor and recipient, for example in human
leukocyte antigen (HLA)-identical siblings (termed syngeneic transplant). This suggests
the presence of other antigens involved in transplant rejection by immune mechanisms
(reviewed in Janeway et al., 2001)(reviewed in Simpson et al., 2002)
Minor H antigens are derived by endogenous polymorphic peptides and are
expressed on the MHC complex on the surface of the APC. Some of the minor H antigens
recognised by female transplant recipients are encoded by the Y chromosome, and in
mouse include the MHC class I Db-restricted peptides Uty  (WMHHNMLDI) and Smcy
(KCSRNRQYL), the former thought to be immunodominant, as well as the Ab-restricted
class II Dby peptide (NAGFNSNRANSSRSS) (Greenfield et al., 1996; Millrain et al.,
2001; Scott et al., 2000; reviewed in Simpson et al., 2002). T cells specific for these
antigens can be generated by in vivo immunisation of female mice with male APCs;
tetramer-staining of CD8+ T cells from the female recipients immunised with male
splenocytes or DCs revealed that with weekly immunisations, antigen-specific
populations can be observed as early as day 14 (Millrain et al., 2001).
The HY system has previously been successfully used in studies examining the
migration of antigen-specific T cells both in vitro and in vivo (Marelli-Berg et al., 2004;
Mirenda et al., 2006). For this reason, HY-specific T cells were generated from WT and
Vav1-/- female mice as described in the material and methods section, and were used to
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investigate the role of the GEF Vav1 in T cell migration. This chapter describes the
characterisation of the generated T cells in terms of specificity, surface and intracellular
antigen expression as well as adhesion.
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1.2. Results
1.2.1. Proliferative responses and co-receptor expression by Vav1-/- T cells
Studies on Vav1 in mice have revealed that Vav1-/- T cells have altered thymic
development, defective positive selection and altered sensitivity to negative selection,
which may result in expression of different variable TCR chains than the WT controls
(Turner et al., 1997). It was therefore possible that the primed WT and Vav1-/- T cells
may have had different epitope specificity.
To test epitope specificity of the WT and Vav1-/- T cells we used proliferation
assays based on tritiated thymidine incorporation. WT and Vav1-/- T cells (104 per well)
were incubated with irradiated female APCs, including either splenocytes (5x105 per
well) or ECs (104 per well), and HY peptides, including the class I-restricted Uty and
Smcy, as well as the class II Dby peptide. Different concentrations (0-100nM) of the
peptides were also examined to determine the highest proliferative response.
Figure 8 a,b shows the proliferation of WT and Vav1-/- T cells in response to the
class I-restricted epitopes upon initial isolation. WT T cells responded with high levels of
proliferation against both the immunodominant Uty as well as the Smcy epitope, while
the Vav1-/- T cells showed very little proliferation against the immunodominant Uty
epitope, primarily responding to Smcy. Flow cytometry analysis revealed that at this
stage, both WT and Vav1-/- T cells were a mixed population of CD4+ and CD8+ T cells,
but both expressed the CD8 co-receptor (Figure 8 d).
Both Uty and Smcy are MHC class I Db epitopes (reviewed in Simpson et al.,
2002). To examine the proliferative responses of WT and Vav1-/- T cells further, we
added a Db blocking antibody to the culture. As shown in Figure 8 c, proliferation of both
WT and Vav1-/- T cells was significantly inhibited in the presence of the Db blocking
antibody, suggesting that the observed proliferative response was due to presentation by
MHC class I.
At around passage eight, i.e. after eight rounds of re-stimulation with male
splenocytes in vitro, CD4+ T cells overgrew the CD8+ ones in both WT and Vav1-/- T
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cells (Figure 8f). For this reason, the specificity of WT and Vav1-/- T cells against the
class II Dby peptide was once again examined by tritiated thymidine incorporation. As
shown in Figure 8 e, both WT and Vav1-/- T cells were specific for the class II Dby
peptide, with the highest response shown at the peptide concentration of 50nM. The
specificity to this peptide was routinely examined thereafter to certify that both WT and
Vav1-/- T cells remained HY-specific throughout the study. It is important to note that
both WT and Vav1-/- T cells used in the in vitro and in vivo functional assays were CD4+
and specific for the Dby peptide.
Figure 8: Vav1-/- T cells display reduced proliferative responses to antigenic
challenge
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Viable WT and Vav1-/- T cells used between days seven and ten post-stimulation
were incubated with 104 irradiated female ECs pulsed with different concentrations of
Uty (a) or Smcy (b) peptide for 48 hours, followed by pulsing with 1µCi tritiated
thymidine (a)(b). WT and Vav1-/- T cells were incubated with irradiated 104 female ECs
pulsed with peptide and with or without Db blocking antibody for 48 hours, followed by
pulsing with 1µCi tritiated thymidine (c). WT and Vav1-/- T cells were labelled with CD8
and analysed for expression by flow cytometry (d) WT and Vav1-/- T cells were incubated
with irradiated 5x105 female splenocytes pulsed with the Ab- Dby peptide for 48 hours,
followed by pulsing with 1µCi tritiated thymidine (e). WT and Vav1-/- T cells were
labelled with CD4 and analysed for expression by flow cytometry (f). The proliferative
response is measured as counts per minute (cpm). Co-receptor expression in the flow
cytometry plots is depicted in black while isotype control expression is depicted in grey.
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1.2.2. Expression of co-receptors and co-stimulatory molecules by Vav1-/- T
cells
The expression of co-receptors CD8 and CD4 was routinely examined on the HY-
specific WT and Vav1-/- by flow cytometry. Upon isolation, both WT and Vav1-/- T
cells were a mixed population of CD4+ and CD8+, as shown in Figure 9 a. However, as
mentioned earlier, around passage eight, i.e. eight rounds of re-stimulation with male
splenocytes, the CD4+ populations overgrew the CD8+.
For this reason, we examined the kinetics of CD4 overgrowth by analysing co-
receptor expression in freshly-isolated T cells as well as after the first round of
stimulation with male splenocytes. As shown in Figure 9 a, upon isolation, HY-specific
WT and Vav1-/- T cells expressed both co-receptors, but after the first round of
stimulation, both populations displayed similar kinetics of CD4+ overgrowth, as shown in
Figure 9 b. This phenomenon was more readily observed in the Vav1-/- T cells. Both
HY-specific WT and Vav1-/- T cells used in functional assays were CD4+.
The expression of the co-stimulatory molecule CD28 was also examined because of
its importance in some of the functional studies (Figure 9c). Both HY-specific WT and
Vav1-/- T cells were found to express high levels of CD28 by flow cytometry.
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Figure 9: Co-receptor and co-stimulatory molecule expression of WT and Vav1-/- T
cells
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Viable WT and Vav1-/- T cells were labelled with CD4 or CD8 and analysed by flow
cytometry on day zero (a) and day seven (b). WT and Vav1-/- T cells were labelled with
CD28 and analysed by flow cytometry between days seven and ten post-stimulation (c).
Co-receptor and co-stimulatory molecule expression is represented by the black line and
isotype control by the grey line. rMFI is calculated by dividing the MFI of the labelled T
cells with the MFI of the isotype control.
1.2.3. Phenotypic characterisation of Vav1-/- T cells
Memory T cells can be subdivided based on their homing potential to central
memory and effector memory T cells. Central memory T cells are characterised by the
expression of CCR7 and preferentially migrate to the lymph nodes, while effector
memory T cells have little or no expression of CCR7 and preferentially migrate to sites of
inflammation (Sallusto et al., 1999; Weninger et al., 2001).
To determine whether the HY-specific WT and Vav1-/- T cells belonged to the
effector memory or central memory subset, they were labelled with CD62L (L-selectin)
and CCR7 and expression was analysed by flow cytometry. Figure 10 shows that both
WT and Vav1-/- T cells expressed CCR7 in very low levels and did not express CD62L,
suggesting that they belonged to the effector memory subset. The relative MFI of
expression of CCR7 and CD62L is summarised in Table 6.
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Figure 10: Vav1-/- T cells belong to the effector memory subset
Viable WT and Vav1-/- T cells were labelled between days seven and ten post-stimulation
with CCR7 and CD62L and analysed by flow cytometry. Expression of CD62L and CCR7 is
shown in black while the grey line represents the isotype control
Table 6: rMFI of CD62L and CCR7
Marker Average rMFI WT Average rMFI Vav1-/-
CD62L 0 0
CCR7 2.3 2.2
rMFI was calculated by dividing the MFI of the sample by that of the isotype
control
Memory T cells can also be categorised based on cytokine secretion. Traditionally,
T cells have been classified as belonging to the Th1 or Th2 subtypes, the former
characterised by secretion IFNγ and the latter IL-4 (reviewed in Janeway et al., 2001).
Reports on cytokine secretion of Vav1-/- T cells have been confusing. One study
observed that Vav1-/- T cells do not secret IFNγ or IL-4 when stimulated with their
cognate peptide in vitro (Korn et al., 2003), while another report suggested that Vav1-/- T
cells have a skewed Th1 profile, with impaired IL-4 production (Tanaka et al., 2005).
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To determine their cytokine profile ex vivo, HY-specific Ab-restricted WT and
Vav1-/- T cells (106 per condition) were stimulated with Dby peptide (50nM) -pulsed
irradiated splenocytes (5x106 per conditions) and then analysed for intracellular IFNγ by
flow cytometry. As seen in Figure 11 and Figure 12, both WT and Vav1-/- T cells had a
polarised Th1 phenotype, as they secreted IFNγ but not IL-4. Both WT and Vav1-/- T
cells secreted IFNγ in response to peptide stimulation as well as TCR triggering through
CD3 and CD28 and the non-specific mitogens PMA/ionomycin.
Figure 11: Expression of intracellular IL-4
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Viable WT and Vav1-/- T cells used between days seven and ten post-stimulation were
stimulated for four hours with irradiated female splenocytes and Dby peptide (a),
PMA/ionomycin (b) or Golgi plug alone as a negative control (c) and labelled with CD4
and intracellular IL-4. Flow cystometry analysis was performed using FlowJo.
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Figure 12: Expression of intracellular IFNγ
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Viable WT and Vav1-/- T cells used between days seven and ten post-stimulation were
stimulated for four hours with irradiated female splenocytes and Dby peptide (a),
PMA/ionomycin (b) Golgi plug alone as a negative control (c) plastic-bound CD3 and
CD28 (d) or hamster IgG (e) and labelled with CD4 and IFNγ. Flow cytometry analysis
was performed using FlowJo.
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1.2.4 Upregulation of activation markers by Vav1-/- T cells
The importance of Vav1 in T cell activation has been described, with studies
showing reduced TCR-induced proliferation and IL-2 production as well as reduced Ca2+
flux (Tarakhovsky et al., 1995; Turner et al., 1997; Fischer et al., 1998). In addition,
Vav1 is thought to be required for CD69 upregulation upon activation (Villalba et al.,
2000).
CD69 is thought to be the earliest glycoprotein upregulated following activation in
T cells, and is involved in lymphocyte proliferation and function (Cambiaggi et al.,
1992). Upon 24-hour activation with plastic-bound CD3 (1µg/ml) and CD28 (5µg/ml),
HY-specific WT T cells significantly upregulated CD69 while CD69 upregulation was
not statistically significant for Vav1-/- T cells as shown in Figure 13. The relative MFI of
expression of CD69 in resting and activated T cells is summarised in Table 7.
CD25 is the receptor for IL-2 and is promptly upregulated by T cells upon
activation (Leonard et al., 1985). In this experiment, 24-hour stimulation of HY-specific
Vav1-/- T cells by plastic-bound CD3 (1µg/ml) and CD28 (5µg/ml) resulted in
upregulation of CD25 to levels similar to the WT control (Figure 13), suggesting that
Vav1 is not important for CD25 upregulation upon activation. The relative MFI of
expression of CD25 in resting and activated T cells is summarised in Table 7.
Interestingly, expression of CD25 by resting T cells was significantly higher in Vav1-/- T
cells compared to WT controls.
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Figure 13: Upregulation of surface markers upon activation
Viable WT and Vav1-/- T cells were used between days seven and ten post-stimulation
and were incubated with plastic-bound CD3 and CD28 antibodies or medium alone for
24 hours. The expression of the activation markers CD69 and CD25 was examined by
flow cytometry. The expression of the markers on resting and activated T cells is
represented in black and of isotype control in grey. Statistical analysis was performed
using Student’s t test comparing resting and activated rMFI (*p<0.05, **p<0.01).
Table 7: Average relative MFI and percentage positive expression of CD25 and
CD69
Average rMFI
resting
Average %
positive resting
Average rMFI
activated
Average % positive
activated
Marker
WT Vav1-/- WT Vav1-/- WT Vav1-/- WT Vav1-/-
CD25 1.4 6.3 76.3 84.6 4.7 26 81.3 87.6
CD69 5.6 8.1 41.7 74.1 8.5 12.2 64.2 86.4
rMFI is calculated by dividing the MFI of the marker expression by the MFI isotype control
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1.2.4 Expression of migration-related markers by Vav1-/- T cells
As the focus of this study is T cell migration, the expression of several migration
related markers was examined by flow cytometry. The importance of integrins and
chemokine receptors in T cells migration has already been described in the introduction.
Briefly, CXCR4 is the chemokine receptor for CXCL12 and is postulated to have a role
in migration of T cells to the lymph nodes (Okada et al., 2002; Scimone et al., 2004).
CXCR3 is the chemokine receptor for CXCL10 and has an important role in migration to
sites of inflammation as well as in transplantation, while CCR5 has been involved in the
migration to the liver and CNS during inflammatory conditions such as cirrhosis and
multiple sclerosis respectively (Grant et al., 2002; Guint et al., 2003; Hancock et al.,
2000). Finally, α4β7 has been shown to be the homing receptor for the gut (Schweighoffer
et al., 1993; Campbell et al, 2002; Abitorabi et al, 1996; Hamann et al, 1994), while
PSGL-1 directs T cells to the skin (Campbell et al, 2002).
As shown in Figure 14, HY-specific CD4+ WT and Vav1-/- T cells did not express
α4β7 integrin but had high expression of PSGL-1 and high expression of the inflammatory
chemokine receptor CXCR3. Both HY-specific CD4+ WT and Vav1-/- had very low
expression of CXCR4 and CCR5. The average relative MFI of expression of each of
these markers is summarised in Table 8. The expression of these homing receptors
directly correlates with some of the data observed in the migration studies, as will be
discussed later on.
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Figure 14: Expression of migration-related markers
WT and Vav1-/- T cells were used between days seven and ten post-stimulation in vitro
and were labelled with antibodies against α4β7, PSGL-1, CXCR3, CXCR4 and CCR5 and
analysed by flow cytometry. Expression of the markers is represented by the black line,
while the grey line represents the isotype control. rMFI is calculated by dividing the MFI
of the sample with the MFI of the isotype control
Table 8: rMFI and percentage positive cells of migration-related markers
Markers Average
rMFI WT
Average %
WT
Average rMFI
Vav1-/-
Average %
Vav1-/-
α4β7 0.07 0 0.04 0
PSGL-1 19.7 95.83 20.6 90.95
CXCR3 9.3 87.18 9 73.5
CXCR4 1.4 9 0.6 0
CCR5 4.4 37 3.3 24.3
 rMFI is calculated by dividing the MFI of the sample with the MFI of the isotype control
1.2.5 Expression of adhesion and cytoskeletal molecules by Vav1-/- T cells
Vav1-/- has previously been shown to be important for the transduction of LFA-1
“inside-out” signals (Krawczyk et al., 2002; Ardouin et al., 2003). To determine whether
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this would affect LFA-1 surface expression, HY-specific CD4+ WT and Vav1-/- T cells
were labelled with anti-LFA-1 antibody expression was examined by flow cytometry.
Figure 15 a shows the expression of LFA-1 in HY-specific CD4+ WT and Vav1-/-
T cells as determined by flow cytometry. Interestingly, although WT T cells had a
homogeneous high expression of LFA-1, Vav1-/- T cell LFA-1 expression was
heterogeneous  and consistently lower than that of the WT controls (Figure 15 b).
Integrins such as LFA-1 bind to adhesion molecules on the surface of ECs, such as
ICAM-1 (de Fougerolles et al., 1991). Vav1 has previously been shown to be important
in the adhesion of thymocytes and peripheral T cells to different adhesion molecules and
extracellular matrix proteins such as fibronectin, and collagen (Krawzcyk et al., 2002).
As Vav1-/- T cells were shown to have lower expression of LFA-1, we examined whether
this translated to reduced adhesion to ICAM-1.
HY-specific CD4+ WT and Vav1-/- were examined for adhesion to recombinant
ICAM-1 using wide-field fluorescence microscopy, as described in the materials and
methods section. Briefly, PKH26-labelled WT and Vav1-/- T cells were plated on ICAM-
1-coated 96-well plates (5µg/ml) at a concentration of 103 per well and allowed to adhere.
Non-adherent cells were removed at different time-points by gentle washing and adhesion
was examined by wide-field fluorescence microscopy.
As shown in Figure 15 c, the percentage adhesion of HY-specific CD4+ Vav1-/- T
cells, calculated by dividing the number of T cells adhering to ICAM-1 with the number
of T cells adhering to PBS alone, was significantly lower than that observed with WT T
cells at two of the three time-points tested. This suggests that LFA-1/ICAM-1-mediated
adhesion of memory T cells requires Vav1.
As a GEF for Rac1, Vav1 has been extensively implicated in the regulation of the
cytoskeleton. In T cells, Vav1 interacts with the actin polymerising WASp (Savoy et al.,
2000) while it has also been implicated in the inactivation of ERM proteins (Faure et al.,
2004). It was thus interesting to examine whether the HY-specific CD4+ T cells had
normal expression of the cytoskeletal proteins actin and tubulin.
To this effect, HY-specific CD4+ WT and Vav1-/- T cells were plated on glass
coverslips coated with ICAM-1 (5µg/ml) and stained for actin and tubulin for one hour as
described in the materials and methods section. Both WT and Vav1-/- T cells expressed
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the two proteins when examined with wide-field fluorescence microscopy with x100
magnification (Figure 15d). This suggests that HY-specific CD4+ Vav1-/- T cells express
normal levels of the cytoskeletal proteins actin and tubulin.
Figure 15: Adhesion to ICAM-1 and expression of LFA-1
Viable HY-specific CD4+ WT and Vav1-/- T cells were used between days seven and ten
post-stimulation. WT and Vav1-/- T cells were labelled with LFA-1 and analysed by flow
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cytometry. Expression of LFA-1 is represented by the black line, while the grey line
represents the isotype control (a). The rMFI of LFA-1 in WT and Vav1-/- T cells was
calculated by dividing the MFI of the labelled sample by the MFI of the isotype control
from three independent experiments (b). WT and Vav1-/- T cells were plated on ICAM-1-
coated 96 well plates and non-adherent cells were removed by gentle washing after 10,
30 and 60 minutes of incubation. Percentage adhesion was measured by counting the
number of cells in each well by wide-field fluorescence microscopy and dividing by the
number of cells adhering to PBS alone. The graph represents the average percentage
adhesion from four experiments (c) WT and Vav1-/- T were plated on ICAM-1-coated
coverslips and labelled with phalloidin-Alexa 546 and anti-tubulin-fitc for one hour.
Actin and tubulin expression was visualised using wide-field fluorescence microscopy
(x100 oil immersion lense) (d). Error bars indicate standard error. Statistical analysis
was performed using the Student’s t test. (* p<0.05, **p<0.01 , ***p<0.001)
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1.2.6 Characterisation of other cells used in this study
Many of the functional assays used in this study include vascular ECs generated
from mouse lungs, as described in the materials and methods section. It was therefore
thought important to characterise these cells by flow cytometry for markers that are
typically found in ECs.
CD105, also know as endoglin, is a glycoprotein primarily expressed by ECs
(Gougos and Letarte, 1988), while VCAM-1 binds to VLA-4 on T cells and is expressed
on vascular ECs (Henninger et al., 1997). They are therefore both suitable identification
markers for vascular ECs. As shown in Figure 16 a,b, both male and female ECs
expressed high levels of CD105 and VCAM-1 respectively.
Some of the functional assays have also used BM-derived DCs, as described in the
materials and methods section. These cells were also characterised by flow cytometry
after having been matured overnight in an optimal concentration of LPS. As shown in
Figure 16 (b), mature DCs were positive for CD11c, an adhesion molecule primarily
expressed by these cells. The CD11c+ cells were then found to express the MHC class II
molecule Ab as well as the co-stimulatory molecules CD80 and CD86. These findings
validate the use of these DCs in functional assays.
Figure 16: Characterisation of other cells
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Male and female ECs (between passage two and six) were labelled with VCAM-1 and
CD105 antibody and analysed by flow cytometry (a). Female DCs used seven days post-
isolation were matured overnight with LPS and labelled with CD11c, Ab, CD80 and
CD86 and analysed by flow cytometry (b).
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1.3. Discussion
HY specific WT and Vav1-/- T cells were generated for the purpose of this study
through two fortnightly intraperitoneal immunisations of female 129sv mice with male
splenocytes from WT mice. We used one whole male spleen per injection of female mice,
which differs from the protocol of Millrain et al., (2001), who used 5x106 male
splenocytes per female mouse. The reason for this was that Vav1-/- T cells have altered
sensitivity to negative selection (Turner et al., 1997) and would possibly require higher
dose of antigen for priming.
Korn et al. (2003) observed that Vav1-/- T cells were defective in priming with the
MOG35-55 EAE peptide. However, proliferation assays based on thymidine incorporation
revealed that Vav1-/- T cells showed some proliferative response to the HY peptides,
albeit with lower counts than the WT controls.
Reduced proliferation of Vav1-/- T cells in response to TCR stimuli has previously
been documented in several studies (Tarakhovsky et al., 1997; Fisher et al., 1998;
Costello et al., 1999; Penninger et al., 1999). This could be due to loss of responsiveness
to TCR stimulation in the absence of Vav1, as signals which bypass the TCR elicit higher
proliferation, as well as reduced IL-2 production (Tarakhovsky et al., 1997; Turner et al.,
1997; Fisher et al., 1998; Costello et al., 1999; Penninger et al., 1999). The latter is
interesting, as proliferation of the CD4+ Vav1-/- T cells to the class II Dby peptide
resulted in counts comparable to the WT control, suggesting that IL-2 may compensate
for reduced TCR signalling in Vav1-/- T cells.
Extensive studies by Millrain et al. (2001) have shown that the class I epitope Uty
is immunodominant to the Smcy epitope. In this study, both WT and Vav1-/- T cells
responded to the Uty peptide upon isolation, but the Smcy-specific population in both
WT and especially the Vav1-/- T cells overgrew the Uty-specific one. Millrain et al.
(2001) examined the responses of immunised HY Db C57BL/6 mice, so it is possible that
the kinetics of priming HY Db 129sv mice are different. It would have been informative
to examine HY-specificity using tetramer staining, as the method would allow us to
identify the percentage of each population at different time-points, thus dissecting the
“switch” from primarily Uty positive to Smcy positive. Unfortunately, these tetramers are
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no longer commercially available, and pentamer staining has been ineffective for the
staining of polyclonal T cells in our hands as well as others,
Both CD4+ WT and Vav1-/- T cells overgrew CD8+ ones in culture. This effect has
been observed by others in our lab (S. Jarmin, personal communication) as well as other
labs using HY-specific T cells (J. Dyson, personal communication). The importance of
this is not understood, but it is possible that CD4+ T cells are more likely to survive and
be ”naturally selected” over CD8+ T cells due to higher autocrine IL-2 secretion. This
may also explain why this phenomenon was observed more readily in the Vav1-/- T cells
than the WT control.
Both HY-specific CD4+ Ab-restricted WT and Vav1-/- T cells generated by our
protocol of immunisation appear to be effector memory T cells as they consistently have
little or low expression CCR7 or L-selectin (CD62L). In addition, they have a Th1
polarised phenotype, as they do not secrete IL-4 and secrete IFNγ.  This is interesting, as
previous reports on cytokine secretion have been confounding, with Korn et al. (2003)
finding no IFNγ secretion upon peptide stimulation of antigen-specific cells in vitro, and
Tanaka et al. (2005) observing defective IL-4 secretion in Vav1-/- T cells in vitro.
Previous studies have implied reduced activation of Vav1-/- T cells, with reduced
proliferation, IL-2 production and Ca2+ flux (Tarakhovsky et al., 1997; Turner et al.,
1997; Fisher et al., 1998; Costello et al., 1999; Penninger et al., 1999). It was interesting
to observe that upregulation of CD25 in Vav1-/- T cells was comparable to the WT
controls and no significant differences were seen when comparing the rMFI of both
resting and activated T cells. It is possible that one of the other Vav proteins compensated
for the loss of Vav1 in this case. It is worth mentioning that resting Vav1-/- T cells also
had higher expression of CD25 than the WT controls. As CD25 is the receptor for IL-2,
higher expression of this marker as well as comparable upregulation to the WT controls
may have been a compensatory mechanism in response to reduced IL-2 secretion.
The second activation marker tested was CD69. HY-specific CD4+ Vav1-/- T cells
expressed CD69 when resting, which is surprising as previous studies have observed that
Vav1 is necessary for CD69 expression via the MAPK signalling pathways (Villalba et
al., 2001). However, Vav1-/- T cells did not significantly upregulate this marker when
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stimulated with CD3 and CD28 antibodies. It is therefore possible that Vav1 is required
for upregulation of CD69 upon activation.
Characterisation of expression of migration-related markers was an essential
preliminary experiment for the future investigation of the migratory properties of the HY-
specific CD4+ Ab-restricted WT and Vav1-/- T cells in vitro and in vivo. Expression of
α4β7 , PSGL-1, CXCR3, CXCR4 and CCR5 was comparable between both WT and
Vav1-/- T cells, suggesting that Vav1 does not regulate the expression of these markers.
This migratory phenotype correlates with the data obtained from the migration studies, as
will be discussed in Chapter 2.
The importance of Vav1-/- in T cell adhesion had previously been highlighted by
Krawczyk et al. (2002). Our findings confirm this observation, with HY-specific CD4+
Vav1-/- T cells showing significantly lower adhesion to ICAM-1 compared to the WT
control. Defects in the cytoskeleton, as implied by several studies (Savoy et al., 2000)
(Faure et al., 2004), may account for this effect. The reduced expression of LFA-1, which
is the integrin that binds to ICAM-1, may also partially explain this phenotype.  In
addition, Vav1 has been found to be required for the transduction of “inside-out” signals
for LFA-1 as well as LFA-1 clustering (Krawczyk et al., 2002; Ardouin et al., 2003).
Thus, diminished LFA-1 signalling and clustering may also account for reduced adhesion
to its ligand, ICAM-1.
Despite having reduced adhesion to ICAM-1, HY-specific CD4+ Vav1-/- T cells
expressed both actin and tubulin when plated on ICAM-1 coverslips and no differences in
clustering and distribution were observed when compared to the WT control. It is
possible that although Vav1 is a GEF for RhoGTPases, its absence does not result in
reduced expression of actin and tubulin. Quantifying the levels of actin and tubulin by
Western blotting may be useful in establishing any differences in levels of expression of
the two proteins. In addition, confocal microscopy may provide more detailed images
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Chapter 2: Constitutive and chemokine-driven migration of WT
and Vav1-/- T cells
2.1. Introduction
As part of dissecting the role of Vav1 in T cell migration, we assessed its
involvement in T cell trafficking in the absence of antigen. This would allow us to
uncover any underlying migratory defects which could have been incorrectly interpreted
when examining the role of Vav1 in antigen-dependent T cell migration.
Migration of T cells from the bloodstream into tissues is tightly controlled by
molecular checkpoints. Integrins, whose conformational changes mediated by
chemokines and shear flow lead to tight adhesion, are important regulators of T cell
migration (reviewed in Janeway et al, 2001; Garood et al, 2006; Alon and Dustin, 2007).
They can also act as homing receptors, directing T cells to different sites of the body
(reviewed in Ebert et al, 2005). Of the various integrin heterodimers, LFA-1 has a
fundamental role in T cell migration. As discussed in Chapter 1, HY-specific CD4+ Vav1-
/- T cells showed reduced LFA-1 expression and reduced adhesion to ICAM-1. This part
of the study will therefore aim to investigate whether these defects will translate to
impaired integrin-mediated migration both in vitro and in vivo.
Chemokines also play an important role in T cell migration, mediating tight
adhesion of integrins as well as acting as homing receptors. The two chemokines tested in
this study are CXCL12 and CXCL10 which are known to bind to CXCR4 and CXCR3 on
the surface of T cells. CXCL10 is particularly relevant in this study, as it is induced by
the secretion of IFNγ (Luster and Ravetch, 1987) which will be used to induce MHC
class II expression in the antigen-dependent migration studies.
This part of the study aims to investigate the requirement for Vav1 activity in
constitutive migration of memory T cells. Defects in HY-specific CD4+ Vav1-/- T cell
migration at the cellular level are investigated using in vitro assays, while the in vivo
experiments provide information on the role of Vav1 activity in a more physiological
setting.
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2.2. Results
2.2.1 Assessing the role of Vav1 in T cell migration in vitro
As a preliminary experiment in dissecting the role of Vav1 in T cell migration, the
migration of HY-specific CD4+ WT and Vav1-/- T cells was first examined through
syngeneic endothelial monolayer using female-derived ECs. Briefly, female ECs were
plated on the transwells at a concentration of 104 per transwell and allowed to form a
monolayer. Viable WT and Vav1-/-T cells (3-5x105 per transwell) were used between
days seven and ten post-activation to ensure that they were not cycling, as this has been
found to be the optimal time for T cell migration in our laboratory. T cells were allowed
to migrate for 24 hours and the number of migrated cells was counted every two hours.
As shown in Figure 17, HY-specific CD4+ Vav1-/- T cells migrated significantly
less through the syngeneic female endothelial monolayer compared to the WT control,
suggesting that they have a lower baseline migration.
Figure 17: Vav1-/- T cells show reduced baseline migration compared to WT
Viable WT and Vav1-/- T cells were used between days seven and ten post-stimulation
and were plated on syngeneic female endothelial monolayer. Migration was measured at
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two, four, six and twenty-four hours. Percentage of migrated cells was calculated by
dividing the number of cells in the bottom chamber by the total number of plated T cells
from the average of three experiments. Error bars indicate standard error. Statistical
analysis was performed using Student’s t test (**p<0.01, ***p<0.0001)
2.2.2 Investigation of the role of Vav1 in integrin-mediated migration
As discussed in Chapter 1, HY-specific CD4+ Vav1-/- T cells were found to have
lower expression of LFA-1 in the flow cytometry assays and reduced adhesion to ICAM-
1. As LFA-1 is an important regulator of T cell migration, the involvement of Vav1
activity in T cell migration was examined using transwell-based migration assays as well
as time-lapse microscopy.
Figure 18a shows the results of the transwell-based assay. Briefly, 3-5x105 T cells
were plated on ICAM-1-coated transwells and allowed to migrate for six hours. WT T
cells showed enhanced migration in response to ICAM-1 at all time-points tested. In
contrast, Vav1-/- T cells did not respond to ICAM-1 with increased migration.
The requirement for Vav1 activity in T cell migration in response to ICAM-1 was
also examined by time-lapse microscopy. 106 HY-specific CD4+ WT and Vav1-/- T cells
were serum starved in RPMI 2% FCS for one hour and were subsequently plated on
ICAM-1-coated dishes. Non-adherent cells were removed by gentle washing prior to the
assay. The movie was made by taking pictures every 15 seconds for 25 minutes and
mathematical analysis of T cell migration was performed using Mathematica workbooks
after having tracked the path of ten cells per condition.
Figure 18b shows the average number of cells migrating, calculated by counting
motile HY-specific CD4+ WT and Vav1-/- T cells from each video. As expected from the
transwell-based assay, Vav1-/- T cells were found to migrate less than the WT control. In
addition, although retraction of leading edge and uropod normally occurs in a co-
ordinated fashion, Vav1-/- T cells displayed a “jumping” phenotype (Supplementary
videos 1 and 2) whereby the leading edge moved forward while the uropod stayed
stationary until it detached and retracted.
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The speed of migration of the HY-specific CD4+ WT and Vav1-/- T cells was
calculated using Mathematic workbooks provided by Professor Anne Ridley (Ludwig
Institute, UCL) (Wells and Ridley, 2005). As shown in Figure 18 c, Vav1-/- T cells had a
higher average migratory speed (µm/min) than the WT control. A representative example
of the raw data obtained from the Mathematica workbook is shown in Figure 18d.
Although it appears that WT and Vav1-/- T cells had similar average migratory speed in
the first five minutes, the high migratory speed was maintained by the Vav1-/- T cells but
not by the WT controls.
Figure 18: Vav1-/- T cells have reduced LFA-1-mediated migration but display
increased migratory speed
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Viable WT and Vav1-/- T cells, used between days seven and ten post-stimulation, were
plated on plastic-bound recombinant ICAM-1 coated transwells and allowed to migrate
for six hours. Percentage migration was calculated from the average of four independent
experiments.  (a) WT and Vav1-/- T cells (1x106) were serum-starved in RPMI 2% FCS
for one hour and were plated on ICAM-1-coated 35mm dishes. Their migration on
ICAM-1 was followed by time-lapse microscopy. The number of cells migrating was
quantified by counting motile T cells (b). T cells were tracked using Kinetiq tracking
software and their migratory speed (µm/min) was quantified using Mathematica
spreadsheets (c). Representative data from one experiment obtained from the
Mathematica spreadsheet. Each line represents the average migratory speed at each
time-point (µm/0.25min) (d). The average percentage of motile cells and average speed
was calculated from data of three independent experiments. Statistical analysis was
performed using Student’s t-test (*p<0.05, **p<0.01). Error bars indicate standard
error.
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2.2.3 The role of Vav1 in chemokine-driven migration
Previous studies have implicated Vav1 in chemokine-driven migration of T cells.
Vicente-Manzanares et al. (2005) showed that in vitro Vav1 is important in CXCL12-
mediated T cell migration using a dominant-negative form of Vav1, while Garcia-Bernal
et al. (2005) observed that Vav1 and Rac1 are necessary for CXCL12-mediated adhesion
and transendothelial migration in vitro.
To examine this further, we used transwell-based migration assays as described in
the materials and methods section. Briefly, 3-5x105 HY-specific CD4+  WT and Vav1-/-
T cells were plated on transwells in the presence of CXCL12 (50ng/ml) or CXCL10
(300ng/ml) in the lower chamber and allowed to migrate for six hours.
Figure 19 shows the migration of the HY-specific CD4+  WT and Vav1-/- T cells
in response to CXCL12 and CXCL10 at different time-points. HY-specific CD4+ WT T
cells showed significantly enhanced migration in response to CXCL12 (Figure 19 a) and
CXCL10 (Figure 19 b) compared to medium alone. In contrast, HY-specific CD4+ Vav1-
/- T cells did not show enhanced migration in the presence of chemokines.
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Figure 19: Vav1-/- T cells do not response to CXCL12 or CXCL10
WT and Vav1-/-T cells (used between day seven and ten post-stimulation) were allowed
to migrate in response to CXCL12 (a) or CXCL10 (b) for six hours. Migration was
examined by counting the cells in the bottom chamber at two, four and six hours.
Percentage migration was calculated by dividing the number of cells in the bottom
chamber by the original number of cells plated on the transwell. Error bars indicate
standard error. Statistical analysis was performed using the Student’s t test (*p<0.05, **
p<0.01). The average percentage migration was calculated using data from four
independent experiments.
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2.2.4. Constitutive trafficking of Vav1-/- T cells
Constitutive trafficking of primed memory Vav1-/- T cells has never been
examined before. We, as well as others (Vicente-Manzanares et al, 2005; Garcia-Bernal
et al, 2005), have shown that Vav1-/- T cells have defects in migration in vitro, and the
migration of Vav1-/- T cells in response to syngeneic non-antigenic ECs was shown to be
significantly lower than that of the WT controls in the transwell assays. To examine
whether these defects translated into altered T cell trafficking in vivo, PKH26-labelled
HY-specific CD4+ WT and CFSE-labelled HY-specific CD4+ Vav1-/- T cells (5-10x106 T
cells) were co-injected iv in female C57BL/6 mice. The mice were culled 24 hours later
and T cell migration to the kidney, lung, liver and spleen was examined by wide-field
fluorescence microscopy, following cryotomy.
Figure 20 a shows representative examples of sections obtained through wide-field
fluorescence microscopy following cryotomy of the tissue samples at each time-point.
The number of cells present in each section was quantified using the algorithm in the
appendix and is represented in Figure 20 b. Both HY-specific CD4+ WT and Vav1-/- T
cells migrated readily to liver, lung and spleen, with some cells present in kidney as well.
No difference in number of migrated cells was observed in any of the tissues tested at six
and 24 hours, however at two hours there were less HY-specific CD4+ Vav1-/- T cells in
the lung and spleen compared to WT control (Figure 20 b)
Trafficking of HY-specific CD4+ WT and Vav1-/- T cells to the heart and lymph
nodes was also examined. Consistent with the effector memory phenotype observed in
Chapter 1 (little or no expression of CCR7 and CD62L), no cells were found in either of
the two tissues at any of the time points tested. Figure 20c shows a representative
example of the sections obtained at 24 hours.
Regulation of T cell migration by the guanidine exchange factor Vav1
Rachel David
122
Figure 20: Constitutive trafficking of Vav1-/- T cells
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Viable WT and Vav1-/- T cells (used between days seven and ten post-stimulation) were
labelled with PKH26 (red) or CFSE (green) respectively and injected iv in female
C57BL/6 mice. Trafficking into kidney, liver, lung and spleen was monitored at two, six
and 24 hours post-injection by harvesting, snap-freezing the tissue and taking 5-10µm
sections. The sections were examined by wide-field fluorescence microscopy by mounting
with vectorshield medium containing DAPI which stains the nucleus blue and an average
of six representative pictures was taken per sample (x10 magnification) (a). The number
of cells present in each field was quantified using the algorithm in the appendix (b).
Representative examples of trafficking into heart and lymph nodes at 24 hours (x10
magnification) (c).  Statistical analysis was performed using the Student’s t-test
(*p<0.05). Error bars indicate standard error. Each experimental group consisted of
three female C57BL/6 mice.
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2.2.4 Chemokine-driven migration in vivo
HY-specific CD4+ Vav1-/- T cells showed no defects in constitutive trafficking in
vivo as shown in section 2.2.3. To complete this part of the study and get a more
complete picture prior to commencing the antigen-dependent migration experiments, we
sought to examine the recruitment of HY-specific CD4+ Vav1-/- T cells in response to an
inflammatory stimulus in the absence of antigen. We chose to examine migratory
responses to the chemokine CXCL10 in vivo, as its receptor, CXCR3, was found to be
expressed in very high levels by both HY-specific CD4+ WT and Vav1-/- T cells in
Chapter 1. In addition, CXCL10 is the chemokine induced by the secretion of IFNγ,
which was also used to induce MHC class II expression in the antigen-dependent
migration studies that will follow.
To investigate the involvement of Vav1 in chemokine-driven migration in vivo, a
dose of CXCL10 (1.2µg/ml) that was previously found to induce chemotaxis in vivo
(unpublished observations) was injected ip into female C57BL/6 mice, followed by an iv
injection of 10x106 PKH26 labelled HY-specific CD4+ WT or Vav1-/- T cells.
Recruitment to the peritoneal cavity was analysed 20-hours post-injection.
Figure 21a,b and c shows the migration of T cells into the peritoneal lavage in mice
injected with CXCL10 or PBS alone as a control. In addition, the lavage of a female
mouse injected with PBS alone (i.e. no T cells) is also shown to indicate the presence of
an autofluorescent population in the absence of T cells.  Both HY-specific CD4+ WT and
Vav1-/- T cells showed significantly enhanced migration to the peritoneal cavity in the
presence of the chemokine, as shown in Figure 21a and b. Interestingly, the Δ migration
of HY-specific CD4+ Vav1-/- T cells (i.e. the average percentage of T cells in the
peritoneal lavage with the PBS background subtracted) was higher than that of the WT T
cells (Figure 21c). Concomitant with this observation, more HY-specific CD4+ WT T
cells were found in the peritoneal membrane of mice injected with chemokine, compared
to Vav1-/- T cells or the controls (Figure 21 d,e). The significance of this will be further
examined in the discussion.
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Figure 21: Chemokine-driven migration in vivo
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Viable WT and Vav1-/- T cells (used between days seven and ten post-stimulation) were
labelled with PKH26 (red) and injected iv in female C57BL/6 mice that had previously
received an ip injection of 1.2µg CXCL10 or PBS as a control. Female mice were also
injected with PBS alone (i.e. no T cells) as an autofluorescence control. The mice were
sacrificed 20 hours post-injection. The peritoneal lavage was labelled with anti-CD4
antibody and analysed by flow cytometry (a). The average percentage of cells present in
the peritoneal lavage (b). Δ percentage migration was calculated by subtracting the
average background migration (i.e. in the presence of PBS) from the percentage of
migrated cells in the presence of CXCL10. (c) The peritoneal membrane was mounted
with vectorshield mounting medium containing DAPI and analysed by wide-field
fluorescence microscopy (x10 magnification). Red cells are indicated by the red arrow
(d). The number of cells present in the peritoneal membrane was quantified manually (e).
Statistical analysis was performed using the Student’s t-test (*p<0.05). Error bars
indicate standard error. Each experimental group consisted of four to five female
C57BL/6 mice.
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2.3. Discussion
Phenotypic results in Chapter 1 suggested that HY-specific CD4+ Vav1-/- T cells
expressed LFA-1 in lower levels that the WT controls and showed reduced adhesion to
ICAM-1. This, in conjunction with previous studies implicating Vav1 in adhesion to
ICAM-1 and LFA-1 “inside-out” signalling (Krawczyk et al., 2002; Ardouin et al.,
2003), suggested that Vav1 may also be important in LFA-1/ICAM-1-mediated
migration. In line with this hypothesis, we observed that Vav1-/- T cells did not show
enhanced migration in the presence of ICAM-1. It is difficult to determine whether the
absence of enhanced migration in response to ICAM-1 in Vav1-/- T cells was due to
reduced adhesion, as previously documented, or reduced interaction with ICAM-1 due to
reduced LFA-1 expression, as indicated in Chapter 1.
To examine this further, we used time-lapse microscopy. In this case, we observed
that HY-specific CD4+ Vav1-/- T cells showed reduced migratory response to ICAM-1,
as less Vav1-/- T cells showed a motile phenotype compared to the WT control despite
the removal of non-adhering cells prior to the assay. It is possible that adhering Vav1-/- T
cells may have had reduced interaction to ICAM-1 due to lower expression of LFA-1, as
indicated by the findings in Chapter 1.
Interestingly, HY-specific CD4+ Vav1-/- T cells were found to have enhanced
speed compared to the WT controls, which has been useful in explaining some of the in
vivo migration data. In addition, Vav1-/- T cells showed a “jumping” phenotype, i.e. a
sudden and irregular retraction of the uropod while the leading edge moved forward. This
phenotype suggests a defect in T cell de-adhesion from ICAM-1 and has previously been
described in T cells with a mutated form of CD43 that abrogates its redistribution to the
uropod (Savage et al., 2002). CD43 is a T cell surface glycoprotein which can bind to
ICAM-1 (Rosenstein et al., 1991) and is thought to be involved in T cell adhesion
(Manjunath et al., 1993) and cell polarisation (del Pozo, 1995). Interestingly, CD43 has
been found to regulate T cell activation by facilitating the formation of the Vav1-Slp76
complex through Vav1 tyrosine phosphorylation (Pedraza-Alva et al., 1998). It is
possible that in the absence of Vav1, CD43 redistribution to the uropod may be defective,
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resulting in faulty de-adhesion and the “jumping” phenotype. It would therefore be
interesting to examine the expression and distribution of CD43 in Vav1-/- T cells.
Previous studies have shown that Vav1 is important for T cell migration and in
particular chemotaxis. Vicente-Manzanares et al. (2005) showed that Vav1 is important
in CXCL12-mediated T cell migration using a dominant-negative form of Vav1, while
Garcia-Bernal et al. (2005) observed that Vav1 and Rac1 are necessary for CXCL12-
mediated adhesion and transendothelial migration in vitro.  In this study, we examined T
cell chemotaxis using both in vitro and in vivo models of migration. In the in vitro
transwell-based migration assay, HY-specific CD4+ Vav1-/- T cells did not show
enhanced migration in the presence of CXCL12 or CXCL10 compared to medium alone,
suggesting that Vav1 is involved in chemokine-mediated T cell migration in vitro.
Interestingly, Gallego et al. (2006) have shown that WIP and WASp are important in
CXCL12-mediated migration of T cells in vitro, using murine WIP-/- and WASp-/- T
cells. As Vav1 is known to interact with WIP (Savoy et al., 2000), it is possible that the
loss of responsiveness to CXCL12 in our transwell-based assays may partially be due to
the reduced activation of these molecules.
Transwell-based assays are useful for identifying defects at the cellular level but
their physiological relevance must be tested in vivo. Indeed, other factors which cannot be
faithfully replicated in vitro, such as shear flow, have been shown to be important in T
cell migration, in particular integrin activation (reviewed in Alon and Dustin, 2007).
Taking this into account, we examined chemokine-mediated migration in vivo, by
injecting CXCL10 ip in female mice prior to iv injection of T cells. Interestingly, the in
vivo data did not replicate the in vitro findings, as both HY-specific CD4+ WT and Vav1-
/- T cells showed enhanced trafficking in the presence of the chemokine compared to the
PBS control. Therefore, the defects in migration which are revealed in vitro must be
compensated for in vivo by other molecules in the bloodstream as well as shear flow.
Shear flow in particular has previously been shown to have a fundamental role in T
cell migration by facilitating integrin conformational changes induced by chemokines
(reviewed in Alon and Dustin, 2007). To dissect this further, it would be interesting to
examine chemokine-driven migration of Vav1-/- T cells in an in vitro flow chamber,
which simulates shear flow in the bloodstream; comparable levels of chemokine-driven
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migration of Vav1-/- T cells to the WT controls in these conditions would indicate that
shear flow acts as an important compensatory factor for the loss of Vav1 activity in vivo.
Furthermore, the in vivo chemokine-driven migration assays indicated higher
enrichment of HY-specific CD4+ Vav1-/- T cells in the peritoneal lavage of female
C57BL/6 mice compared to the WT controls, once the PBS background had been
subtracted. This could be due to higher migratory speed of Vav1-/- T cells, as indicated
by the time-lapse microscopy assays, which may have resulted in the Vav1-/- T cells
migrating through the peritoneal membrane faster than the WT T cells and reaching the
peritoneal cavity first. In fact, WT T cells could still be observed in the peritoneal
membrane of mice injected with chemokine, suggesting that they had not yet entered the
peritoneal cavity.  Examining enrichment of the peritoneal lavage by HY-specific CD4+
WT and Vav1-/- T cells at different time-points could provide further evidence on this, as
it would be expected that at later time-points, no difference would be seen between WT
and Vav1-/- T cell enrichment. However, preliminary in vivo data, as well as the data
obtained from the in vitro studies, suggested that at later time-points, the chemokine loses
its chemotactic effect on T cells, probably because it diffuses further into the
bloodstream.
Note that the peritoneal lavage of mice injected with PBS alone also shows the
presence of PE-positive non-T cells. We often observe this autofluorescent population in
the peritoneal lavage cell suspension and it is therefore essential to identify recruited T
cells by labelling with anti-CD4 antibody.
As mentioned earlier, in vitro migration assays are limited in that they do not take
into account other molecules present in the bloodstream as well as shear flow, which are
likely to influence T cell migration in vivo. The in vitro transwell-based assays suggested
that baseline migration in response to syngeneic, non-antigenic ECs was significantly
lower in HY-specific CD4+ Vav1-/- T cells compared to the WT control. To examine
constitutive T cell trafficking in vivo, HY-specific CD4+ WT and Vav1-/- T cells were
injected iv and their migration into different tissues was analysed at different time-points.
At 24 hours, we observed no difference in tissue localisation between WT and Vav1-/- T
cells, which suggested that other molecules in the bloodstream and well as shear flow
may have compensated for any migratory defects of Vav1-/- T cells, as previously
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discussed. In addition, the enhanced speed of Vav1-/- T cells as revealed by the time-
lapse microscopy assays, may have accelerated their localisation into tissues over 24
hours.
To assess the effect of enhanced speed in Vav1-/- T cell trafficking, WT and Vav1-
/- T cell trafficking was examined at different time-points. No defect was seen at six
hours post-injection, however at two hours, less HY-specific CD4+ Vav1-/- T cells were
found in the spleen and lung of female C57BL/6 mice compared to the WT control. We
have previously observed that the lung is one of the first organs infiltrated by T cells
when injected iv and this has also been shown in a study by Pittet et al. (2007) who
observed increased infiltration of the lung two hours post-injection. It is therefore
possible that the enhanced speed of HY-specific CD4+ Vav1-/- T cells accelerated their
entry and exit from the lungs compared to the WT controls, which would explain why
less Vav1-/- T cells were found there. This would also explain why no differences were
observed at six and 24 hours, as the WT T cells would have had enough time to “catch
up” with the faster Vav1-/- T cells.
It is possible that a similar explanation applies for the spleen as well. An intra-vital
microscopy study revealed that lymphocytes in spleen vessels have higher rolling
velocity than cells in the HEV of the lymph nodes, which may suggest that T cells in the
bloodstream would enter the spleen faster than other tissues (Grayson et al., 2003).
 Note that the average number of cells present in each tissue decreased at later time-
points, and this is probably due to cell death, further re-distribution into the body or
simply decay of the fluorescent dyes.
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Chapter 3: Regulation of TCR-dependent T cell recruitment to
non-lymphoid antigenic sites by Vav1
3.1. Introduction
Primed T cells recirculating in the bloodstream need to locate their cognate antigen
in order to localise to antigenic sites. Recent evidence suggests that antigen presented by
ECs lining the post-capillary venules of non-lymphoid antigenic tissue is recognised by
circulating T cells, resulting in enhanced diapedesis and entry into the antigenic tissue
(Greening et al., 2003) (Savinov et al., 2001) (Marelli-Berg et al., 2004)
Vav1 is activated during TCR triggering through phosphorylation by ZAP70 and
acts as a GEF for Rac1, a RhoGTPase which is known to regulate actin polymerisation
(Crespo et al., 1996; Garcia-Bernal et al., 2006; Garcia-Bernal et al., 2005; Han et al.,
1997). Therefore, Vav1 provides an essential link between TCR signalling and the
regulation of cytoskeletal re-arrangements. Based on this, it was hypothesised that loss of
Vav1 activity would result in impaired T cell recruitment and retention into antigenic
sites.
Previous experiments in Chapter 2 have indicated that although HY-specific CD4+
Vav1-/- T cells showed impaired migration in vitro, they did not display gross defects in
T cell trafficking in vivo, probably due to other compensatory factors. This would suggest
that any defects potentially observed in TCR-dependent recruitment and retention to sites
of antigen presentation are not due to a generic defect in migration, but specifically due to
an involvement of Vav1 in antigen-dependent migration.
Due to the disparity of the in vitro and in vivo data obtained when assessing
antigen-independent migration, we examined TCR-dependent migration using both in
vitro and in vivo assays.
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3.2. Results
3.2.1. The role of Vav1 in TCR-dependent T cell migration in vitro
To investigate the requirement of Vav1 activity in antigen-dependent T cell
migration, we first performed transwell-based and time-lapse microscopy in vitro assays
using syngeneic antigenic (male) and non-antigenic (female) EC monolayer. For the
transwell-based migration assays, 3-5x105 HY-specific CD4+ WT and Vav1-/- T cells
were plated on male or female EC monolayer-coated transwells previously pulsed with
IFNγ to induce MHC class II expression, antigen presentation and proliferation, and
allowed to migrate for 24 hours.
Figure 22 a shows the result on the transwell-based assay. As predicted, HY-
specific CD4+ WT T cells showed enhanced migration through the male monolayer
compared to the female, non-antigenic one. In contrast, HY-specific CD4+ Vav1-/- T cells
did not have any significant differences in migration through male or female endothelial
monolayer, suggesting that Vav1 activity is required for TCR-dependent migration in
vitro. In addition, as mentioned in Chapter 2, HY-specific CD4+ Vav1-/- T cells showed
reduced baseline migration in the absence of antigen through female monolayer,
compared to the WT controls.
These findings were confirmed using time-lapse microscopy (Supplementary
videos 3-6). In this case, 106 WT and Vav1-/- T cells were serum-starved in RPMI 2%
FCS for one hour and subsequently plated on male or female endothelial monolayer-
coated 35mm dishes that had previously been pulsed with IFNγ to induce MHC class II
expression, antigen presentation and proliferation. As shown in Figure 22 b, HY-specific
CD4+ WT T cells showed enhanced transmigration when plated on male EC monolayer
than when plated on female, as defined by the change of phase (i.e. turning from bright to
dark when under the monolayer)(Supplementary videos 3-6). This effect was not
observed in the HY-specific CD4+ Vav1-/- T cells confirming that in vitro, Vav1 activity
is required for TCR-dependent migration.
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Figure 22: Vav1-/- T cells do not show enhanced migration in the presence of
antigen
Viable HY-specific CD4+ WT and Vav1-/- T cells were used between days seven and ten
post-stimulation with male splenocytes and recombinant IL-2. T cells were plated on
transwells coated with antigenic (male) or non-antigenic (female) 129sv ECs that had
previously received an optimal dose of IFNγ to induce MHC class II expression and
allowed to migrate for 24 hours. Percentage migration was calculated by dividing the
number of cells in the bottom chamber by the total number of cells plated from three
experiments (a). 1x106 T cells were plated on 35mm dishes coated with antigenic (male)
or non-antigenic (female) 129sv ECs that had previously received an optimal dose of
IFNγ to induce MHC class II expression and allowed to migrate for 50 minutes. The
movie was made by taking photos every 30 seconds. Transmigrating T cells were defined
as changing phase i.e. turning from bright to dark once under the endothelial monolayer.
Average percentage of cells transmigrating was calculated from three independent
experiments from a sample of 100 cells per movie (b). Error bars indicate standard error.
As the standard error was very small in this case, the error bars are not visible Statistical
analysis was performed using Student’s t-test (*p<0.05, **p<0.01).
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3.2.2 The role of Vav1 in TCR-dependent recruitment and retention in vivo-
antigen-dependent peritoneal recruitment model
The in vitro migration assays indicated that HY-specific CD4+ Vav1-/- T cells had
impaired TCR-dependent migration, as predicted by our hypothesis. To examine whether
this also applied in vivo, we used the peritoneal recruitment model. In this model, HY-
specific T cells are injected iv in male and female mice that previously received an ip
injection of IFNγ to induce MHC class II expression and localised antigen presentation in
the peritoneal membrane (Figure 23). Previous studies (Marelli-Berg et al., 2004) have
shown that iv injection of HY-specific WT T cells in mice results in recruitment to the
peritoneal cavity and retention to the peritoneal membrane in male but not female mice
injected with  IFNγ.
Figure 23: Injection of IFNγ ip results in increased MHC class I and induction of
MHC class II expression in mice
C57BL/6 mice were injected with 600 units recombinant IFNγ ip or PBS as a control.
MHC class I and II expression was analysed 48 hours later by labelling with a FITC-
conjugated anti-MHC class I and II antibody and mounting with DAPI which stains the
nucleus blue (x40 magnification)(courtesy of Federica Marelli-Berg).
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To examine antigen-dependant migration in vivo, we employed the afore mentioned
peritoneal recruitment model. Briefly, PKH26-labelled 107 HY-specific CD4+ WT and
CFSE-labelled 107 HY-specific CD4+ Vav1-/- T cells were co-injected iv in male and
female mice that had previously received an ip injection of IFNγ  to induced MHC class II
expression and cause localised antigen presentation in the peritoneal cavity. Control mice
were injected ip with PBS. The mice were culled 24 hours later and the enrichment of T
cells to the peritoneal lavage was examined by flow cytometry, while the presence of T
cells to the peritoneal membrane was examined by wide-field fluorescence microscopy.
Figure 24 a shows the recruitment of T cells to the peritoneal cavity as analysed by
flow cytometry. As shown in Figure 24 b, both HY-specific CD4+ WT and Vav1-/- T
cells showed enhanced recruitment to the peritoneal cavity in male but not female mice,
which suggests that Vav1 activity is not necessary for TCR-dependent recruitment to
sites of antigen presentation. As expected, ip injection of PBS did not result in
recruitment of either HY-specific CD4+ WT or Vav1-/- T cells to the peritoneal cavity.
However, we observed a significantly lower number of HY-specific CD4+ Vav1-/-
T cells retained in the peritoneal membrane in male mice compared to the WT controls,
as shown in Figure 24 d, with representative examples of the peritoneal membrane
sections shown in Figure 24 c. This suggests that although Vav1 activity appears to be
dispensable for TCR-dependent recruitment, it may be important for TCR-dependent
retention to sites of antigen presentation. As expected, a negligible number of T cells was
found in the peritoneal lavage and membrane of female mice injected with HY-specific
CD4+ WT and Vav1-/- T cells as well as the male and female mice injected with PBS
instead of IFNγ.
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Figure 24: Vav1-/- T cells have normal recruitment but defective retention to
antigenic sites.
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Viable HY-specific CD4+ WT and Vav1-/- T cells were used between days seven and ten
post-stimulation. 107 WT and Vav1-/- T cells were labelled with PKH26 (red) and CFSE
(green) respectively and co-injected iv into male or female C57BL/6 mice which had
previously received an ip injection of IFNγ or PBS as a control. The mice were culled 24
hours later. Enrichment into the peritoneal lavage was analysed by flow cytometry (a).
Average percentage of T cells in the peritoneal lavage (b). Retention of T cells into the
peritoneal membrane was analysed by wide-field fluorescence microscopy after mounting
with vectorshield medium containing DAPI which labels the nucleus blue (x10
magnification). Red arrows indicated retained WT T cells, while green arrows indicated
retained Vav1-/- T cells (c). The average number of cells in the peritoneal membrane was
quantified manually (d). Error bars indicate standard error. Statistical analysis was
performed using Student’s t-test (*p<0.05, **p<0.01). Experimental groups consisted of
three to seven mice.
3.2.3. The role of Vav1 in TCR-dependent T cell recruitment and retention-
peritoneal tissue infiltration model
The results of the peritoneal recruitment model were surprising, as they suggested
that Vav1 is dispensable for TCR-dependent T cell recruitment to sites of inflammation
but may be required for retention to the antigenic tissue. As we had previously speculated
that flow compensates for the loss of Vav1 activity in T cells in vivo, we examined T cell
infiltration to antigenic tissue in static conditions. In this peritoneal tissue infiltration
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model, HY-specific T cells are injected directly into the peritoneal cavity of male and
female mice that have previously received an ip injection of IFNγ to induce MHC class II
expression and localised antigen presentation. Previous studies have shown that HY-
specific WT T cells injected in male mice migrate out of the peritoneal cavity and are
retained into the peritoneal membrane due to presentation by local APCs, whereas HY-
specific WT T cells injected in female mice remain in the peritoneal cavity and do not
infiltrate the peritoneal membrane (James et al., 2003).
As shown in Figure 25 a,b, significantly higher numbers of HY-specific CD4+ WT
T cells were found in the peritoneal cavity of female mice than that of male mice, as
expected for WT HY-specific T cells. In contrast, there was no difference between the
male and female peritoneal lavage when HY-specific CD4+ Vav1-/- were injected ip.
To examine this further, the peritoneal membrane, which serves as the antigenic
tissue in this case, was examined by wide-field fluorescence microscopy. As expected,
more HY-specific CD4+ WT T cells were found in peritoneal membrane of male mice
compared to that of female mice (Figure 25 c,d). However, no difference in the number
of cells present in the male and female peritoneal membranes was observed when HY-
specific CD4+ Vav1-/- T cells were injected ip. Interestingly, significantly higher number
of HY-specific CD4+ WT T cells were found in the peritoneal membrane of male mice
compared to HY-specific CD4+ Vav1-/- T cells, suggesting that Vav1-/- T cells have a
defect in infiltrating antigenic tissue in the absence of flow.
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Figure 25: Vav1-/- T cells do not infiltrate the peritoneal membrane of male mice
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Viable HY-specific CD4+ WT and Vav1-/- T cells were used between days seven and ten
post-stimulation. 3x10b T cells were injected ip in male and female mice that had
previously received an ip injection of IFNγ to induce MHC class II expression. The mice
were culled 24 hours later. T cells remaining in the peritoneal lavage were analysed by
flow cytometry (a) Average percentage of cells in the peritoneal lavage (b).
Representative examples of retained T cells in the peritoneal membrane (x10
magnification) (c) The average number of cells in the peritoneal membrane was
quantified using the algorithm in the appendix (d). Error bars indicate standard error.
Statistical analysis was performed using Student’s t-test (*p<0.05, **p<0.01).
Experimental groups consisted of four to six mice.
Regulation of T cell migration by the guanidine exchange factor Vav1
Rachel David
142
2.4. Skin graft infiltration by Vav1-/- T cells
The previous findings suggest that, although HY-specific CD4+ Vav1-/- T cells
have no gross defects in recruitment to the site of antigen presentation, they are not
retained in the antigenic tissue in vivo. A recent study by Weckbecker et al. (2007)
observed increased heart allograft survival in Vav1-/- mice compared to WT mice, with
only mild cellular rejection observed upon histological examination. In addition, Wang et
al. (2007) observed increased heart allograft survival when treating mice with 6-thio-
GTP, a metabolite of azathioprine which blocks the Vav1-Rac1 interaction.
Prompted by these findings, HY-specific CD4+ WT and Vav1-/- T cell graft
infiltration was compared using an established skin graft model. In this model, male skin
grafts, which serve as the allograft, are rapidly rejected while female grafts remain
healthy (Zelenika et al., 1998). We have previously observed that iv injection of HY-
specific WT T cells at day four post-grafting results in skin graft infiltration despite the
absence of vasculature connection between donor and recipient (unpublished
observations). Based on this, female C57BL/6 mice were grafted with male or female
C57BL/6 tail grafts, and at day four, 107 HY-specific CD4+ WT and Vav1-/- T cells were
labelled with PKH26 or CFSE respectively and co- injected iv. Skin graft infiltration was
examined 24 hours post-injection using wide-field fluorescence microscopy following
sectioning by cryotomy.
Figure 26 a shows representative examples of sections obtained from the male and
female skin grafts. Significantly more HY-specific CD4+ WT T cells than Vav1-/- T cells
were found in the male skin graft, as shown in Figure 26 b. Neither HY-specific CD4+
WT nor Vav1-/- T cells infiltrated the female skin graft.
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Figure 26: Vav1-/- T cells do not infiltrate the antigenic skin graft
Viable HY-specific CD4+ WT and Vav1-/- T cells were used between days seven and ten
post-stimulation. 107 WT and Vav1-/- T cells were labelled with PKH26 (red) and CFSE
(green) respectively and co-injected iv into female C57BL/6 mice that had previously
received a tail skin graft from male or female C57BL/6 donors. The mice were culled 24
hours later and tissue infiltration was measured by wide-field fluorescence microscopy
after mounting with vectorshield medium containing DAPI which stains the nucleus blue
(x10 magnification). Representative examples of male and female skin grafts sections (a).
The number of cells present in each section was quantified manually (b). Error bars
indicate standard error. Statistical analysis was performed using Student’s t-test
(**p<0.01). Each group consisted of three female mice.
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3.3. Discussion
Vav1 acts as an essential link between the TCR and the cytoskeleton so we had
hypothesised that loss of Vav1 will result in impaired T cell recruitment and retention to
sites of antigen presentation. The first part of this study aimed to test this hypothesis
using in vitro migration assays. Indeed we observed that the HY-specific CD4+ Vav1-/- T
cells did not show enhanced migration in the presence of antigen in the transwell-based
migration assays, as no significant differences in transendothelial migration through
antigenic male and non-antigenic female EC monolayer were detected. This observation
was further supported by the time-lapse microscopy assays. As expected, the HY-specific
CD4+ WT T cells showed enhanced transmigration through male endothelial monolayer
in both assays.
Our previous findings in Chapter 2 showed disparity between the in vitro and the in
vivo findings, whereby any defects in migration observed in vitro appeared to be
compensated for in vivo by other factors, possibly shear flow. It was therefore essential to
assess whether in vitro findings on the role of Vav1 in TCR-dependent migration were
reflected in vivo.
In the first part of the in vivo study we used an antigen-driven peritoneal
recruitment model, previously established in our laboratory (Marelli-Berg et al., 2004); ip
injection of IFNγ causes localised antigen presentation in the peritoneal membrane, which
results in HY-specific WT T cells being recruited to the peritoneal cavity and membrane
of male but not female mice when injected iv. Based on our preliminary data as well as
the in vitro assays, we hypothesised that HY-specific CD4+ Vav1-/- T cells would show
inefficient recruitment to the peritoneal cavity in male mice. Surprisingly, HY-specific
CD4+ Vav1-/- T displayed normal recruitment suggesting that Vav1 activity is not
required for TCR-dependent T cell recruitment to antigenic sites in vivo.
We have previously speculated that shear flow may compensate for the loss of
Vav1 activity in T cell migration in vivo. To confirm this hypothesis, T cell migration
was examined in the absence of flow using an in vivo peritoneal tissue infiltration model.
In this case, T cells are injected directly into the peritoneal cavity and infiltration of the
antigenic tissue, the peritoneal membrane, is only observed in male mice (James et al.,
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2003). Indeed the HY-specific CD4+ WT T cells infiltrated the peritoneal membrane in
male mice, while in female mice, they remained in the peritoneal lavage. However HY-
specific CD4+ Vav1-/- T cells showed significantly lower infiltration of the peritoneal
membrane of male mice compared to the WT controls, confirming that flow may
compensate for the loss of Vav1 activity in TCR-dependent T cell migration in vivo.
In the peritoneal recruitment model, more HY-specific T cells are retained in the
peritoneal membrane of male mice compared to female controls. It is thought that
retention to the peritoneal membrane is mediated by the presentation of antigen by
resident APCs, which has previously been shown to result in temporary loss of migratory
ability, allowing the T cell to polarise and proliferate; this is known as the stop signal
(Dustin et al., 1997).
An interesting possibility explaining the reduced number of HY-specific Vav1-/- T
cells in the peritoneal membrane is reduced susceptibility to the migratory stop signal. In
this case, engagement of the TCR through presentation of antigen by resident APCs in the
peritoneal membrane does not result is loss of migratory ability, allowing the Vav1-/- T
cells to continue migrating to the peritoneal cavity. This possibility will be explored
further in Chapter 4.
One of the first studies to demonstrate a role for Vav1 in T cell migration to sites of
inflammation in vivo was by Korn et al. (2003) who observed reduced brain infiltration of
MOG peptide-primed Vav1-/- T cells in a model of EAE. This could be explained as
reduced recruitment of T cells from these Vav1-/- mice to sites of inflammation, but our
studies suggest that Vav1-/- T cells show normal recruitment. It is therefore possible that
reduced brain infiltration observed in this study may have been due to reduced retention
to the antigenic brain tissue.
Previous studies of transplant tolerance have observed that Vav1-/- mice show
increased heart allograft tolerance with significantly reduced histological damage
compared to WT mice, suggesting a role for Vav1 in T cell-mediated transplant rejection
(Weckbecker et al., 2007). This was further supported by a study by Wang et al. (2007),
who used 6-thio-GTP, an inhibitor of the Vav1/Rac1 interaction to prolong heart allograft
tolerance in mice. Based on these findings, we hypothesised that Vav1-/- T cells may
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migrate to the transplant but are not retained following antigen presentation by graft
APCs, leading to reduced transplant rejection.
To test this hypothesis, we used tail skin grafting of syngeneic male and female
grafts on female C57BL/6 mice. We have previously observed that although the
vasculature of donor and recipient are not connected, HY-specific WT T cells are able to
infiltrate the graft when injected at day four post-grafting. Other studies have also
demonstrated that CD8+ T cells infiltrate the skin graft between days three and seven
post-transplantation (Jones et al., 2001) suggesting that vascularisation of the skin graft,
which is thought to start at day three and progress until day 21 post-transplantation, is not
necessary for the entry of T cells to the graft. Therefore, retention may play a dominant
role in mediating T cell localisation to the skin in this model.
Using this tail skin grafting model, we observed reduced infiltration of HY-specific
CD4+ Vav1-/- T cells to the male skin graft compared to the WT control. This suggests
that in the absence of Vav1 activity, T cells either did not migrate to the male skin or
were not retained due to reduced responsiveness to the migratory stop signal, mediated by
resident APCs. As we have previously shown that HY-specific CD4+ Vav1-/- T cells are
able to traffic to different organs in the body, are efficiently recruited to sites of antigen
presentation and express high levels of the skin homing marker, PSGL-1, we can
hypothesise that HY-specific CD4+ Vav1-/- T cells migrated to the male skin graft but
were not retained. Nevertheless, as the skin graft was not vascularised, it is possible that
in the absence of flow, HY-specific CD4+ Vav1-/- T cells showed impaired infiltration to
the site of antigen presentation, as previously described in the peritoneal infiltration
model.
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Chapter 4: Regulation of the migratory stop signal by Vav1
4.1. Introduction
The data presented in Chapter 3 suggest that HY specific CD4+ Vav1-/- T cells
were recruited but not retained into the antigenic tissue. Retention to antigenic tissue is
likely to be sustained by two factors; enhanced adhesion due to upregulation of integrins
such as LFA-1 by memory T cells as well as migratory stop signals induced by
presentation of antigen by resident APCs. These two factors are not actually mutually
exclusive; Dustin et al. (1997) showed that engagement of the TCR results in increased
adhesion to ICAM-1. This suggests that presentation of antigen by resident APCs governs
retention to antigenic tissue by engagement of the TCR leading to increased adhesion and
loss of migratory ability.
The functional consequences of antigen presentation differ significantly depending
on the context they occur. Co-engagement of the TCR and co-stimulatory molecules,
mediated by conventional APCs which may be found in the peritoneal membrane, has
been shown to result in loss of migratory ability, allowing the T cell to polarise, interact
with the APC and proliferate. This phenomenon is known as the stop signal (Dustin et al.,
1997). In contrast, antigen presentation by ECs does not result in proliferation in the
absence of cytokines (Lodge and Haisch, 1993; Pardi and Bender, 1991) and in fact has
been shown to increase migration (Marelli-Berg et al., 2000).
Vav1 has previously been implicated in T cell: APC conjugate formation. Vav1-/-
thymocytes were defective in transducing LFA-1 signals for the formation of conjugates
(Ardouin et al., 2003) while T cells from TCR transgenic Vav1-/- mice showed reduced
ability to form peptide-specific conjugates (Krawczyk et al., 2002). Given the reduced
retention of HY-specific CD4+ Vav1-/- T cells to the antigenic tissue, we investigated the
involvement of Vav1 in the regulation of the stop signal.
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4.2. Results
4.2.1 Regulation of antigen-induced conjugate formation between DCs and
T cells by Vav1
Previous studies have implicated Vav1 in conjugate formation; Ardouin et al.
(2003) observed reduced transduction of LFA-1 signals required for conjugate formation
in Vav1-/- thymocytes, while Krawczyk et al. (2002) observed reduced peptide-specific
conjugate formation in naïve T cells from TCR-transgenic Vav1-/- mice. To extend these
findings to memory T cells, we examined conjugate formation between antigen-specific
memory T cells and peptide-pulsed DCs using HY-specific CD4+ Vav1-/- T cells. More
specifically, 2.5x105 HY-specific CD4+ WT and Vav1-/- T cells were incubated for two
hours with 105 female DCs pulsed with an optimal dose of Dby peptide (50nM),
previously established in the proliferation assays, or female DCs alone as a control and
conjugate formation was analysed by flow cytometry. Single stains were used as controls
and conjugates were defined as the double-positive population formed between the
CFSE-labelled DCs and the PKH26-labelled T cells.
As shown in Figure 27 a,b, HY-specific Ab-restricted CD4+ WT T cells showed
enhanced conjugate formation in the presence of the class II Dby peptide. In contrast,
HY-specific Ab-restricted CD4+ Vav1-/- T cells displayed no significant differences in
conjugate formation in the presence or absence of peptide. This indicates that Vav1 is
required for antigen-induced conjugate formation between memory T cells and DCs in
vitro.
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Figure 27: Vav1-/- have impaired conjugate formation in vitro
Viable HY-specific Ab-restricted CD4+ WT and Vav1-/- T cells were used at day ten post-
stimulation. DCs were isolated from the bone marrow of female C57BL/6 mice and
cultured for seven days, followed by overnight LPS maturation on the day before the
experiment. T cells were labelled with PKH26 and incubated with DCs labelled with
CFSE and pulsed with 50nM Dby peptide for two hours. DCs alone were used as a
control. Conjugate formation was analysed by flow cytometry (a). Average percentage of
conjugate formation from four experiments (b). Error bars indicate standard error.
Statistical analysis was performed using Student’s t-test (**p<0.01, ***p<0.001).
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4.2.2 Regulation of the migratory stop signal by Vav1 in vitro
Findings in Chapter 3 implied that HY-specific CD4+ Vav1-/- T cells may have lost
susceptibility to the migratory stop signal induced by TCR engagement, resulting in
reduced retention to the antigenic tissue. To examine this further, we used in vitro
transwell-based migration assays. Briefly, 24-well plates were coated with 5µg/ml CD28
and 1µg/ml CD3 or hamster IgG (2µg/ml) as an isotype control in 200µl Tris pH 8.5 for
two hours at 37oC. The wells were subsequently washed and HY-specific CD4+ WT and
Vav1-/- T cells (5x105 per transwell) were plated for activation for 45 minutes at at 37oC.
Following activation, T cells were plated on ICAM-1-coated tranwells and migration was
measured at different time-points over 24 hours.
Figure 28 a shows the migration of HY-specific CD4+ WT and Vav1-/- T cells
through ICAM-1-coated transwells. When stimulated with plastic-bound CD3 and CD28,
WT T cells showed a significant reduction of migration in response to ICAM-1 compared
to medium alone or the isotype control. In contrast, ligation of the TCR and CD28 did not
result in significantly reduced migration of Vav1-/- T cells migration on ICAM-1
compared to the medium and isotype controls.
We then proceeded to examine the migration of activated HY-specific CD4+ WT
and Vav1-/- T cells through syngeneic ECs using transwell-based migration assays. HY-
specific CD4+ WT and Vav1-/- T cells were activated with plastic-bound CD3 and CD28
antibody or an isotype control, then plated on syngeneic EC-coated transwells and
allowed to migrate for 24 hours.
 As shown in Figure 28 b, HY-specific CD4+ WT T cells showed a significant loss
of migratory ability following ligation of the TCR and CD28 compared to the isotype
control and medium alone. Once again, Vav1-/- T cells did not respond to CD3/CD28
stimulation, as their migration through the syngeneic endothelial monolayer was
comparable to the isotype and medium alone controls. This suggests that in vitro, Vav1 is
required for the transduction of the migratory stop signal.
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Figure 28: Vav1-/- T cells are not susceptible to the stop signal
Viable HY-specific Ab-restricted WT and Vav1-/- T cells were used between days seven
and ten post-stimulation. T cells were activated with plastic bound anti-CD3 and anti-
CD28, hamster IgG isotype control or medium alone and plated on ICAM-1-coated
transwells (a) or syngeneic endothelial monolayer- coated transwells (b). Migration was
measured at two, four, six and 24 hours. Percentage of migrated cells was calculated by
dividing the number of cell in the lower chamber with the original number of cells plated
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on the traswells. Error bars indicate standard error. Statistical analysis was performed
from the average of at least three independent experiments using Student’s t-test
comparing CD3/CD28 with isotype control and medium (** p<0.01, *** p<0.001).
4.2.3 Regulation of conjugate formation and the transduction of the
migratory stop signal by Vav1 in vivo
Our findings in the first two sections of this chapter suggested that in vitro, loss of
Vav1 activity impaired both conjugate formation as well as transduction of the migratory
stop signal in T cells. To examine the physiological relevance of these observations, we
developed an in vivo model to assess the interaction of antigen-specific T cells and
peptide-pulsed APCs in both lymphoid and non-lymphoid antigenic tissue (depicted in
Figure 29). C57BL/6 female mice were injected with 107 PKH26-labelled HY-specific
Ab-restricted CD4+ WT or Vav1-/- T cells iv and 2x106 CFSE labelled LPS-matured DCs
pulsed with an optimal dose (50nM) of Dby peptide ip. The mice were sacrificed 24
hours later and the presence of conjugates in lymphoid and non-lymphoid tissue was
examined by wide-field fluorescence microscopy. We defined conjugates as the presence
of yellow fluorescence formed by the interaction between the membrane of the red
PKH26-labelled T cells and the green CFSE-labelled DCs.
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Figure 29: Conjugate formation in vivo model
107 PKH26-labelled T cells were injected iv in female C57BL/6 mice that simultaneously
received an ip injection of Dby peptide pulsed DCs labelled with CFSE, or DCs alone as
a control (a). T cells travel into the bloodstream and reach the peritoneal membrane as
well as the spleen, while DCs travel out of the peritoneal cavity, through the peritoneal
membrane, enter the bloodstream and reach the spleen. T cells and peptide-pulsed DCs
may form conjugates in both lymphoid (i.e. spleen) or non-lymphoid (i.e. peritoneal
membrane) tissue, resulting in the transduction of the migratory stop signal and tissue
retention.
Being of an effector memory T cell phenotype, HY-specific CD4+ WT and Vav1-/-
T cells readily migrate to the spleen but not the lymph nodes, as described in Chapters 1
and 2. As a secondary lymphoid organ, the spleen is a premier site of antigen presentation
(reviewed in Janeway et al, 2001). In addition, DCs injected ip have previously been
shown to promptly circulate in the bloodstream and reach secondary lymphoid tissues
(Mirenda et al., 2005). Based on these observations, we initially examined conjugate
formation between HY-specific CD4+ WT and Vav1-/- T cells and peptide-pulsed DCs in
the spleen.
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As shown in Figure 30 a,b, WT T cells showed interaction with the peptide-pulsed
DCs, appearing as yellow fluorescence, compared to DCs alone. In contrast, the presence
of peptide did not result in enhanced conjugate formation between HY-specific Ab-
restricted CD4+ Vav1-/- T cells and DCs in the spleen. This confirms that Vav1 activity is
required for conjugate formation between memory T cells and APCs in lymphoid tissue
in vivo. As expected, no conjugates were observed in the spleens of female mice injected
with T cells alone or DCs alone.
Figure 30: Vav1-/- T cells form less conjugates in the spleen
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Viable HY-specific CD4+ WT and Vav1-/- T cells were used between days seven and ten
post-stimulation. Female DCs were isolated from the bone marrow of female C57BL/6
mice and were matured overnight with LPS after having been placed in culture for seven
days. HY-specific CD4+ WT and Vav1-/- T cells were labelled with PKH26 (red) and
injected iv in female C57BL/6 mice that simultaneously received an ip injection of CFSE
(green)-labelled Dby peptide pulsed DCs or DCs alone as a control. HY-specific CD4+
WT and Vav1-/- T cells and DCs were injected alone as a control. The mice were culled
24 hours later. The spleen was snap-frozen in OCT medium, cut in 5-10µm sections and
analysed by wide-field fluorescence microscopy following mounting with vectorshield
medium containing DAPI which stains the nucleus blue. Representative examples of
sections from each condition. Conjugates are indicated by a yellow circle, white if
magnified to x20 and red if magnified to x40 (a) Average number of conjugates in the
spleen (b) Error bars indicate standard error. Statistical analysis was performed using
the Student’s t-test (**p<0.01). Experimental groups consisted of six female mice.
We then proceeded to examine conjugate formation in peritoneal membrane (i.e.
non-lymphoid tissue containing APCs). Figure 31 a shows the peritoneal membrane of
female mice in all the conditions tested. As shown in Figure 31 b,c,d, the peritoneal
membrane of female mice injected with HY-specific CD4+  WT T cells and Dby peptide
pulsed DCs showed the presence of yellow fluorescence which, as mentioned earlier, we
defined as conjugates. This effect was not observed in any of the other conditions,
including the peritoneal membrane of female mice injected with HY-specific CD4+ WT T
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cells and DCs alone, as well as female mice injected with HY-specific CD4+ WT T cells
alone or DCs alone (Figure 31a,d). In addition, yellow fluorescence was not observed in
the peritoneal membrane of female mice injected with HY-specific CD4+ Vav1-/- T cells,
including those injected with Dby peptide pulsed DCs, DCs alone and Vav1-/- T cells
alone (Figure 31a,d). This suggests the HY-specific Ab-restricted CD4+ WT T cells were
interacting with the Dby-peptide pulsed DCs, which appeared as yellow fluorescence in
the non-lymphoid antigenic tissue.
Figure 31: Vav1-/- T cells do not efficiently interact with peptide-pulsed APCs in
non-lymphoid tissue
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Viable HY-specific CD4+ WT and Vav1-/- T cells were used between days seven and ten
post-stimulation. Female DCs were isolated from the bone marrow of female C57BL/6
mice and were matured overnight with LPS after having been placed in culture for seven
days. HY-specific CD4+ WT and Vav1-/- T cells were labelled with PKH26 (red) and
injected iv in female C57BL/6 mice that simultaneously received an ip injection of Dby-
peptide pulsed DCs or DCs alone as a control labelled with CFSE (green). HY-specific
CD4+ WT and Vav1-/- T cells and DCs were injected alone as a control. The mice were
culled 24 hours later. The peritoneal membrane was analysed by wide-field fluorescence
microscopy following mounting with vectorshield medium containing DAPI which stains
the nucleus blue. Representative examples of each condition (x10 magnification). The
yellow arrow indicates the presence of a conjugate (a) Representative examples of
conjugates between HY-specific CD4+ WT T cells and Dby-peptide pulsed DCs at x40
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magnification (b,c).  The HY-specific CD4+ WT T cell (red) and the Dby-peptide pulsed
DC (green) have a tight interphase, which appears yellow (b) The HY-specific CD4+ WT
T cell (red) is on top of the Dby-peptide pulsed DC (green) resulting in yellow
fluorescence (c) Average number of conjugates in the peritoneal membrane (d). Error
bars indicate standard error. Statistical analysis was performed using the Student’s t-test
(**p<0.01, ***p<0.001). Experimental groups consisted of six female mice
We have thus far observed that in the presence of antigen, HY-specific CD4+ WT T
cells form conjugates with peptide-pulsed DCs in both lymphoid and non-lymphoid
tissue. In addition to this, we observed increased retention of HY-specific CD4+ WT T
cells to the peritoneal membrane of female mice injected with peptide-pulsed DCs, as
shown in Figure 32 a,b. This effect was not observed in any of the other conditions
tested, suggesting that these cells may have previously formed conjugates with peptide-
pulsed DCs and would have thus received the migratory stop signal.
To examine whether this correlated with reduced migration to the peritoneal cavity,
we analysed T cell enrichment of the peritoneal lavage by flow cytometry and FlowJo
software. As shown in Figure 32 c,d HY-specific CD4+ WT T cells showed significantly
reduced infiltration of the peritoneal cavity of female mice injected with Dby-peptide
pulsed female DCs compared to DCs alone. In contrast, no significant difference was
observed in the recruitment of HY-specific CD4+ Vav1-/- T cells to the peritoneal cavity
on female mice injected with DCs in the presence or absence of peptide.
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Figure 32: Vav1-/- T cells do not respond to the stop signal in vivo
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Viable HY-specific CD4+ WT and Vav1-/- T cells were used between days seven and ten
post-stimulation. Female DCs were isolated from female C57BL/6 mice and were
matured overnight with LPS after having been placed in culture for seven days. HY-
specific CD4+ WT and Vav1-/- T cells were labelled with PKH26 (red) and injected iv in
female C57BL/6 mice that simultaneously received an ip injection of CFSE-labelled
(green) Dby-peptide pulsed DCs or DCs alone as a control. HY-specific CD4+ WT and
Vav1-/- T cells and DCs were injected alone as a control. The mice were culled 24 hours
later. The peritoneal membrane was analysed by wide-field fluorescence microscopy
following mounting with vectorshield medium containing DAPI which stains the nucleus
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blue (x10 magnification). Red cells are indicated by red arrows. (a). Average number of
cells retained in the peritoneal membrane (b).  The peritoneal lavage was analysed by
flow cytometry (c) Average percentage of cells present in the peritoneal lavage (c). Error
bars indicate standard error. Statistical analysis was performed using the Student’s t-test
(*p<0.05, **p<0.01, ***p<0.001). Experimental groups consisted of at least three
female mice.
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4.3. Discussion
In Chapter 3 we observed reduced retention of HY-specific CD4+ Vav1-/- T cells to
antigenic tissue, the peritoneal membrane, despite accelerated recruitment. In this chapter
we have examined the possibility that reduced retention of Vav1-/- T cells to antigenic
tissue may be due to lack of responsiveness to the migratory stop signal delivered by
local conventional APCs. Loss of migratory ability occurs upon strong engagement of the
TCR by professional APCs, such as DCs, so we commenced this investigation by
examining the role of Vav1 in memory T cell conjugate formation.
Indeed HY-specific CD4+ Vav1-/- T cells showed impaired conjugate formation in
vitro, with no significant difference in percentage of conjugates in the presence or
absence of antigen. This is not surprising as Vav1 has previously been shown to be
involved in conjugate formation between TCR-transgenic T cells and APCs (Krawczyk et
al., 2002). In addition, Vav1 has been found to be necessary for the formation of the
immunological synapse; Vav1 activity has been found to be required for the activation of
LFA-1 upon TCR triggering (Krawczyk et al. 2002, Ardouin et al., 2003) and for the
translocation of lipid rafts to the immunological synapse (Villalba et al., 2001). Finally,
Vav1-/- T cells have previously been shown to have defective accumulation of
TCR/MHC II in the immunological synapse, impaired actin cap formation and reduced
interaction of actin with CD3ζ (Fischer et al., 1998; reviewed in Hornstein et al., 2004).
Our findings therefore confirm that Vav1 activity is required for stable conjugate
formation during the interaction of the TCR with MHC-bound peptide.
Conjugate formation in non-lymphoid tissue has not been extensively examined in
vivo and certainly never for Vav1-/- T cells. Given the disparity of in vitro and in vivo
findings due to physiological factors affecting T cells in the body, we tried to examined
the requirement for Vav1 activity in vivo using two approaches; conjugate formation in
the spleen, which is known to occur as the spleen is a secondary lymphoid organ where
memory T cells migrate, and conjugate formation in non-lymphoid antigenic tissue,
which has not been extensively described. Due to the abundance of T cells and DCs in the
spleen, examination of conjugate formation was relatively easy. We defined conjugate
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formation as the presence of yellow fluorescence between a red T cell and a green DC.
As expected, HY-specific Ab-restricted CD4+ WT T cells showed enhanced conjugate
formation in the spleen in the presence of peptide-pulsed DCs compared to DCs alone.
This was not observed with HY-specific Ab-restricted CD4+ Vav1-/- T cells, which
confirms our in vitro findings on the requirement for Vav1 activity for T cell:APC
conjugate formation.
Conjugate formation in the peritoneal membrane, which serves as the antigenic
tissue in this model, was rather more difficult to assess due to the scarcity of both DCs
and T cells in the tissue; DCs have in fact previously been shown to promptly leave the
peritoneal cavity when injected ip (Mirenda et al., 2005). In spite of the low numbers of
cells, areas of yellow fluorescence in the peritoneal membrane of female mice injected
with HY-specific WT T cells and Dby-peptide pulsed DCs were observed, validating our
model for the evaluation of conjugate formation in non-lymphoid tissue. These findings
indicate that Vav1 activity is required for conjugate formation in non-lymphoid antigenic
tissues in vivo. Confocal microscopy may provide more information on the interaction as
it has depth resolution, which allows distinguishing the overlap of two cells (Y. Gu,
personal communication). This would allow for better visualisation of the interaction
between the T cell and the peptide-bound DC. However, as we primarily wanted to
quantify the number of conjugates present in the tissues, wide-field fluorescence
microscopy was a more appropriate method of analysis.
A previous study on conjugate formation in vivo was able to visualise the
interaction of lymphocytic choriomeningitis virus (LCMV)-specific CD8+ T cells with
LCMV targets in the brain using tetramer staining of brain sections from mice
(McGavern et al., 2002). This study also defined conjugates as the yellow interface
between the red CD8+ T cells and the green tetramer staining, validating our definition. It
would have been interesting to use a similar approach, however there are no MHC class
II tetramers. The authors of this paper have also justly noted that their observation of
conjugate formation is just a “snap-shot” in time, which also applies is our case. Real-
time in vivo imaging would provide more information of the dynamics of this interaction.
We have observed a requirement for Vav1 in conjugate formation both in vitro and
in vivo. Conjugate formation is an integral part of the loss of migratory ability in T cells,
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as only strong engagement of the TCR results in the transduction of the stop signal
(Dustin et al., 1997). As HY-specific CD4+ Vav1-/- T cells showed reduced conjugate
formation, we hypothesised that they would show impaired responsiveness to the
migratory stop signal.
Previous findings by Berg et al. (2002) have indicated that antibody engagement of
the TCR and CD28 can lead to loss of migratory ability in vitro. Based on this
observation, we examined loss of migratory ability in vitro using a transwell-based
migration assay. We detected that engagement of the TCR and CD28 by plastic-bound
antibody resulted in loss of migratory ability in HY-specific CD4+ WT T cells migrating
through ICAM-1-coated transwells. In contrast, HY-specific CD4+ Vav1-/- T cell
migration was unaffected by ligation of the TCR and CD28. We further confirmed our
findings using syngeneic endothelial monolayer-coated transwells, and once again
observed loss of migratory ability in HY-specific CD4+ WT T cells treated with CD3 and
CD28 antibody, but not in HY-specific CD4+ Vav1-/- T cells. This suggests that in vitro,
Vav1 activity is required for the transduction of the migratory stop signal due to TCR and
CD28 engagement.
To examine the physiological relevance of our findings, we used the afore
mentioned in vivo model, whereby HY-specific CD4+ T cells were injected iv in female
mice that had simultaneously received an ip injection of Dby-peptide pulsed DCs. In
addition to increased conjugate formation, we observed increased retention of HY-
specific CD4+ WT T cells, compared to Vav1-/- T cells, which may have been the result
of loss of migratory ability due to prior interaction with peptide-pulsed DCs. HY-specific
CD4+ Vav1-/- T cells also showed enhanced recruitment to the peritoneal cavity
compared to HY-specific CD4+ WT T cells, suggesting that they had impaired interaction
with the Dby peptide-pulsed DCs in the peritoneal membrane, which did not result in
strong engagement of the TCR, and thus did not result in the transduction of the
migratory stop signal. These findings suggest that Vav1 activity is required for the loss of
migratory ability due to engagement of the TCR both in vitro and in vivo.
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Chapter 5: Regulation of T cell migration by CD28 and Vav1
5.1. Introduction
It is clear from Chapter 3 that the role of Vav1 in the regulation of T cell trafficking
is more complex than we originally hypothesised. HY-specific CD4+ Vav1-/- T cells
showed normal recruitment to antigenic tissues under flow, but defective antigenic tissue
retention and defective antigenic tissue infiltration under static conditions. These results
were similar to findings by Korn et al. (2003) who observed reduced brain infiltration in
a model of EAE in Vav1-/- mice. Administration of an anti-CTLA-4 antibody which
increases CD28 signalling partially increased disease incidence, suggesting that dominant
CD28 signalling may moderately compensate for the impaired tissue localisation of
Vav1-/- T cells.
Entry into peripheral tissues is dependant on diapedesis through ECs on the surface
of post-capillary venules, which have little or no expression of B7 molecules
(CD80/CD86) in humans and mice respectively. On the other hand, retention to antigenic
tissues is dependent on antigen presentation by resident APCs, which are B7 positive, and
are thus capable of inducing co-stimulatory signalling (reviewed in Marelli-Berg and
Jarmin, 2004). This indicates that CD28 signalling contributes to the delivery of stop
signals required for the retention of T cells into antigenic tissues.
Induction of Vav1 activity by CD28 signalling has previously been described.
CD28 ligation has been shown to activate Vav1 by both phosphorylation and arginine
methylation (reviewed in Michel and Acuto, 2002; Blanchet et al., 2005). This allows
CD28 to activate signalling pathways independently of TCR signals, including the non-
canonical NfkB activation pathway (Picollela et al, 2003). In addition, Vav1 activated by
CD28 ligation has been found to associate with Rac1 as well as WASp, thus mediating
cytoskeletal re-modelling (Raab et al., 2001; reviewed in Secchi and Wehland, 2004).
We have recently shown that CD28 signalling can act in conjunction with the TCR
to enhance T cell recruitment to antigenic sites. In addition, CD28 was also found to act
independently of TCR signalling for the regulation of T cell migration (Mirenda et al.,
2006).
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Prompted by the apparent importance of Vav1 in CD28 signalling and our
observations of a requirement for Vav1 activity in T cell tissue retention and the
transduction of the migratory stop signal, we examined the relative importance of CD28
co-stimulatory signals in HY-specific CD4+ Vav1-/- T cell migration.
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5.2. Results
5.2.1 The role of CD28 in skin graft infiltration
Recent evidence from our laboratory has indicated a role for CD28 in T cell
migration; CD28 co-stimulatory signals were required for T cell localisation to antigenic
sites following priming, while CD28 over-stimulation resulted in aberrant tissue
infiltration (Mirenda et al. 2006). As part of those studies, we examined the role of CD28
in T cell skin graft infiltration. Briefly, female C57BL/6 mice were grafted with
syngeneic antigenic male tail skin grafts and were iv injected four days post-grafting with
107 HY-specific WT T cells which had either been treated with a mixture of hamster anti-
mouse CD28 (5µg/5x106 cells), and rabbit anti-hamster Ig (2.5µg/5x106 cells) to induce
CD28 signalling and labelled with PKH26 or an isotype control of Hamster Ig (5
µg/5x106 cells) and rabbit anti-hamster Ig (2.5 µg/5x106 cells) and labelled with CFSE.
Infiltration of the skin grafts was examined 24 hours later by wide-field fluorescence
microscopy following sectioning by cryotomy. As discussed in Chapter 3, T cells injected
on day 4 post-grafting are able to infiltrate the skin graft in the absence of vasculature
connection between donor and recipient.
Figure 33 shows the average number of HY-specific WT T cells infiltrating the
male tail-derived skin grafts. Induction of CD28 signalling resulted in T cell infiltration
of the antigenic skin graft compared to the isotype control. This suggests that CD28
signalling in conjunction with TCR triggering can enhance T cell localisation to antigenic
sites.
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Figure 33: CD28 cross-linking enhances WT T cell localisation into antigenic tissue
Viable HY specific WT T cells from C57BL/6 mice were used between days seven and ten
post-stimulation. Female C57BL/6 mice were grafted with tail skin grafts from male
C57BL/6 mice. On day 4, HY-specific WT T cells were cross-linked with CD28 and
labelled with PKH26 or an isotype control and labelled with CFSE, and injected iv into
the grafted female mice. Skin graft T cell infiltration was examined on day five. Error
bars indicate standard error. Statistical analysis was performed using the Student’s t-test
(*p<0.05). Experimental groups consisted of two female mice.
5.2.2 The role of CD28 signalling in Vav1-/- T cell migration in vitro
To investigate the requirement for Vav1 in CD28 regulation of migration in the
presence or absence of TCR triggering, we examined HY-specific CD4+ Vav1-/- T cell
migration using in vitro transwell-based migration assays. 3-5x105 HY-specific CD4+ WT
and Vav1-/- T cells were cross-linked with a mixture of hamster anti-mouse CD28
(5µg/5x106 cells), and rabbit anti-hamster Ig (2.5µg/5x106 cells) or Hamster Ig (5
µg/5x106 cells) and rabbit anti-hamster Ig (2.5 µg/5x106 cells) as an isotype control for 45
minutes to induce CD28 signalling and were subsequently washed and allowed to migrate
on male and female endothelial monolayer treated with IFNγ to induce MHC class II
expression.
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Figure 34 shows the results of the in vitro transwell-based migration assay. As
expected, HY-specific CD4+ WT T cells migrated more through the male monolayer than
the female in both isotype control and CD28 antibody treatments. In addition, HY-
specific CD4+ WT T cells showed enhanced migration upon induction of CD28 signalling
through the male but not the female monolayer, compared to the isotype control (Figure
34 a). Note that enhanced migration due to CD28 triggering occurs at 24 hours, which
might be due to enhanced expression of chemokine receptors (Walker et al., 1999).
In contrast, as shown in Figure 34 b, CD28 triggering of HY-specific CD4+ Vav1-
/- T cells did not result in enhanced migration through either male or female monolayer.
Concomitant with results in Chapter 3, HY-specific CD4+ Vav1-/- T cells did not show
enhanced migration through the male monolayer compared to the female control, and
CD28 cross-linking did not compensate for this defect. These findings indicated a
requirement for Vav1 activity in CD28-mediated enhancement of TCR-dependent T cell
migration in vitro.
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Figure 34: CD28 cross-linking does not enhance Vav1-/- T cell migration in vitro
Viable HY-specific CD4+ WT and Vav1-/- T cells were used between days seven and ten
post-stimulation. WT  (a) and Vav1-/- T cells (b) were cross-linked with CD28 or an
isotype control for 45 minutes to induce CD28 signalling and were subsequently plated
on male and female endothelial monolayer treated with IFNγ to induce MHC class II
expression. T cells were allowed to migrate for 24 hours. Percentage migration was
calculated by dividing by the number of cells plated on the transwell. Error bars indicate
standard error. Statistical analysis was performed using Student’s t-test (**p<0.01,
***p< 0.001) from the data from at least three experiments.
5.2.3 The role of Vav1 in CD28-mediated T cell trafficking in vivo
Previous studies have shown that CD28 triggering results in enhanced T cell
infiltration to non-lymphoid tissue in the absence of inflammation (Mirenda et al., 2006).
We have already shown that HY-specific CD4+ Vav1-/- T cells do not show any gross
impairments in tissue trafficking in vivo. As CD28 triggering did not affect HY-specific
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CD4+ Vav1-/- T cell migration in vitro, we examined whether this translated to a defect in
vivo.
 HY-specific CD4+ WT and Vav1-/- T cells were cross-linked with a mixture of
hamster anti-mouse CD28 (5µg/5x106 cells), and rabbit anti-hamster Ig (2.5µg/5x106
cells) to induce CD28 signalling and subsequently labelled with PKH26, or Hamster Ig (5
µg/5x106 cells) and rabbit anti-hamster Ig (2.5 µg/5x106 cells) as an isotype control and
labelled with CFSE. CD28 and isotype control-treated T cell were co-injected iv in
female mice (107 T cells per mouse) and allowed to traffic for 24 hours. Infiltration into
different organs was examined by wide-field fluorescence microscopy.
Induction of CD28 signalling by antibody cross-linking resulted in enhanced
trafficking of HY-specific CD4+ WT T cells to kidney (Figure 35), lung (Figure 36),
spleen (Figure 37), peritoneal membrane (Figure 38) and liver (Figure 39), as expected
from previous studies (Mirenda et al., 2006). In contrast, CD28 cross-linking did not
enhance the trafficking of HY-specific CD4+ Vav1-/- T cells in kidney (Figure 35), lung
(Figure 36), spleen (Figure 37) and peritoneal membrane (Figure 38. Interestingly,
induction of CD28 antibody triggering induced increased localisation of HY-specific
CD4+ Vav1-/- T cells to the liver compared to the isotype control, as shown in Figure 39,
possibly due to enhanced phagocytosis mediated by Fc receptors. These findings suggest
that Vav1 is importat in transducing CD28-mediated signals regulating memory T cell
migration.
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Figure 35: CD28 cross-linking does not enhance Vav1-/- T cell migration to the
kidney
Viable HY-specific CD4+ WT and Vav1-/- T cells were used between days seven and ten
post-stimulation. 107 WT and Vav1-/- T cells were cross-linked with CD28 or an isotyoe
control (IsC), labelled with PKH26 (red) or CFSE (green) respectively and injected iv in
female C57BL/6 mice. Tissue infiltration was examined 24 hours later (x10
magnification) (a). The number of cells in each section was quantified using the
algorithm in the appendix (b). Error bars indicate standard error. Statistical analysis
was performed using Student’s t-test (*p<0.05). Experimental groups consisted of five
female mice.
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Figure 36: CD28 cross-linking does not enhance Vav1-/- T cell migration to the lung
Viable HY-specific CD4+ WT and Vav1-/- T cells were used between days seven and ten
post-stimulation. 107 WT and Vav1-/- T cells were cross-linked with CD28 or an isotype
control (IsC) labelled with PKH26 (red) or CFSE (green) respectively and injected iv in
female C57BL/6 mice. Tissue infiltration was examined 24 hours later (x10
magnification) (a). The number of cells in each section was quantified using the
algorithm in the appendix (b). Error bars indicate standard error. Statistical analysis
was performed using Student’s t-test (*p<0.05). Experimental groups consisted of five
female C57BL/6 mice.
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Figure 37: CD28 cross-linking does not enhance Vav1-/- T cell migration to the
spleen
Viable HY-specific CD4+ WT and Vav1-/- T cells were used between days seven and ten
post-stimulation. 107 WT and Vav1-/- T cells were cross-linkedwith CD28 or an isotype
control (IsC), labelled with PKH26 (red) or CFSE (green) respectively and injected iv in
female C57BL/6 mice. Tissue infiltration was examined 24 hours later (x10
magnification) (a). The number of cells in each section was quantified using the
algorithm in the appendix (b). Error bars indicate standard error. Statistical analysis
was performed using Student’s t-test (*p<0.05). Experimental groups consisted of five
female mice.
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Figure 38: CD28 cross-linking does not enhance trafficking to the peritoneal
membrane of female mice
Viable HY-specific CD4+ WT and Vav1-/- T cells were used between days seven and ten
post-stimulation. WT and Vav1-/- T cells were cross-linked with CD28 or an isotype
control, labelled with PKH26 (red) or CFSE (green) respectively and injected iv in
female C57BL/6 mice that had previously received an ip injection of IFN. Tissue
infiltration of the female peritoneal membrane was examined 24 hours later (x10
magnification). Red arrows indicate CD28-cross-linked T cells while green arrows
indicate the isotype control (a) The number of cells in the female peritoneal membrane
was quantified manually (b) Error bars indicate standard error. Statistical analysis was
performed using Student’s t-test (*p<0.05). Experimental groups consisted of three to
four  mice.
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Figure 39: CD28 cross-linking enhances Vav1-/- T cell migration to the liver
Viable HY-specific CD4+ WT and Vav1-/- T cells were used between days seven and ten
post-stimulation. WT and Vav1-/- T cells were cross-linked with CD28 or an isotype
control (IsC), labelled with PKH26 (red) or CFSE (green) respectively and injected iv in
female C57BL/6 mice. Tissue infiltration was examined 24 hours later (x10
magnification) (a). The number of cells in each section was quantified using the
algorithm in the appendix (b). Error bars indicate standard error. Statistical analysis
was performed using Student’s t-test (*p<0.01). Experimental groups consisted of five
female C57BL/6 mice.
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4.2.4 Role of CD28 signalling in Vav1-/- T cell migration to sites of
inflammation
Previous studies have suggested that CD28 co-stimulatory signals can act in
conjunction with TCR-dependent T cell migration to antigenic sites. More specifically, in
the peritoneal recruitment model, cross-linking of HY-specific WT T cells with CD28
antibody resulted in induction of recruitment and retention to the peritoneal membrane of
male mice that had previously received an ip injection of IFNγ to induce MHC class II
expression and localised antigen presentation (Mirenda et al., 2006).
To examine whether Vav1 activity is required for the induction of TCR-dependent,
CD28-mediated T cell migration, 107 HY-specific CD4+ WT and Vav1-/- T cells were
treated with a mixture of hamster anti-mouse CD28 (5µg/5x106 cells), and rabbit anti-
hamster Ig (2.5µg/5x106 cells) to induce CD28 signalling and labelled with PKH26, or
hamster Ig (5 µg/5x106 cells) and rabbit anti-hamster Ig (2.5 µg/5x106 cells) as an isotype
control and labeled with CFSE. T cells were subsequently co-injected iv in male
C57BL/6 mice that had previously received an ip injection of IFNγ to induce MHC class
II expression and localised antigen presentation. Infiltration and retention to the
peritoneal membrane was analysed by wide-field fluorescence microscopy, while
recruitment to the peritoneal cavity was analysed by flow cytometry and FlowJo
software.
Figure 40 a,b shows the infiltration of the male peritoneal membrane by HY-
specific CD4+ WT and Vav1-/- T cells. As expected, induction of CD28 signalling by
antibody cross-linking resulted in enhanced migration and retention of HY-specific CD4+
WT T cells to the peritoneal membrane, suggesting a co-operative role for CD28 and
TCR signalling in the regulation of migration. In contrast, CD28 cross-linking of HY-
specific CD4+ Vav1-/- T cells did not induce migration to the male peritoneal membrane,
indicating that Vav1 activity is required for TCR-dependent, CD28-mediated regulation
of T cell migration.
To examine this further, enrichment of T cells in the peritoneal lavage was also
analysed. As shown in Figure 40 c,d, CD28 cross-linking of HY-specific CD4+ WT T
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cells resulted in increased recruitment to the peritoneal cavity, compared to the isotype
control. However, induction of CD28 signalling did not enhance the recruitment of HY-
specific CD4+ Vav1-/- T cells to the peritoneal cavity, once again confirming that Vav1
activity is not only necessary for the transduction of migratory stop signal but also for
CD28-mediated recruitment to antigenic sites.
Figure 40: CD28 cross-linking does not enhance non-lymphoid antigenic tissue
infiltration by Vav1-/- T cells
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Viable HY-specific CD4+ WT and Vav1-/- T cells were used between days seven and ten post
stimulation. WT and Vav1-/- T cells were cross-linked with CD28 or an isotype control,
labelled with PKH26 (red) or CFSE (green) respectively and injected iv in C57BL/6 mice that
had previously received an ip injection of IFNγ to induce MHC class II expression and
localised antigen presentation. Retention to the peritoneal membrane was examined 24 hours
later (x10 magnification). Red arrows indicate CD28-cross-linked T cells while green arrows
indicate the isotype control (a) The number of cells in the peritoneal membrane was quantified
manually (b). Recruitment of T cells to the peritoneal cavity was examined by flow cytometry
using FlowJo software (c). Average percentage of CD4+ labelled T cells in the peritoneal
lavage (d).  Error bars indicate standard error. Statistical analysis was performed using
Student’s t-test (*p<0.05). Experimental groups consisted of at least three mice.
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5.3. Discussion
Previous studies had demonstrated a role for CD28 in T cell migration, with
enhanced CD28 signalling or blockade of negative co-stimulatory CTLA-4 signals
resulting in enhanced and aberrant tissue infiltration (Chang et al., 1999); Walker et al.,
1999; Girvin et al., 2000; Mirenda et al, 2006; reviewed in David and Marelli-Berg,
2007). Vav1 can be activated directly by CD28 in the absence of TCR triggering, which
makes it an interesting candidate for the transduction of the CD28 migratory signals
(reviewed in Michel and Acuto, 2002).
To assess the potential role for Vav1 in CD28-mediated regulation of T cell
migration, CD28 signalling was induced in the HY-specific CD4+ Vav1-/- T cells by
antibody cross-linking as previously described in Mirenda et al. (2006). In the in vitro
transwell-based migration assays, we observed that CD28 cross-linking did not enhance
HY-specific CD4+ Vav1-/- T cell migration through male or female endothelial
monolayer suggesting that Vav1 is probably utilised by CD28 to enhance TCR signals
driving T cell migration.
In the in vitro assays, induction of CD28 signalling did not enhance HY-specific
CD4+ WT T cell migration through the non-antigenic female monolayer which suggests
that TCR triggering is also required in this context. This is not in agreement with findings
by Mirenda et al. (2006), who observed enhanced migration upon CD28 signalling in the
absence of TCR triggering in vitro. It is possible that this is due to different experimental
systems, as this study used human blasts cross-linked with a human CD28 antibody
which may have induced a stronger signal than the mouse one used in this study.
However, when confirming the physiological relevance of our findings in vivo, we
observed that CD28 cross-linking enhances WT T cell trafficking in female mice. As
expected, and in agreement with previous findings by Mirenda et al. (2006), HY-specific
CD4+ WT T cells showed enhanced infiltration of all the tissues examined, including
kidney, heart, liver, lung and the peritoneal membrane of female mice. This effect was
not observed with the HY-specific CD4+ Vav1-/- T cells, where no significant difference
in infiltration of CD28 and isotype cross-linked T cells was observed. Interestingly, we
did observe enhanced infiltration of the liver when CD28 signalling was induced in HY-
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specific CD4+ Vav1-/- T cells. The liver is enriched with macrophages and Kupffer cells
bearing Fc receptors which are used for the phagocytosis of immune system complexes,
resulting in their clearance (reviewed in Janeway et al., 2001). It is therefore possible that
CD28 cross-linked HY-specific CD4+ Vav1-/- T cells were endocyted by these cells to
levels higher than the HY-specific CD4+ Vav1-/- T cells cross-linked with isotype
control.
The involvement of CD28 signalling in TCR-dependent T cell recruitment and
retention to antigenic sites was further investigated in vivo. Mirenda et al. (2006) had
previously shown that CD28 cross-linking resulted in recruitment and retention to the
peritoneal membrane of male mice that had previously received an ip injection of IFNγ to
induce MHC class II expression and localised antigen presentation. This suggested that
CD28 signalling can act co-operatively with TCR triggering to enhance T cell migration.
Indeed we observed enhanced recruitment and retention of HY-specific CD4+ WT T cells
to the peritoneal membrane and cavity of male mice, which confirms previous findings.
However, induction of CD28 signalling by antibody triggering in Vav1-/- T cells did not
result in enhanced retention to the peritoneal membrane or increased recruitment to the
peritoneal cavity. This confirms that Vav1 is utilised by both TCR and CD28 for the
transduction of the migratory stop signal which is required for T cell retention to
antigenic sites.
Our findings suggest that Vav1 plays a pivotal role in transducing CD28 migratory
signals, even in the absence of TCR triggering. Recruitment to sites of antigen
presentation is dependent on antigen presentation by ECs which in mice express little or
no levels of B7 molecules (CD80/CD86), the ligands to CD28. However, retention is
dependent on antigen presentation by resident APCs which are B7 positive, suggesting
that CD28 signalling may be crucial for the retention of antigen-specific T cells.  As HY-
specific CD4+ Vav1-/- T cells showed defective retention to the peritoneal membrane, an
effect not compensated for by the induction of CD28 signalling, as well as reduced
responsiveness to the migratory stop signal, we can conclude that Vav1 is utilized by both
the TCR and CD28 for the transduction of migratory signals.
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Discussion
1. Summary of findings
The GEF Vav1 has previously been shown to be an important link between TCR
signalling and the regulation of cytoskeletal re-arrangements. Vav1 is activated upon
TCR trigerring through tyrosine phosphorylation, and acts as a GEF for the RhoGTPase
Rac1, the latter being an important regulator of actin polymerisation (reviewed in
Tybulewicz, 2005). In addition, Vav1 interacts with WASp to mediate cytoskeletal re-
arrangements (reviewed in Secchi and Wehland, 2004), is required for the formation of
the immunological synapse (Fischer et al., 1998; Wulfing et al.,2000; Villaba et al 2001;
Krawczyk et al., 2002; Ardouin et al., 2003) and has been shown to influence motility in
various cell types including T cells (Ticchioni et al., 2002) (Kim et al., 2003; Korn et al.,
2003) (Gakidis et al., 2004; Garcia-Bernal et al., 2005) (Vicente-Manzanares et al., 2005)
(Vedham et al., 2005) (Wells et al., 2005) (Bartolome et al., 2006) (Wilsbacher et al.,
2006). These findings, in conjunction with preliminary data showing loss of
responsiveness to TCR-mediated regulation of motility in Vav1-/- splenocytes, led us to
hypothesise that loss of Vav1 will result in impaired recruitment and retention to sites of
antigen presentation.
Our first aim was to establish a physiological role for Vav1 in memory T cell
trafficking in vitro and in vivo. Using HY-specific CD4+ effector memory T cells, we
observed that loss of Vav1 activity impairs baseline T cell migration in vitro, as well as
ICAM-1 and chemokine-driven migration in vitro.  This was in agreement with previous
studies that have observed reduced CXCL12-mediated chemotaxis in Vav1-/- T cells in
vitro (Ticchioni et al., 2002; Vicente-Manzanares et al., 2005 ; Garcia-Bernal et al.,
2005), suggesting that in vitro, Vav1 activity is required for T cell motility.
Interestingly, the in vitro findings did not translate to a defect in vivo. HY-specific
WT and Vav1-/- T cells showed comparable levels of constitutive trafficking at two of
the three time-points tested and comparable recruitment to sites of non-specific
inflammation. As we observed increased speed by Vav1-/- T cells in vitro, we
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hypothesised that this may have partially compensated for the loss of Vav1 activity.
Examination of Vav1-/- T cell speed in vivo through real-time imaging would provide an
answer to this question. Another possibility is that shear flow may have compensated for
the loss of Vav1 activity in vivo, which could be further examined by the use of in vitro
flow chambers.
Based on these findings, we can conclude that although Vav1 activity is required
for T cell migration in vitro, loss of Vav1 is compensated for in vivo by other factors,
possibly Vav1-/- T cell enhanced speed or the presence of shear flow.
We then proceeded to examine the requirement for Vav1 activity in TCR-
dependent T cell migration. We observed that in the absence of Vav1 activity, T cells lost
susceptibility to antigen-dependent migration, as HY-specific CD4+ Vav1-/- T cells did
not show enhanced migration through the antigenic male monolayer compared to the
female one in in vitro transwell-based and time-lapse migration assays.
Nevertheless, our in vitro findings once again were not reflected in vivo. T cells
showed normal recruitment to antigenic sites in the absence of Vav1, suggesting that
Vav1 is dispensable for this process. We hypothesised that this may have been due to a
compensatory effect by shear flow, and investigated this further using the peritoneal
tissue infiltration model which examines T cell migration under static conditions. In the
absence of flow, HY-specific CD4+ Vav1-/- T cells showed reduced infiltration of the
antigenic tissue, the peritoneal membrane, suggesting that flow is essential for TCR-
dependent migration of T cells in the absence of Vav1 activity.
Thus far, we have observed a requirement for Vav1 activity for T cell retention to
antigenic tissue. The latter is regulated by antigen presentation by resident APCs, which
results in temporary loss of migratory ability, allowing the T cell to polarise and
proliferate (Dustin et al., 1997). In this part of the study, we decided to examine whether
Vav1 is required for the transduction of the migratory stop signal.
As loss of migratory ability is regulated by engagement of the TCR by resident
APCs, we commenced this investigation by examining conjugate formation in the
absence of Vav1. Furthering previous findings by Ardouin et al. (2003) and Krawczyk et
al. (2002), we observed reduced conjugate formation in memory Vav1-/- T cells
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compared to WT controls. This was further examined in vivo in the spleen and the
antigenic tissue, the peritoneal membrane, and confirmed the in vitro findings.
We hypothesised that reduced ability to form conjugates may result in reduced
susceptibility to the migratory stop signal. We observed that in vitro, antibody triggering
of the TCR and CD28 did not result to loss of migratory ability in the absence of Vav1 in
T cells. We further extended this finding in vivo, whereby the presence of peptide-loaded
DCs did not result in enhanced retention to the antigenic tissue, the peritoneal membrane.
We can therefore conclude that Vav1 activity is necessary for conjugate formation and
the transduction of migratory stop signals both in vitro and in vivo.
Although HY-specific CD4+ Vav1-/- T cells showed normal recruitment to sites of
antigen presentation, they displayed reduced retention to the antigenic tissue. Recruitment
to antigenic sites is thought to be regulated by antigen presentation by ECs lining post-
capillary venules, which are B7 (CD80/CD86) negative and thus do not activate the co-
stimulatory molecule CD28. In contrast, retention to antigenic sites is mediated by
antigen presentation by resident APCs which may activate CD28 signalling pathways as
they are B7 positive (reviewed in Marelli-Berg and Jarmin, 2004). As Vav1 is thought be
to be utilised by CD28 for the transduction of signals independently of the TCR
(reviewed in Michel and Acuto, 2002) we examined the possibility that reduced retention
was due to the absence of co-stimulatory signal transduction.
To investigate the requirement of CD28 signalling via Vav1 in T cell migration we
first employed in vitro transwell-based migration assays. In the absence of Vav1 activity,
CD28 triggering did not enhance T cell migration through non-antigenic female
endothelial monolayer, suggesting that Vav1 is required for the transduction of TCR-
independent CD28 migratory signals in vitro. In addition, Vav1 activity was found to be
necessary for both TCR-dependent and independent CD28 migratory signals in T cells in
vivo, as in the absence of Vav1, T cells did not show enhanced trafficking in female mice
or enhanced recruitment and retention to the peritoneal lavage and membrane in male
mice. These findings suggest that Vav1 is utilised by both the TCR and CD28 to
transduce migratory signals.
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2. Regulation of the migratory stop signal by CD28 and CTLA-4
The co-stimulatory molecules CD28 and CTLA-4 have both been shown to affect T
cell motility, as discussed in the previous chapters. We have previously speculated that
CD28 and CTLA-4 do not simply act as positive and negative regulators of migration, as
they do with activation. More specifically, CD28 engagement has been shown to be
required for entry of T cells to non-lymphoid antigenic tissue following priming. CTLA-4
on the other hand seems to prevent slowing down of activated T cells when they come in
contact with antigen, thereby preventing recruitment and entry to antigenic sites
(reviewed in David and Marelli-Berg, 2007).
The mechanism by which they can differentially affect T cell motility is at present
unclear. Although both have been shown to increase adhesion, CD28 and CTLA-4 may
differentially regulate cell orientation and de-adhesion, which may explain their
differential effects on T cell motility. CD28 is known to directly affect the cytoskeleton
by activating Vav1 in the absence of a TCR signal (Michel et al, 2000), thus activating
the Rho GTPase Cdc42 and WASp. As CTLA-4 is thought to prevent the transduction of
the migratory stop signal (Schneider et al., 2006), it may regulate motility by mediating a
de-adhesion process, possibly by activating one of the three Rho proteins which have
been shown to promote detachment by acting at the rear of the cell (reviewed in Wheeler
and Ridley, 2004).
Recent findings by Wei et al. (2007) have proposed a role for Vav1 in CTLA-4-
mediated regulation of T cell motility. In this study, transduction of CTLA-4-expressing
hybridomas with Vav1 mutants resulted in the conclusion that CTLA-4 utilises Vav1 to
induce T cell polarization.
Despite the rather artificial nature of this study, it is interesting to suggest that
perhaps both CTLA-4 and CD28 mediate migratory signals via Vav1. CD28 activates
Vav1 upon TCR triggering as well as in the absence of a TCR signal (Michel et al.,
2000), mediating T cell retention to antigenic sites, T cell infiltration to peripheral tissues
and the migratory stop signal, while CTLA-4 may utilize Vav1 in the absence of a strong
enough TCR stimulus mediating de-adhesion and preventing unnecessary encounters
with APCs.
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3. Differential regulation of T cell motility by Vav1 and PI3kinase
Vav1 activation through tyrosine phosphorylation and its association with adaptor
molecules such as Slp76 and Grb-2 results in the activation of downstream signalling
cascades. One of the pathways thought to be triggered by this interaction is the PI3k
pathway (reviewed in Tybulewicz, 2005).
PI3kinases are a family of heterodimeric lipid kinases divided into three classes
(IA, II, III) that are involved in signalling in a variety of cell types and are thought to
regulate various cell functions, including motility (Leevers et al., 1999). Class IA
PI3kinases have been extensively implicated in immune cell signalling, and of the
different isoforms, p110δ is thought to be the most important in regulating immune cell
function (Okkenhaug et al., 2006).
The interaction between Vav1 and PI3kinase p110δ  is at present unclear. Vav1 is
thought to activate the RhoGTPases Rac1 which in turn is thought to activate PI3kinase,
(reviewed in Tybulewicz et al., 2003). Interestingly, there has been evidence that Vav1
can also act downstream of PI3kinase, as PI3 kinase inhibition can lead to reduced Vav1
phosphorylation. Thus, it has been suggested that PI3kinase and Vav1 may act in a
positive feedback loop (Reynolds et al., 2002; reviewed in Tybulewicz et al., 2003).
A recent study in our laboratory has investigated the role of the PI3kinase p110δ
subunit in TCR-dependent T cell migration (accepted for publication in the Journal of
Clinical Investigation). We observed that loss of p110δ  through mutation or
pharmacological inhibition resulted in impaired recruitment and retention to sites of
antigen presentation. In addition, HY-specific p110δ-/- T cells did not infiltrate the
peritoneal membrane of male mice in the absence of flow and showed reduced infiltration
of the male skin graft compared to the WT control, suggesting an essential role for
PI3kinase p110δ in TCR-dependent T cell migration.
The requirement for PI3kinase in CD28 –mediated migration was also examined
through the use of a T cell clone with a mutation on the cytoplasmic tail of CD28 which
abrogates the interaction with PI3kinase (Y170F). Using the antigen-dependent peritoneal
recruitment model, we observed that mutation of the cytoplasmic tail of CD28 resulted in
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moderate impairment of T cell recruitment to the peritoneal cavity, whereas p110δ
PI3kinase deficient T cells were virtually undetectable in the peritoneal lavage or
membrane.
Contrary to these results, the present study has observed that loss of Vav1 activity
only affects retention to non-lymphoid antigenic sites. This suggests that Vav1 and
PI3kinase have differential effects in TCR-dependent T cell motility.  However, evidence
from these studies suggests that both Vav1 and PI3kinase can be utilised by CD28 to
mediate retention of primed T cells to non-lymphoid antigenic sites.
Although the interaction between PI3kinase and Vav1 is at present unclear, from
our findings, we can hypothesise that p110δ PI3kinase and Vav1 act in parallel pathways
in the regulation of T cell migration; p110δ PI3kinase primarily transduces TCR-
mediated signals for the regulation of T cell migration while Vav1 is utilised by CD28,
mediating T cell retention to antigenic sites and the migratory stop signal.
 PI3kinase can in fact regulate T cell migration independently of Vav1; Rac1 has
been shown to be activated by the PI3kinase signalling product PIP3 which has a PH
domain that can bind to other Dbl-homology GEFs (reviewed in Barber and Welch,
2007). It is therefore possible that the TCR-dependent signals regulating T cell
recruitment utilise this pathway of activation of Rac1.
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Figure 41: Proposed model of the regulation of T cell migration
TCR signalling (indicated by purple arrows) utilises PI3kinase to mediate T cell
recruitment to sites of antigen presentation, while CD28 (indicated by red arrows)
mediates T cell retention to antigenic tissue via Vav1. Vav1 also transduces the migratory
stop signal mediated by triggering of the TCR and CD28.
To examine this further, we would have to inhibit p110δ PI3kinase in Vav1-/- T
cells using a pharmacological inhibitor, which would provide information on whether
these pathways act independently of each other in the context of T cell migration. One
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would hypothesise that pharmacological inhibition of p110δ PI3kinase in Vav1-/- T cells
would result in a more severe phenotype than loss of either molecule separately.
4. Clinical implications of this study
We have proposed a model whereby Vav1 is required for the retention of T cells to
antigenic sites as well as for the transduction of the migratory stop signal upon strong
activation of the TCR. It therefore is an interesting candidate for pharmacological
inhibition for the prevention of T cell retention into antigenic sites.
Indeed, we observed that loss of Vav1 resulted in reduced antigenic graft
infiltration in female mice grafted with male tail-derived skin. In addition, Weckbecker et
al. (2007) observed enhanced heart allograft survival in Vav1-/- mice, suggesting that
loss of Vav1 activity may be promising way of inducing transplant tolerance.
A potential inhibitor of Vav1 activity is the azathioprine metabolite 6-thio-GTP.
More specifically, a study by Tiede et al. (2003) reported that administration of 6-thio-
GTP in human CD4+ T cells blocked the binding of GTP to Rac1, resulting in increased
levels of Vav1. The same group subsequently described that this effect was Rac1 specific,
as it did not affect other RhoGTPases, and resulted in blockade of ERM protein
inactivation. This effect was due to specific inhibition of the Vav1/Rac1 interaction upon
CD28 signalling, which resulted in reduced lamellipodia formation and inhibition of the
T cell:APC conjugate formation (Poppe et al., 2006).
More recently, 6-thio-GTP was used to induce heart allograft tolerance in mice.
Daily administration of 6-thio-GTP in mice transplanted with Balb/c hearts resulted in
significant increase in allograft survival compared to the PBS control. In addition, they
observed reduced leukocyte infiltration in the heart allograft and reduced ex vivo
proliferative responses to alloantigen in splenocytes from mice treated with 6-thio-GTP.
Therefore, inhibition of the Vav1/Rac1 interaction may have beneficial effects in
prolonging transplant survival (Wang et al., 2007).
Other than graft survival, inhibition of Vav1 activity may also be advantageous in
the treatment of autoimmune and inflammatory diseases such as rheumatoid arthritis. We
have observed that Vav1-/- T cells show reduced migration compared to the WT controls
Regulation of T cell migration by the guanidine exchange factor Vav1
Rachel David
190
in vitro. In addition, although Vav1-/- T cells showed normal recruitment to antigenic
sites, they were not retained, and were not susceptible to the migratory stop signal
mediated by strong TCR engagement, suggesting that inhibition of this molecule would
potentially prevent damage caused by the accumulation of T cells.
In addition to the potential uses of 6-thio-GTP as a Vav1 inhibitor, a patent has
been filed for the development of Vav1 inhibitors for graft survival. This patent details
potential inhibitors of Vav1 which may interfere with Vav1 phosphorylation by binding
to the SH2 domain or by mimicking Vav1 phosphorylation through binding of Tyr174, or
may interfere with Vav1 binding of Grb2 by binding its SH3 domain (United States
Patent 20070042948). This patent also details the potential uses of Vav1 inhibitors, which
include prolonging graft survival alone or in conjunction with other treatments such as
cyclosporine, as well as treatment of autoimmune diseases and lymphoproliferative
disorders, such as lupus and leukaemia.
5. Conclusion
This study aimed to establish a physiological role for the GEF Vav1 in T cell
trafficking, T cell recruitment and retention to antigenic sites as well T cell susceptibility
to the migratory stop signal. Based on our findings, we have concluded that although
Vav1 is necessary for T cell migration and antigen-dependent T cell recruitment in vitro,
other factors have compensated for the loss of Vav1 in vivo, possibly shear flow. In
addition, Vav1 is required for the retention of T cells to antigenic tissue in vivo,
potentially suggesting its importance in CD28-mediated control of migration. Finally,
Vav1 is a mediator of the migratory stop signal in T cells, which occurs upon engagement
of the TCR and co-stimulatory molecules by antigenic tissue resident APCs. We therefore
propose a model, whereby Vav1 may primarily be utilised by CD28 for the transduction
of migratory signals in T cells. These findings provide useful information for the
development of pharmacological inhibitors for Vav1, which could potentially be used for
prolonging transplant survival as well as treatment of autoimmune and inflammatory
disorders.
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Appendix . Automatic cell counting algorithm
The automatic cell counting algorithm is an intensity profile based approach for
the calculation of single and double fluorescence labelled cell population. As
illustrated in fig 1, cells in an image can be represented as groups of spatially
clustered glowing pixels with certain intensity distribution. Assuming each cell has a
single-peak fluorescence profile, the brightest pixel in each cell may be used as a
countable feature of cell population.
The approach consists of three major steps, including image pre-processing,
region masking and cell counting. Image pre-processing uses auto-level technique to
eliminate uniform background and normalize the intensity scale of the image. Region
masking is used to define the counting area. In a dual-colour (fluorophore)
application, one colour is usually used for non-specifically cell labelling; while the
other colour labels the positive areas with its fluorescence profile defining cell
clusters. We use the positive indicator to mask the counting area in the non-
specifically labelled channel, and count cells within the unmasked area by their
maximum pixels. To find the maximum pixel in a cell, the pixel values of a counting
area are segmented into a number of fluorescence levels (fig.1a), through which
locations of the brightest spots are searched reiteratively. In details, all intensity pixels
above a certain threshold are classified into groups according to their spatial
distribution, from which the maximum pixel of each group is located. Repeating the
search level by level, all cell profiles will be examined, and all maximums will be
included. The number and location of the maximum pixels should be exactly the same
between two adjacent loops, unless lowering threshold includes new cells (fig 1b, and
1d). Finally, cell counts from each level are combined, and a filter is applied to
remove all repeatedly counted maximum pixels. The number of maximums left
represents the number of cells.
The algorithm is robust to uneven cell expression level, and poor contrast tissue
images with non-uniform background. It is not sensitive to the variation of cell size
and shape, neither critical to extend of cell overlapping. The algorithm can identify
and ignore holes in a cell, and eliminate small artefacts and noise influences, making
the counting more accurate. However, it is less capable to identify a cell with multi-
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peak profile, although adjusting the number of thresholding levels will reduce the rate
of miscount.
(a) (b)
(c) (d)
Fig 1. Schematic of cell counting algorithm, (a) no cell is above Level 1, (b) Cell 1 is above Level 2
from which its peak at Posmax1(x,y) can be detected, (c) Cell 1 is above Level 3 with the calculated peak
at the same position as (b), and (d) Cell 1 and Cell 2 are above Level n, and a 2nd peak at Posmax2(x,y) is
detected.
An example of image pre-processing, region masking and cell counting is illustrated
in panels e-g.
e)                                     f)                                   g)
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